Last updated: 2024-05-03
Checks: 7 0
Knit directory: ATAC_learning/
This reproducible R Markdown analysis was created with workflowr (version 1.7.1). The Checks tab describes the reproducibility checks that were applied when the results were created. The Past versions tab lists the development history.
Great! Since the R Markdown file has been committed to the Git repository, you know the exact version of the code that produced these results.
Great job! The global environment was empty. Objects defined in the global environment can affect the analysis in your R Markdown file in unknown ways. For reproduciblity it’s best to always run the code in an empty environment.
The command set.seed(20231016)
was run prior to running
the code in the R Markdown file. Setting a seed ensures that any results
that rely on randomness, e.g. subsampling or permutations, are
reproducible.
Great job! Recording the operating system, R version, and package versions is critical for reproducibility.
Nice! There were no cached chunks for this analysis, so you can be confident that you successfully produced the results during this run.
Great job! Using relative paths to the files within your workflowr project makes it easier to run your code on other machines.
Great! You are using Git for version control. Tracking code development and connecting the code version to the results is critical for reproducibility.
The results in this page were generated with repository version f57f2ee. See the Past versions tab to see a history of the changes made to the R Markdown and HTML files.
Note that you need to be careful to ensure that all relevant files for
the analysis have been committed to Git prior to generating the results
(you can use wflow_publish
or
wflow_git_commit
). workflowr only checks the R Markdown
file, but you know if there are other scripts or data files that it
depends on. Below is the status of the Git repository when the results
were generated:
Ignored files:
Ignored: .RData
Ignored: .Rhistory
Ignored: .Rproj.user/
Ignored: data/All_merged_peaks.tsv
Ignored: data/CAD_gwas_dataframe.RDS
Ignored: data/DEG_toplist_sep_n45.RDS
Ignored: data/FRiP_first_run.txt
Ignored: data/Frip_1_reads.csv
Ignored: data/Frip_2_reads.csv
Ignored: data/Frip_3_reads.csv
Ignored: data/Frip_4_reads.csv
Ignored: data/Frip_5_reads.csv
Ignored: data/Frip_6_reads.csv
Ignored: data/GO_KEGG_analysis/
Ignored: data/Ind1_75DA24h_dedup_peaks.csv
Ignored: data/Ind1_TSS_peaks.RDS
Ignored: data/Ind1_firstfragment_files.txt
Ignored: data/Ind1_fragment_files.txt
Ignored: data/Ind1_peaks_list.RDS
Ignored: data/Ind1_summary.txt
Ignored: data/Ind2_TSS_peaks.RDS
Ignored: data/Ind2_fragment_files.txt
Ignored: data/Ind2_peaks_list.RDS
Ignored: data/Ind2_summary.txt
Ignored: data/Ind3_TSS_peaks.RDS
Ignored: data/Ind3_fragment_files.txt
Ignored: data/Ind3_peaks_list.RDS
Ignored: data/Ind3_summary.txt
Ignored: data/Ind4_79B24h_dedup_peaks.csv
Ignored: data/Ind4_TSS_peaks.RDS
Ignored: data/Ind4_V24h_fraglength.txt
Ignored: data/Ind4_fragment_files.txt
Ignored: data/Ind4_fragment_filesN.txt
Ignored: data/Ind4_peaks_list.RDS
Ignored: data/Ind4_summary.txt
Ignored: data/Ind5_TSS_peaks.RDS
Ignored: data/Ind5_fragment_files.txt
Ignored: data/Ind5_fragment_filesN.txt
Ignored: data/Ind5_peaks_list.RDS
Ignored: data/Ind5_summary.txt
Ignored: data/Ind6_TSS_peaks.RDS
Ignored: data/Ind6_fragment_files.txt
Ignored: data/Ind6_peaks_list.RDS
Ignored: data/Ind6_summary.txt
Ignored: data/Knowles_4.RDS
Ignored: data/Knowles_5.RDS
Ignored: data/Knowles_6.RDS
Ignored: data/MI_gwas.RDS
Ignored: data/SNP_supp_schneider.RDS
Ignored: data/all_TSSE_scores.RDS
Ignored: data/aln_run1_results.txt
Ignored: data/anno_ind1_DA24h.RDS
Ignored: data/anno_ind4_V24h.RDS
Ignored: data/background_n45_he_peaks.RDS
Ignored: data/cardiac_muscle_FRIP.csv
Ignored: data/cardiomyocyte_FRIP.csv
Ignored: data/cormotif_full_4_run.RDS
Ignored: data/cormotif_full_4_run_he.RDS
Ignored: data/cormotif_full_6_run.RDS
Ignored: data/cormotif_full_6_run_he.RDS
Ignored: data/cormotif_probability_45_list.csv
Ignored: data/cormotif_probability_45_list_he.csv
Ignored: data/cormotif_probability_all_6_list.csv
Ignored: data/cormotif_probability_all_6_list_he.csv
Ignored: data/embryo_heart_FRIP.csv
Ignored: data/enhancer_list_ENCFF126UHK.bed
Ignored: data/filt_Peaks_efit2.RDS
Ignored: data/filt_Peaks_efit2_bl.RDS
Ignored: data/filt_Peaks_efit2_n45.RDS
Ignored: data/first_Peaksummarycounts.csv
Ignored: data/first_run_frag_counts.txt
Ignored: data/full_bedfiles/
Ignored: data/gene_ref.csv
Ignored: data/gwas_1_dataframe.RDS
Ignored: data/gwas_2_dataframe.RDS
Ignored: data/gwas_3_dataframe.RDS
Ignored: data/gwas_4_dataframe.RDS
Ignored: data/gwas_5_dataframe.RDS
Ignored: data/high_conf_peak_counts.csv
Ignored: data/high_conf_peak_counts.txt
Ignored: data/high_conf_peaks_bl_counts.txt
Ignored: data/high_conf_peaks_counts.txt
Ignored: data/hits_files/
Ignored: data/ind1_DA24hpeaks.RDS
Ignored: data/ind1_TSSE.RDS
Ignored: data/ind2_TSSE.RDS
Ignored: data/ind3_TSSE.RDS
Ignored: data/ind4_TSSE.RDS
Ignored: data/ind4_V24hpeaks.RDS
Ignored: data/ind5_TSSE.RDS
Ignored: data/ind6_TSSE.RDS
Ignored: data/initial_complete_stats_run1.txt
Ignored: data/left_ventricle_FRIP.csv
Ignored: data/mergedPeads.gff
Ignored: data/mergedPeaks.gff
Ignored: data/motif_list_full
Ignored: data/motif_list_n45
Ignored: data/motif_list_n45.RDS
Ignored: data/multiqc_fastqc_run1.txt
Ignored: data/multiqc_fastqc_run2.txt
Ignored: data/multiqc_genestat_run1.txt
Ignored: data/multiqc_genestat_run2.txt
Ignored: data/my_hc_filt_counts.RDS
Ignored: data/my_hc_filt_counts_n45.RDS
Ignored: data/n45_bedfiles/
Ignored: data/n45_files
Ignored: data/other_papers/
Ignored: data/peakAnnoList_1.RDS
Ignored: data/peakAnnoList_2.RDS
Ignored: data/peakAnnoList_24_full.RDS
Ignored: data/peakAnnoList_24_n45.RDS
Ignored: data/peakAnnoList_3.RDS
Ignored: data/peakAnnoList_3_full.RDS
Ignored: data/peakAnnoList_3_n45.RDS
Ignored: data/peakAnnoList_4.RDS
Ignored: data/peakAnnoList_5.RDS
Ignored: data/peakAnnoList_6.RDS
Ignored: data/peakAnnoList_full_motif.RDS
Ignored: data/peakAnnoList_n45_motif.RDS
Ignored: data/siglist_full.RDS
Ignored: data/siglist_n45.RDS
Ignored: data/testnames.txt
Ignored: data/toplist_6.RDS
Ignored: data/toplist_full.RDS
Ignored: data/toplist_full_DAR_6.RDS
Ignored: data/toplist_n45.RDS
Ignored: data/trimmed_seq_length.csv
Ignored: data/unclassified_full_set_peaks.RDS
Ignored: data/unclassified_n45_set_peaks.RDS
Ignored: data/xstreme/
Ignored: trimmed_Ind1_75DA24h_S7.nodup.splited.bam/
Untracked files:
Untracked: EAR_2_plot.pdf
Untracked: ESR_1_plot.pdf
Untracked: Firstcorr plotATAC.pdf
Untracked: IND1_2_3_6_corrplot.pdf
Untracked: LR_3_plot.pdf
Untracked: NR_1_plot.pdf
Untracked: analysis/Jaspar_motif.Rmd
Untracked: analysis/my_hc_filt_counts.csv
Untracked: code/IGV_snapshot_code.R
Untracked: code/LongDARlist.R
Untracked: code/TSSE.R
Untracked: code/corMotifcustom.R
Untracked: code/just_for_Fun.R
Untracked: code/toplist_assembly.R
Untracked: lcpm_filtered_corplot.pdf
Untracked: log2cpmfragcount.pdf
Untracked: output/cormotif_probability_45_list.csv
Untracked: output/cormotif_probability_all_6_list.csv
Untracked: splited/
Untracked: trimmed_Ind1_75DA24h_S7.nodup.fragment.size.distribution.pdf
Untracked: trimmed_Ind1_75DA3h_S1.nodup.fragment.size.distribution.pdf
Unstaged changes:
Modified: analysis/CorMotif_data_n45.Rmd
Modified: analysis/Enrichment_motif.Rmd
Modified: analysis/Peak_analysis.Rmd
Modified: analysis/Smaller_set_DAR.Rmd
Modified: analysis/index.Rmd
Note that any generated files, e.g. HTML, png, CSS, etc., are not included in this status report because it is ok for generated content to have uncommitted changes.
These are the previous versions of the repository in which changes were
made to the R Markdown (analysis/GO_KEGG_analysis.Rmd
) and
HTML (docs/GO_KEGG_analysis.html
) files. If you’ve
configured a remote Git repository (see ?wflow_git_remote
),
click on the hyperlinks in the table below to view the files as they
were in that past version.
File | Version | Author | Date | Message |
---|---|---|---|---|
Rmd | f57f2ee | reneeisnowhere | 2024-05-03 | first update |
library(tidyverse)
# library(ggsignif)
# library(cowplot)
# library(ggpubr)
# library(sjmisc)
library(kableExtra)
library(broom)
# library(biomaRt)
library(RColorBrewer)
library(gprofiler2)
# library(qvalue)
library(ChIPseeker)
library("TxDb.Hsapiens.UCSC.hg38.knownGene")
library("org.Hs.eg.db")
# library(ATACseqQC)
library(rtracklayer)
library(edgeR)
library(ggfortify)
library(limma)
library(readr)
library(BiocGenerics)
library(gridExtra)
library(VennDiagram)
library(scales)
# library(ggVennDiagram)
# library(Cormotif)
library(BiocParallel)
library(ggpubr)
# library(devtools)
# # install_github('davetang/bedr')
# library(bedr)
library(biomaRt)
peakAnnoList_n45_motif <- readRDS("data/peakAnnoList_n45_motif.RDS")
# list2env(peakAnnoList_n45_motif, envir = .GlobalEnv)
EAR_df <- as.data.frame(peakAnnoList_n45_motif$EAR_n45_gr)
EAR_df_gr <- GRanges(EAR_df)
ESR_df <- as.data.frame(peakAnnoList_n45_motif$ESR_n45_gr)
ESR_df_gr <- GRanges(ESR_df)
LR_df <- as.data.frame(peakAnnoList_n45_motif$LR_n45_gr)
LR_df_gr <- GRanges(LR_df)
NR_df <- as.data.frame(peakAnnoList_n45_motif$NR_n45_gr)
NR_df_gr <- GRanges(NR_df)
exp_neargene_table <- read_delim("data/n45_bedfiles/exp_neargene_table.tsv",
delim = "\t", escape_double = FALSE,
trim_ws = TRUE)
# col_ng_peak <- exp_neargene_table %>%
# group_by(chr, start, end, peakid) %>%
# summarise(NCBI_gene = paste(unique(ENTREZID),collapse=","),
# ensembl_ID= paste(unique(ensembl_id),collapse = ","),
# SYMBOL= paste(unique(SYMBOL),collapse = ",") ,
# dist_to_NG =min(dist_to_NG))
#
EAR_NG_list <- exp_neargene_table %>%
dplyr::filter(peakid %in% EAR_df$id) %>%
dplyr::select(ENTREZID) %>%
distinct()
ESR_NG_list <- exp_neargene_table %>%
dplyr::filter(peakid %in% ESR_df$id) %>%
dplyr::select(ENTREZID) %>%
distinct()
LR_NG_list <- exp_neargene_table %>%
dplyr::filter(peakid %in% LR_df$id) %>%
dplyr::select(ENTREZID) %>%
distinct()
NR_NG_list <- exp_neargene_table %>%
dplyr::filter(peakid %in% NR_df$id) %>%
dplyr::select(ENTREZID) %>%
distinct()
background_df <- exp_neargene_table %>%
dplyr::select(ENTREZID) %>%
distinct()
EAR_resgenes <- readRDS("data/GO_KEGG_analysis/EAR_resgenes.RDS")
ESR_resgenes <- readRDS("data/GO_KEGG_analysis/ESR_resgenes.RDS")
LR_resgenes <- readRDS("data/GO_KEGG_analysis/LR_resgenes.RDS")
NR_resgenes <- readRDS("data/GO_KEGG_analysis/NR_resgenes.RDS")
# EAR_resgenes <- gost(query = EAR_NG_list$ENTREZID,
# organism = "hsapiens",
# significant = FALSE,
# ordered_query = FALSE,
# domain_scope = "custom",
# measure_underrepresentation = FALSE,
# evcodes = FALSE,
# user_threshold = 0.05,
# correction_method = c("fdr"),
# custom_bg = background_df$ENTREZID,
# sources=c("GO:BP","KEGG"))
# saveRDS(EAR_resgenes,"data/GO_KEGG_analysis/EAR_resgenes.RDS")
EARnom <- gostplot(EAR_resgenes, capped = FALSE, interactive = TRUE)
# EARnom
EARnomtable <- EAR_resgenes$result %>%
dplyr::select(c(source, term_id,
term_name,intersection_size,
term_size, p_value))# %>%
EARnomtable %>%
filter(source=="GO:BP", p_value < 0.05) %>%
mutate_at(.vars = 6, .funs = scientific_format()) %>%
kable(.,caption = "GO:BP terms found in EAR neargenes" ) %>%
kable_paper("striped", full_width = FALSE) %>%
kable_styling(
full_width = FALSE,
position = "left",
bootstrap_options = c("striped", "hover")
) %>%
scroll_box(width = "100%", height = "400px")
source | term_id | term_name | intersection_size | term_size | p_value |
---|---|---|---|---|---|
GO:BP | GO:0009653 | anatomical structure morphogenesis | 898 | 1844 | 4.11e-28 |
GO:BP | GO:0032502 | developmental process | 1806 | 4179 | 6.83e-26 |
GO:BP | GO:0048856 | anatomical structure development | 1683 | 3867 | 2.86e-25 |
GO:BP | GO:0007275 | multicellular organism development | 1413 | 3170 | 3.48e-25 |
GO:BP | GO:0032501 | multicellular organismal process | 1918 | 4504 | 2.88e-24 |
GO:BP | GO:0048869 | cellular developmental process | 1262 | 2804 | 8.92e-24 |
GO:BP | GO:0030154 | cell differentiation | 1261 | 2803 | 1.02e-23 |
GO:BP | GO:0050793 | regulation of developmental process | 809 | 1697 | 7.18e-22 |
GO:BP | GO:0048731 | system development | 1211 | 2719 | 1.94e-20 |
GO:BP | GO:0016477 | cell migration | 515 | 1011 | 3.91e-20 |
GO:BP | GO:0051239 | regulation of multicellular organismal process | 890 | 1924 | 1.81e-19 |
GO:BP | GO:0007154 | cell communication | 1686 | 3983 | 1.59e-18 |
GO:BP | GO:0023052 | signaling | 1660 | 3918 | 2.46e-18 |
GO:BP | GO:0048699 | generation of neurons | 535 | 1076 | 3.58e-18 |
GO:BP | GO:0040012 | regulation of locomotion | 380 | 720 | 1.16e-17 |
GO:BP | GO:0030334 | regulation of cell migration | 357 | 668 | 1.16e-17 |
GO:BP | GO:2000145 | regulation of cell motility | 371 | 700 | 1.19e-17 |
GO:BP | GO:0048870 | cell motility | 549 | 1120 | 4.10e-17 |
GO:BP | GO:0009887 | animal organ morphogenesis | 357 | 673 | 4.96e-17 |
GO:BP | GO:0007165 | signal transduction | 1534 | 3611 | 5.22e-17 |
GO:BP | GO:0022008 | neurogenesis | 602 | 1251 | 8.71e-17 |
GO:BP | GO:0040011 | locomotion | 413 | 805 | 1.25e-16 |
GO:BP | GO:0072359 | circulatory system development | 438 | 864 | 1.52e-16 |
GO:BP | GO:0030182 | neuron differentiation | 500 | 1014 | 4.14e-16 |
GO:BP | GO:0048513 | animal organ development | 901 | 2004 | 1.36e-15 |
GO:BP | GO:0050789 | regulation of biological process | 2957 | 7516 | 2.09e-15 |
GO:BP | GO:0009888 | tissue development | 634 | 1348 | 4.41e-15 |
GO:BP | GO:2000026 | regulation of multicellular organismal development | 469 | 951 | 4.83e-15 |
GO:BP | GO:0051094 | positive regulation of developmental process | 452 | 913 | 8.19e-15 |
GO:BP | GO:0050794 | regulation of cellular process | 2823 | 7153 | 8.19e-15 |
GO:BP | GO:0065007 | biological regulation | 3028 | 7734 | 1.41e-14 |
GO:BP | GO:0045595 | regulation of cell differentiation | 517 | 1073 | 2.39e-14 |
GO:BP | GO:0051716 | cellular response to stimulus | 1900 | 4640 | 4.73e-14 |
GO:BP | GO:0048468 | cell development | 845 | 1886 | 4.95e-14 |
GO:BP | GO:0048519 | negative regulation of biological process | 1571 | 3764 | 4.95e-14 |
GO:BP | GO:0007155 | cell adhesion | 460 | 941 | 5.94e-14 |
GO:BP | GO:0007399 | nervous system development | 800 | 1775 | 6.41e-14 |
GO:BP | GO:0009790 | embryo development | 409 | 821 | 6.86e-14 |
GO:BP | GO:0050896 | response to stimulus | 2170 | 5379 | 1.18e-13 |
GO:BP | GO:0048523 | negative regulation of cellular process | 1486 | 3550 | 1.59e-13 |
GO:BP | GO:0035239 | tube morphogenesis | 328 | 638 | 3.14e-13 |
GO:BP | GO:0048518 | positive regulation of biological process | 1766 | 4301 | 3.91e-13 |
GO:BP | GO:0035295 | tube development | 391 | 787 | 5.10e-13 |
GO:BP | GO:0034330 | cell junction organization | 286 | 545 | 7.88e-13 |
GO:BP | GO:0048646 | anatomical structure formation involved in morphogenesis | 411 | 837 | 9.46e-13 |
GO:BP | GO:0007423 | sensory organ development | 215 | 387 | 1.12e-12 |
GO:BP | GO:0048522 | positive regulation of cellular process | 1631 | 3954 | 1.57e-12 |
GO:BP | GO:0010646 | regulation of cell communication | 1054 | 2444 | 1.80e-12 |
GO:BP | GO:0048666 | neuron development | 408 | 838 | 5.95e-12 |
GO:BP | GO:0003008 | system process | 532 | 1139 | 7.86e-12 |
GO:BP | GO:0023051 | regulation of signaling | 1047 | 2438 | 8.93e-12 |
GO:BP | GO:0045597 | positive regulation of cell differentiation | 302 | 591 | 9.93e-12 |
GO:BP | GO:0022603 | regulation of anatomical structure morphogenesis | 309 | 609 | 1.58e-11 |
GO:BP | GO:0031175 | neuron projection development | 366 | 743 | 1.67e-11 |
GO:BP | GO:0035556 | intracellular signal transduction | 854 | 1951 | 2.38e-11 |
GO:BP | GO:0009966 | regulation of signal transduction | 938 | 2166 | 2.52e-11 |
GO:BP | GO:0048598 | embryonic morphogenesis | 226 | 422 | 3.57e-11 |
GO:BP | GO:0141124 | intracellular signaling cassette | 599 | 1314 | 4.36e-11 |
GO:BP | GO:0000902 | cell morphogenesis | 351 | 713 | 5.76e-11 |
GO:BP | GO:0001501 | skeletal system development | 191 | 347 | 9.68e-11 |
GO:BP | GO:0001944 | vasculature development | 280 | 552 | 2.24e-10 |
GO:BP | GO:0051093 | negative regulation of developmental process | 310 | 622 | 2.24e-10 |
GO:BP | GO:0030900 | forebrain development | 155 | 272 | 3.85e-10 |
GO:BP | GO:0001568 | blood vessel development | 267 | 525 | 5.12e-10 |
GO:BP | GO:0031344 | regulation of cell projection organization | 262 | 516 | 1.02e-09 |
GO:BP | GO:0065008 | regulation of biological quality | 820 | 1893 | 1.15e-09 |
GO:BP | GO:0120035 | regulation of plasma membrane bounded cell projection organization | 257 | 505 | 1.15e-09 |
GO:BP | GO:0007166 | cell surface receptor signaling pathway | 784 | 1801 | 1.15e-09 |
GO:BP | GO:0010975 | regulation of neuron projection development | 191 | 355 | 1.34e-09 |
GO:BP | GO:0060429 | epithelium development | 377 | 792 | 2.17e-09 |
GO:BP | GO:0007507 | heart development | 253 | 499 | 2.66e-09 |
GO:BP | GO:0048514 | blood vessel morphogenesis | 231 | 450 | 4.42e-09 |
GO:BP | GO:0007267 | cell-cell signaling | 494 | 1082 | 4.64e-09 |
GO:BP | GO:0007417 | central nervous system development | 334 | 694 | 6.43e-09 |
GO:BP | GO:0048589 | developmental growth | 252 | 501 | 7.88e-09 |
GO:BP | GO:0051128 | regulation of cellular component organization | 802 | 1862 | 7.88e-09 |
GO:BP | GO:0048729 | tissue morphogenesis | 231 | 453 | 9.50e-09 |
GO:BP | GO:0051240 | positive regulation of multicellular organismal process | 475 | 1040 | 1.03e-08 |
GO:BP | GO:0048812 | neuron projection morphogenesis | 242 | 479 | 1.06e-08 |
GO:BP | GO:0030155 | regulation of cell adhesion | 254 | 508 | 1.35e-08 |
GO:BP | GO:0001503 | ossification | 164 | 302 | 1.35e-08 |
GO:BP | GO:0048583 | regulation of response to stimulus | 1130 | 2717 | 1.35e-08 |
GO:BP | GO:0071495 | cellular response to endogenous stimulus | 472 | 1035 | 1.47e-08 |
GO:BP | GO:0034329 | cell junction assembly | 173 | 323 | 1.74e-08 |
GO:BP | GO:0120039 | plasma membrane bounded cell projection morphogenesis | 247 | 494 | 2.33e-08 |
GO:BP | GO:0009967 | positive regulation of signal transduction | 494 | 1093 | 2.57e-08 |
GO:BP | GO:0030030 | cell projection organization | 529 | 1182 | 3.41e-08 |
GO:BP | GO:0048858 | cell projection morphogenesis | 248 | 498 | 3.42e-08 |
GO:BP | GO:0014706 | striated muscle tissue development | 122 | 213 | 3.92e-08 |
GO:BP | GO:0045596 | negative regulation of cell differentiation | 228 | 452 | 4.03e-08 |
GO:BP | GO:0060322 | head development | 265 | 539 | 4.21e-08 |
GO:BP | GO:0070848 | response to growth factor | 268 | 547 | 5.16e-08 |
GO:BP | GO:0048738 | cardiac muscle tissue development | 116 | 201 | 5.44e-08 |
GO:BP | GO:0048667 | cell morphogenesis involved in neuron differentiation | 220 | 435 | 5.88e-08 |
GO:BP | GO:0010647 | positive regulation of cell communication | 541 | 1218 | 7.89e-08 |
GO:BP | GO:0007167 | enzyme-linked receptor protein signaling pathway | 338 | 717 | 8.14e-08 |
GO:BP | GO:0023056 | positive regulation of signaling | 542 | 1221 | 8.33e-08 |
GO:BP | GO:0120036 | plasma membrane bounded cell projection organization | 513 | 1150 | 1.06e-07 |
GO:BP | GO:0071363 | cellular response to growth factor stimulus | 258 | 528 | 1.43e-07 |
GO:BP | GO:0007420 | brain development | 245 | 498 | 1.69e-07 |
GO:BP | GO:0061061 | muscle structure development | 261 | 536 | 1.72e-07 |
GO:BP | GO:0043583 | ear development | 91 | 151 | 1.85e-07 |
GO:BP | GO:0048880 | sensory system development | 144 | 266 | 1.96e-07 |
GO:BP | GO:0032989 | cellular anatomical entity morphogenesis | 282 | 588 | 2.55e-07 |
GO:BP | GO:0090596 | sensory organ morphogenesis | 101 | 173 | 2.72e-07 |
GO:BP | GO:0001525 | angiogenesis | 194 | 381 | 2.81e-07 |
GO:BP | GO:0001654 | eye development | 142 | 263 | 3.07e-07 |
GO:BP | GO:0030336 | negative regulation of cell migration | 118 | 210 | 3.07e-07 |
GO:BP | GO:2000146 | negative regulation of cell motility | 121 | 217 | 3.59e-07 |
GO:BP | GO:0150063 | visual system development | 142 | 264 | 4.21e-07 |
GO:BP | GO:0002062 | chondrocyte differentiation | 59 | 88 | 4.53e-07 |
GO:BP | GO:0001667 | ameboidal-type cell migration | 177 | 344 | 4.89e-07 |
GO:BP | GO:0060284 | regulation of cell development | 273 | 570 | 5.02e-07 |
GO:BP | GO:0051216 | cartilage development | 87 | 145 | 5.09e-07 |
GO:BP | GO:0009719 | response to endogenous stimulus | 527 | 1197 | 5.36e-07 |
GO:BP | GO:0010631 | epithelial cell migration | 132 | 243 | 6.17e-07 |
GO:BP | GO:0090132 | epithelium migration | 132 | 243 | 6.17e-07 |
GO:BP | GO:0098609 | cell-cell adhesion | 270 | 564 | 6.20e-07 |
GO:BP | GO:0040007 | growth | 325 | 697 | 6.25e-07 |
GO:BP | GO:0001764 | neuron migration | 79 | 129 | 6.61e-07 |
GO:BP | GO:0060537 | muscle tissue development | 174 | 339 | 7.73e-07 |
GO:BP | GO:0050808 | synapse organization | 173 | 337 | 8.34e-07 |
GO:BP | GO:0003013 | circulatory system process | 211 | 426 | 9.64e-07 |
GO:BP | GO:0008283 | cell population proliferation | 568 | 1306 | 1.06e-06 |
GO:BP | GO:0042221 | response to chemical | 955 | 2304 | 1.08e-06 |
GO:BP | GO:0040013 | negative regulation of locomotion | 131 | 243 | 1.22e-06 |
GO:BP | GO:0002009 | morphogenesis of an epithelium | 186 | 369 | 1.35e-06 |
GO:BP | GO:0007409 | axonogenesis | 172 | 337 | 1.51e-06 |
GO:BP | GO:1902531 | regulation of intracellular signal transduction | 560 | 1289 | 1.56e-06 |
GO:BP | GO:0048839 | inner ear development | 80 | 133 | 1.56e-06 |
GO:BP | GO:0061564 | axon development | 187 | 372 | 1.56e-06 |
GO:BP | GO:0060021 | roof of mouth development | 48 | 69 | 1.71e-06 |
GO:BP | GO:0051241 | negative regulation of multicellular organismal process | 326 | 706 | 1.89e-06 |
GO:BP | GO:0090130 | tissue migration | 132 | 247 | 2.04e-06 |
GO:BP | GO:0016358 | dendrite development | 103 | 183 | 2.18e-06 |
GO:BP | GO:0010632 | regulation of epithelial cell migration | 105 | 188 | 2.76e-06 |
GO:BP | GO:2000147 | positive regulation of cell motility | 201 | 408 | 3.29e-06 |
GO:BP | GO:0040017 | positive regulation of locomotion | 204 | 416 | 4.07e-06 |
GO:BP | GO:0030335 | positive regulation of cell migration | 195 | 395 | 4.26e-06 |
GO:BP | GO:0030029 | actin filament-based process | 297 | 640 | 4.36e-06 |
GO:BP | GO:0044057 | regulation of system process | 190 | 384 | 5.04e-06 |
GO:BP | GO:0048568 | embryonic organ development | 155 | 303 | 5.70e-06 |
GO:BP | GO:0042127 | regulation of cell population proliferation | 472 | 1077 | 6.07e-06 |
GO:BP | GO:0048732 | gland development | 157 | 308 | 6.25e-06 |
GO:BP | GO:0003007 | heart morphogenesis | 117 | 218 | 8.62e-06 |
GO:BP | GO:0061448 | connective tissue development | 111 | 205 | 9.75e-06 |
GO:BP | GO:0048705 | skeletal system morphogenesis | 85 | 148 | 9.75e-06 |
GO:BP | GO:0007169 | transmembrane receptor protein tyrosine kinase signaling pathway | 219 | 456 | 1.01e-05 |
GO:BP | GO:0016055 | Wnt signaling pathway | 177 | 358 | 1.44e-05 |
GO:BP | GO:0007389 | pattern specification process | 146 | 286 | 1.52e-05 |
GO:BP | GO:0043408 | regulation of MAPK cascade | 206 | 427 | 1.53e-05 |
GO:BP | GO:0070887 | cellular response to chemical stimulus | 732 | 1751 | 1.58e-05 |
GO:BP | GO:0198738 | cell-cell signaling by wnt | 177 | 359 | 1.79e-05 |
GO:BP | GO:0007264 | small GTPase-mediated signal transduction | 190 | 390 | 1.90e-05 |
GO:BP | GO:0060411 | cardiac septum morphogenesis | 45 | 67 | 2.05e-05 |
GO:BP | GO:0010604 | positive regulation of macromolecule metabolic process | 985 | 2415 | 2.05e-05 |
GO:BP | GO:0043010 | camera-type eye development | 121 | 230 | 2.05e-05 |
GO:BP | GO:0007411 | axon guidance | 95 | 172 | 2.13e-05 |
GO:BP | GO:0097485 | neuron projection guidance | 95 | 172 | 2.13e-05 |
GO:BP | GO:0048584 | positive regulation of response to stimulus | 635 | 1504 | 2.24e-05 |
GO:BP | GO:0060560 | developmental growth involved in morphogenesis | 103 | 190 | 2.32e-05 |
GO:BP | GO:0051173 | positive regulation of nitrogen compound metabolic process | 897 | 2186 | 2.42e-05 |
GO:BP | GO:0010033 | response to organic substance | 724 | 1736 | 2.71e-05 |
GO:BP | GO:0021537 | telencephalon development | 105 | 195 | 2.73e-05 |
GO:BP | GO:0030111 | regulation of Wnt signaling pathway | 134 | 261 | 2.87e-05 |
GO:BP | GO:0050807 | regulation of synapse organization | 95 | 173 | 2.92e-05 |
GO:BP | GO:0009952 | anterior/posterior pattern specification | 71 | 121 | 2.99e-05 |
GO:BP | GO:0051146 | striated muscle cell differentiation | 122 | 234 | 3.23e-05 |
GO:BP | GO:0016043 | cellular component organization | 1874 | 4802 | 3.24e-05 |
GO:BP | GO:0050803 | regulation of synapse structure or activity | 96 | 176 | 3.77e-05 |
GO:BP | GO:0001649 | osteoblast differentiation | 95 | 174 | 4.04e-05 |
GO:BP | GO:0009987 | cellular process | 3975 | 10686 | 4.12e-05 |
GO:BP | GO:0042692 | muscle cell differentiation | 160 | 323 | 4.12e-05 |
GO:BP | GO:0050877 | nervous system process | 275 | 600 | 4.21e-05 |
GO:BP | GO:0031589 | cell-substrate adhesion | 132 | 258 | 4.23e-05 |
GO:BP | GO:0048588 | developmental cell growth | 97 | 179 | 4.75e-05 |
GO:BP | GO:0034762 | regulation of transmembrane transport | 149 | 298 | 4.85e-05 |
GO:BP | GO:0008015 | blood circulation | 174 | 357 | 5.05e-05 |
GO:BP | GO:0050890 | cognition | 112 | 213 | 5.11e-05 |
GO:BP | GO:0000165 | MAPK cascade | 235 | 504 | 5.53e-05 |
GO:BP | GO:0045785 | positive regulation of cell adhesion | 150 | 301 | 5.61e-05 |
GO:BP | GO:0035265 | organ growth | 73 | 127 | 5.74e-05 |
GO:BP | GO:0071840 | cellular component organization or biogenesis | 1939 | 4988 | 5.76e-05 |
GO:BP | GO:0099536 | synaptic signaling | 226 | 483 | 6.35e-05 |
GO:BP | GO:0035313 | wound healing, spreading of epidermal cells | 16 | 17 | 6.38e-05 |
GO:BP | GO:0006468 | protein phosphorylation | 417 | 958 | 7.02e-05 |
GO:BP | GO:0009893 | positive regulation of metabolic process | 1057 | 2622 | 7.62e-05 |
GO:BP | GO:0045664 | regulation of neuron differentiation | 74 | 130 | 7.84e-05 |
GO:BP | GO:0045444 | fat cell differentiation | 96 | 179 | 9.34e-05 |
GO:BP | GO:0010648 | negative regulation of cell communication | 446 | 1034 | 9.54e-05 |
GO:BP | GO:0048592 | eye morphogenesis | 63 | 107 | 9.78e-05 |
GO:BP | GO:0051960 | regulation of nervous system development | 165 | 339 | 9.94e-05 |
GO:BP | GO:0048638 | regulation of developmental growth | 124 | 243 | 9.94e-05 |
GO:BP | GO:0051130 | positive regulation of cellular component organization | 373 | 850 | 1.00e-04 |
GO:BP | GO:0008285 | negative regulation of cell population proliferation | 219 | 469 | 1.06e-04 |
GO:BP | GO:0048762 | mesenchymal cell differentiation | 105 | 200 | 1.12e-04 |
GO:BP | GO:0031401 | positive regulation of protein modification process | 252 | 550 | 1.14e-04 |
GO:BP | GO:0045944 | positive regulation of transcription by RNA polymerase II | 382 | 874 | 1.18e-04 |
GO:BP | GO:0071310 | cellular response to organic substance | 548 | 1297 | 1.20e-04 |
GO:BP | GO:0009792 | embryo development ending in birth or egg hatching | 240 | 521 | 1.20e-04 |
GO:BP | GO:0072001 | renal system development | 124 | 244 | 1.25e-04 |
GO:BP | GO:0051056 | regulation of small GTPase mediated signal transduction | 119 | 233 | 1.44e-04 |
GO:BP | GO:0023057 | negative regulation of signaling | 445 | 1036 | 1.58e-04 |
GO:BP | GO:0035051 | cardiocyte differentiation | 74 | 132 | 1.58e-04 |
GO:BP | GO:0030855 | epithelial cell differentiation | 201 | 428 | 1.66e-04 |
GO:BP | GO:0099537 | trans-synaptic signaling | 217 | 467 | 1.71e-04 |
GO:BP | GO:0099177 | regulation of trans-synaptic signaling | 157 | 323 | 1.82e-04 |
GO:BP | GO:0044087 | regulation of cellular component biogenesis | 334 | 757 | 1.87e-04 |
GO:BP | GO:0010720 | positive regulation of cell development | 151 | 309 | 1.89e-04 |
GO:BP | GO:0060412 | ventricular septum morphogenesis | 29 | 40 | 1.92e-04 |
GO:BP | GO:0045637 | regulation of myeloid cell differentiation | 75 | 135 | 2.07e-04 |
GO:BP | GO:0050673 | epithelial cell proliferation | 147 | 300 | 2.07e-04 |
GO:BP | GO:0031346 | positive regulation of cell projection organization | 141 | 286 | 2.13e-04 |
GO:BP | GO:0003002 | regionalization | 129 | 258 | 2.19e-04 |
GO:BP | GO:0055007 | cardiac muscle cell differentiation | 61 | 105 | 2.32e-04 |
GO:BP | GO:0010810 | regulation of cell-substrate adhesion | 87 | 162 | 2.32e-04 |
GO:BP | GO:0050804 | modulation of chemical synaptic transmission | 156 | 322 | 2.36e-04 |
GO:BP | GO:0045165 | cell fate commitment | 82 | 151 | 2.42e-04 |
GO:BP | GO:0060828 | regulation of canonical Wnt signaling pathway | 105 | 203 | 2.45e-04 |
GO:BP | GO:0007369 | gastrulation | 77 | 140 | 2.47e-04 |
GO:BP | GO:0050770 | regulation of axonogenesis | 70 | 125 | 2.83e-04 |
GO:BP | GO:0043009 | chordate embryonic development | 232 | 507 | 2.89e-04 |
GO:BP | GO:0051049 | regulation of transport | 467 | 1098 | 2.89e-04 |
GO:BP | GO:1903706 | regulation of hemopoiesis | 128 | 257 | 2.92e-04 |
GO:BP | GO:0035107 | appendage morphogenesis | 63 | 110 | 2.96e-04 |
GO:BP | GO:0035108 | limb morphogenesis | 63 | 110 | 2.96e-04 |
GO:BP | GO:0050767 | regulation of neurogenesis | 142 | 290 | 2.96e-04 |
GO:BP | GO:0003206 | cardiac chamber morphogenesis | 63 | 110 | 2.96e-04 |
GO:BP | GO:0042592 | homeostatic process | 482 | 1137 | 3.01e-04 |
GO:BP | GO:0022612 | gland morphogenesis | 55 | 93 | 3.04e-04 |
GO:BP | GO:0090287 | regulation of cellular response to growth factor stimulus | 124 | 248 | 3.09e-04 |
GO:BP | GO:0043410 | positive regulation of MAPK cascade | 141 | 288 | 3.14e-04 |
GO:BP | GO:1902533 | positive regulation of intracellular signal transduction | 315 | 714 | 3.22e-04 |
GO:BP | GO:0007610 | behavior | 196 | 420 | 3.22e-04 |
GO:BP | GO:0002063 | chondrocyte development | 19 | 23 | 3.51e-04 |
GO:BP | GO:0008150 | biological_process | 4156 | 11244 | 3.65e-04 |
GO:BP | GO:0016049 | cell growth | 180 | 382 | 3.65e-04 |
GO:BP | GO:0065009 | regulation of molecular function | 544 | 1299 | 3.81e-04 |
GO:BP | GO:0048562 | embryonic organ morphogenesis | 95 | 182 | 3.84e-04 |
GO:BP | GO:0099175 | regulation of postsynapse organization | 49 | 81 | 3.87e-04 |
GO:BP | GO:0030036 | actin cytoskeleton organization | 255 | 566 | 3.90e-04 |
GO:BP | GO:0007611 | learning or memory | 98 | 189 | 3.97e-04 |
GO:BP | GO:0002761 | regulation of myeloid leukocyte differentiation | 48 | 79 | 3.98e-04 |
GO:BP | GO:0045667 | regulation of osteoblast differentiation | 57 | 98 | 4.00e-04 |
GO:BP | GO:0007268 | chemical synaptic transmission | 213 | 463 | 4.07e-04 |
GO:BP | GO:0098916 | anterograde trans-synaptic signaling | 213 | 463 | 4.07e-04 |
GO:BP | GO:0048813 | dendrite morphogenesis | 63 | 111 | 4.09e-04 |
GO:BP | GO:0030097 | hemopoiesis | 278 | 624 | 4.34e-04 |
GO:BP | GO:0003281 | ventricular septum development | 43 | 69 | 4.57e-04 |
GO:BP | GO:0010633 | negative regulation of epithelial cell migration | 34 | 51 | 4.71e-04 |
GO:BP | GO:0031325 | positive regulation of cellular metabolic process | 938 | 2333 | 4.73e-04 |
GO:BP | GO:0060041 | retina development in camera-type eye | 60 | 105 | 4.89e-04 |
GO:BP | GO:0099173 | postsynapse organization | 79 | 147 | 5.18e-04 |
GO:BP | GO:0060173 | limb development | 74 | 136 | 5.42e-04 |
GO:BP | GO:0048736 | appendage development | 74 | 136 | 5.42e-04 |
GO:BP | GO:0051897 | positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction | 69 | 125 | 5.53e-04 |
GO:BP | GO:0021953 | central nervous system neuron differentiation | 57 | 99 | 5.80e-04 |
GO:BP | GO:0001822 | kidney development | 118 | 237 | 5.92e-04 |
GO:BP | GO:0022604 | regulation of cell morphogenesis | 99 | 193 | 6.04e-04 |
GO:BP | GO:2001222 | regulation of neuron migration | 27 | 38 | 6.25e-04 |
GO:BP | GO:0060070 | canonical Wnt signaling pathway | 120 | 242 | 6.32e-04 |
GO:BP | GO:0070372 | regulation of ERK1 and ERK2 cascade | 91 | 175 | 6.56e-04 |
GO:BP | GO:0008360 | regulation of cell shape | 60 | 106 | 7.00e-04 |
GO:BP | GO:0060348 | bone development | 78 | 146 | 7.47e-04 |
GO:BP | GO:0050772 | positive regulation of axonogenesis | 40 | 64 | 7.85e-04 |
GO:BP | GO:0003279 | cardiac septum development | 58 | 102 | 7.85e-04 |
GO:BP | GO:0055017 | cardiac muscle tissue growth | 40 | 64 | 7.85e-04 |
GO:BP | GO:0021543 | pallium development | 73 | 135 | 7.85e-04 |
GO:BP | GO:0035113 | embryonic appendage morphogenesis | 51 | 87 | 7.88e-04 |
GO:BP | GO:0030326 | embryonic limb morphogenesis | 51 | 87 | 7.88e-04 |
GO:BP | GO:0006811 | monoatomic ion transport | 314 | 719 | 7.89e-04 |
GO:BP | GO:0016310 | phosphorylation | 481 | 1145 | 8.12e-04 |
GO:BP | GO:0048645 | animal organ formation | 34 | 52 | 8.12e-04 |
GO:BP | GO:0003205 | cardiac chamber development | 80 | 151 | 8.43e-04 |
GO:BP | GO:0032879 | regulation of localization | 594 | 1439 | 9.38e-04 |
GO:BP | GO:0009968 | negative regulation of signal transduction | 413 | 972 | 9.46e-04 |
GO:BP | GO:0032924 | activin receptor signaling pathway | 24 | 33 | 9.46e-04 |
GO:BP | GO:0042476 | odontogenesis | 47 | 79 | 9.46e-04 |
GO:BP | GO:1901888 | regulation of cell junction assembly | 82 | 156 | 9.60e-04 |
GO:BP | GO:0031399 | regulation of protein modification process | 389 | 911 | 9.67e-04 |
GO:BP | GO:0002521 | leukocyte differentiation | 173 | 371 | 9.70e-04 |
GO:BP | GO:0030198 | extracellular matrix organization | 111 | 223 | 9.80e-04 |
GO:BP | GO:0050678 | regulation of epithelial cell proliferation | 122 | 249 | 1.01e-03 |
GO:BP | GO:0007416 | synapse assembly | 73 | 136 | 1.03e-03 |
GO:BP | GO:0008038 | neuron recognition | 25 | 35 | 1.03e-03 |
GO:BP | GO:0060562 | epithelial tube morphogenesis | 127 | 261 | 1.04e-03 |
GO:BP | GO:0071407 | cellular response to organic cyclic compound | 176 | 379 | 1.08e-03 |
GO:BP | GO:1990138 | neuron projection extension | 72 | 134 | 1.10e-03 |
GO:BP | GO:0070169 | positive regulation of biomineral tissue development | 26 | 37 | 1.11e-03 |
GO:BP | GO:0141091 | transforming growth factor beta receptor superfamily signaling pathway | 126 | 259 | 1.12e-03 |
GO:BP | GO:0048663 | neuron fate commitment | 20 | 26 | 1.15e-03 |
GO:BP | GO:0060485 | mesenchyme development | 120 | 245 | 1.16e-03 |
GO:BP | GO:0045778 | positive regulation of ossification | 27 | 39 | 1.18e-03 |
GO:BP | GO:0034220 | monoatomic ion transmembrane transport | 260 | 587 | 1.18e-03 |
GO:BP | GO:0090100 | positive regulation of transmembrane receptor protein serine/threonine kinase signaling pathway | 50 | 86 | 1.18e-03 |
GO:BP | GO:0043062 | extracellular structure organization | 111 | 224 | 1.19e-03 |
GO:BP | GO:0045229 | external encapsulating structure organization | 111 | 224 | 1.19e-03 |
GO:BP | GO:0022029 | telencephalon cell migration | 28 | 41 | 1.22e-03 |
GO:BP | GO:0051247 | positive regulation of protein metabolic process | 388 | 911 | 1.22e-03 |
GO:BP | GO:0007612 | learning | 61 | 110 | 1.23e-03 |
GO:BP | GO:0021885 | forebrain cell migration | 29 | 43 | 1.26e-03 |
GO:BP | GO:0048660 | regulation of smooth muscle cell proliferation | 55 | 97 | 1.27e-03 |
GO:BP | GO:1903522 | regulation of blood circulation | 98 | 194 | 1.27e-03 |
GO:BP | GO:0045666 | positive regulation of neuron differentiation | 36 | 57 | 1.29e-03 |
GO:BP | GO:0044319 | wound healing, spreading of cells | 21 | 28 | 1.32e-03 |
GO:BP | GO:0090505 | epiboly involved in wound healing | 21 | 28 | 1.32e-03 |
GO:BP | GO:0014070 | response to organic cyclic compound | 267 | 606 | 1.40e-03 |
GO:BP | GO:0043269 | regulation of monoatomic ion transport | 135 | 282 | 1.49e-03 |
GO:BP | GO:0060996 | dendritic spine development | 45 | 76 | 1.49e-03 |
GO:BP | GO:0001823 | mesonephros development | 44 | 74 | 1.57e-03 |
GO:BP | GO:0001508 | action potential | 57 | 102 | 1.58e-03 |
GO:BP | GO:0045995 | regulation of embryonic development | 43 | 72 | 1.63e-03 |
GO:BP | GO:0001657 | ureteric bud development | 43 | 72 | 1.63e-03 |
GO:BP | GO:0030501 | positive regulation of bone mineralization | 23 | 32 | 1.67e-03 |
GO:BP | GO:0072073 | kidney epithelium development | 61 | 111 | 1.67e-03 |
GO:BP | GO:0048593 | camera-type eye morphogenesis | 50 | 87 | 1.67e-03 |
GO:BP | GO:0045893 | positive regulation of DNA-templated transcription | 511 | 1231 | 1.67e-03 |
GO:BP | GO:0045937 | positive regulation of phosphate metabolic process | 209 | 463 | 1.67e-03 |
GO:BP | GO:0010562 | positive regulation of phosphorus metabolic process | 209 | 463 | 1.67e-03 |
GO:BP | GO:1902680 | positive regulation of RNA biosynthetic process | 512 | 1234 | 1.72e-03 |
GO:BP | GO:0030879 | mammary gland development | 55 | 98 | 1.76e-03 |
GO:BP | GO:0010717 | regulation of epithelial to mesenchymal transition | 49 | 85 | 1.76e-03 |
GO:BP | GO:0021795 | cerebral cortex cell migration | 24 | 34 | 1.81e-03 |
GO:BP | GO:0031345 | negative regulation of cell projection organization | 76 | 145 | 1.84e-03 |
GO:BP | GO:0086003 | cardiac muscle cell contraction | 39 | 64 | 1.87e-03 |
GO:BP | GO:0045216 | cell-cell junction organization | 79 | 152 | 1.92e-03 |
GO:BP | GO:0033002 | muscle cell proliferation | 79 | 152 | 1.92e-03 |
GO:BP | GO:0010463 | mesenchymal cell proliferation | 25 | 36 | 1.92e-03 |
GO:BP | GO:0034765 | regulation of monoatomic ion transmembrane transport | 104 | 210 | 1.94e-03 |
GO:BP | GO:0090092 | regulation of transmembrane receptor protein serine/threonine kinase signaling pathway | 104 | 210 | 1.94e-03 |
GO:BP | GO:0040008 | regulation of growth | 208 | 462 | 2.02e-03 |
GO:BP | GO:0070371 | ERK1 and ERK2 cascade | 97 | 194 | 2.12e-03 |
GO:BP | GO:0010718 | positive regulation of epithelial to mesenchymal transition | 31 | 48 | 2.21e-03 |
GO:BP | GO:0051254 | positive regulation of RNA metabolic process | 557 | 1354 | 2.22e-03 |
GO:BP | GO:0009892 | negative regulation of metabolic process | 841 | 2100 | 2.23e-03 |
GO:BP | GO:0072164 | mesonephric tubule development | 43 | 73 | 2.39e-03 |
GO:BP | GO:0048706 | embryonic skeletal system development | 43 | 73 | 2.39e-03 |
GO:BP | GO:0072163 | mesonephric epithelium development | 43 | 73 | 2.39e-03 |
GO:BP | GO:0009611 | response to wounding | 175 | 382 | 2.44e-03 |
GO:BP | GO:0060419 | heart growth | 42 | 71 | 2.51e-03 |
GO:BP | GO:0043542 | endothelial cell migration | 88 | 174 | 2.64e-03 |
GO:BP | GO:0035270 | endocrine system development | 48 | 84 | 2.68e-03 |
GO:BP | GO:0030001 | metal ion transport | 232 | 524 | 2.76e-03 |
GO:BP | GO:0031214 | biomineral tissue development | 58 | 106 | 2.76e-03 |
GO:BP | GO:0032970 | regulation of actin filament-based process | 141 | 300 | 2.76e-03 |
GO:BP | GO:0150115 | cell-substrate junction organization | 53 | 95 | 2.76e-03 |
GO:BP | GO:0048675 | axon extension | 53 | 95 | 2.76e-03 |
GO:BP | GO:0090504 | epiboly | 21 | 29 | 2.77e-03 |
GO:BP | GO:0003231 | cardiac ventricle development | 62 | 115 | 2.81e-03 |
GO:BP | GO:0003170 | heart valve development | 39 | 65 | 2.83e-03 |
GO:BP | GO:0060571 | morphogenesis of an epithelial fold | 13 | 15 | 2.91e-03 |
GO:BP | GO:0045598 | regulation of fat cell differentiation | 52 | 93 | 2.92e-03 |
GO:BP | GO:0008284 | positive regulation of cell population proliferation | 264 | 605 | 3.00e-03 |
GO:BP | GO:0007517 | muscle organ development | 127 | 267 | 3.09e-03 |
GO:BP | GO:0031328 | positive regulation of cellular biosynthetic process | 741 | 1841 | 3.11e-03 |
GO:BP | GO:0055006 | cardiac cell development | 45 | 78 | 3.12e-03 |
GO:BP | GO:0044093 | positive regulation of molecular function | 334 | 783 | 3.20e-03 |
GO:BP | GO:0033993 | response to lipid | 251 | 573 | 3.25e-03 |
GO:BP | GO:0051179 | localization | 1448 | 3731 | 3.27e-03 |
GO:BP | GO:0018210 | peptidyl-threonine modification | 44 | 76 | 3.28e-03 |
GO:BP | GO:0051057 | positive regulation of small GTPase mediated signal transduction | 34 | 55 | 3.34e-03 |
GO:BP | GO:0002573 | myeloid leukocyte differentiation | 78 | 152 | 3.34e-03 |
GO:BP | GO:0003179 | heart valve morphogenesis | 34 | 55 | 3.34e-03 |
GO:BP | GO:0048585 | negative regulation of response to stimulus | 493 | 1193 | 3.36e-03 |
GO:BP | GO:1905207 | regulation of cardiocyte differentiation | 17 | 22 | 3.42e-03 |
GO:BP | GO:0042471 | ear morphogenesis | 43 | 74 | 3.43e-03 |
GO:BP | GO:1902105 | regulation of leukocyte differentiation | 96 | 194 | 3.44e-03 |
GO:BP | GO:0098660 | inorganic ion transmembrane transport | 230 | 521 | 3.45e-03 |
GO:BP | GO:0006812 | monoatomic cation transport | 267 | 614 | 3.47e-03 |
GO:BP | GO:0050680 | negative regulation of epithelial cell proliferation | 54 | 98 | 3.48e-03 |
GO:BP | GO:1990090 | cellular response to nerve growth factor stimulus | 27 | 41 | 3.56e-03 |
GO:BP | GO:0055013 | cardiac muscle cell development | 42 | 72 | 3.56e-03 |
GO:BP | GO:1990089 | response to nerve growth factor | 27 | 41 | 3.56e-03 |
GO:BP | GO:0010812 | negative regulation of cell-substrate adhesion | 27 | 41 | 3.56e-03 |
GO:BP | GO:0010557 | positive regulation of macromolecule biosynthetic process | 721 | 1791 | 3.65e-03 |
GO:BP | GO:0031324 | negative regulation of cellular metabolic process | 775 | 1934 | 3.77e-03 |
GO:BP | GO:0032409 | regulation of transporter activity | 76 | 148 | 3.81e-03 |
GO:BP | GO:0022407 | regulation of cell-cell adhesion | 131 | 278 | 3.83e-03 |
GO:BP | GO:0003015 | heart process | 100 | 204 | 3.83e-03 |
GO:BP | GO:0046328 | regulation of JNK cascade | 57 | 105 | 3.83e-03 |
GO:BP | GO:0001704 | formation of primary germ layer | 52 | 94 | 3.93e-03 |
GO:BP | GO:0003272 | endocardial cushion formation | 18 | 24 | 3.95e-03 |
GO:BP | GO:0007160 | cell-matrix adhesion | 85 | 169 | 3.95e-03 |
GO:BP | GO:0051246 | regulation of protein metabolic process | 646 | 1595 | 3.95e-03 |
GO:BP | GO:0009891 | positive regulation of biosynthetic process | 745 | 1856 | 4.05e-03 |
GO:BP | GO:0034764 | positive regulation of transmembrane transport | 68 | 130 | 4.06e-03 |
GO:BP | GO:0035115 | embryonic forelimb morphogenesis | 14 | 17 | 4.09e-03 |
GO:BP | GO:0048659 | smooth muscle cell proliferation | 55 | 101 | 4.39e-03 |
GO:BP | GO:1901700 | response to oxygen-containing compound | 453 | 1093 | 4.47e-03 |
GO:BP | GO:0030177 | positive regulation of Wnt signaling pathway | 59 | 110 | 4.47e-03 |
GO:BP | GO:0010092 | specification of animal organ identity | 19 | 26 | 4.47e-03 |
GO:BP | GO:0051962 | positive regulation of nervous system development | 103 | 212 | 4.57e-03 |
GO:BP | GO:0097435 | supramolecular fiber organization | 273 | 633 | 5.34e-03 |
GO:BP | GO:0060323 | head morphogenesis | 21 | 30 | 5.36e-03 |
GO:BP | GO:0048546 | digestive tract morphogenesis | 21 | 30 | 5.36e-03 |
GO:BP | GO:0150146 | cell junction disassembly | 15 | 19 | 5.39e-03 |
GO:BP | GO:0003156 | regulation of animal organ formation | 15 | 19 | 5.39e-03 |
GO:BP | GO:0035137 | hindlimb morphogenesis | 15 | 19 | 5.39e-03 |
GO:BP | GO:0035136 | forelimb morphogenesis | 15 | 19 | 5.39e-03 |
GO:BP | GO:0042327 | positive regulation of phosphorylation | 186 | 415 | 5.43e-03 |
GO:BP | GO:0016331 | morphogenesis of embryonic epithelium | 64 | 122 | 5.45e-03 |
GO:BP | GO:2000630 | positive regulation of miRNA metabolic process | 31 | 50 | 5.59e-03 |
GO:BP | GO:0098655 | monoatomic cation transmembrane transport | 218 | 495 | 5.59e-03 |
GO:BP | GO:0018107 | peptidyl-threonine phosphorylation | 40 | 69 | 5.73e-03 |
GO:BP | GO:0002065 | columnar/cuboidal epithelial cell differentiation | 46 | 82 | 5.73e-03 |
GO:BP | GO:0003197 | endocardial cushion development | 29 | 46 | 5.84e-03 |
GO:BP | GO:1902895 | positive regulation of miRNA transcription | 28 | 44 | 5.93e-03 |
GO:BP | GO:0019827 | stem cell population maintenance | 73 | 143 | 5.95e-03 |
GO:BP | GO:0010596 | negative regulation of endothelial cell migration | 25 | 38 | 5.95e-03 |
GO:BP | GO:0048013 | ephrin receptor signaling pathway | 25 | 38 | 5.95e-03 |
GO:BP | GO:0007632 | visual behavior | 26 | 40 | 5.95e-03 |
GO:BP | GO:0003151 | outflow tract morphogenesis | 39 | 67 | 5.95e-03 |
GO:BP | GO:0031290 | retinal ganglion cell axon guidance | 12 | 14 | 5.95e-03 |
GO:BP | GO:2000725 | regulation of cardiac muscle cell differentiation | 12 | 14 | 5.95e-03 |
GO:BP | GO:0010634 | positive regulation of epithelial cell migration | 66 | 127 | 6.02e-03 |
GO:BP | GO:0030856 | regulation of epithelial cell differentiation | 54 | 100 | 6.25e-03 |
GO:BP | GO:0030282 | bone mineralization | 44 | 78 | 6.42e-03 |
GO:BP | GO:0014912 | negative regulation of smooth muscle cell migration | 16 | 21 | 6.43e-03 |
GO:BP | GO:0007492 | endoderm development | 37 | 63 | 6.61e-03 |
GO:BP | GO:0007178 | transmembrane receptor protein serine/threonine kinase signaling pathway | 132 | 284 | 6.86e-03 |
GO:BP | GO:0010586 | miRNA metabolic process | 48 | 87 | 6.89e-03 |
GO:BP | GO:0110020 | regulation of actomyosin structure organization | 48 | 87 | 6.89e-03 |
GO:BP | GO:0022898 | regulation of transmembrane transporter activity | 71 | 139 | 6.89e-03 |
GO:BP | GO:0018193 | peptidyl-amino acid modification | 241 | 555 | 7.16e-03 |
GO:BP | GO:0060840 | artery development | 47 | 85 | 7.38e-03 |
GO:BP | GO:0061337 | cardiac conduction | 47 | 85 | 7.38e-03 |
GO:BP | GO:0031128 | developmental induction | 17 | 23 | 7.40e-03 |
GO:BP | GO:0098662 | inorganic cation transmembrane transport | 211 | 480 | 7.52e-03 |
GO:BP | GO:1901342 | regulation of vasculature development | 96 | 198 | 7.53e-03 |
GO:BP | GO:0008016 | regulation of heart contraction | 82 | 165 | 7.56e-03 |
GO:BP | GO:0030099 | myeloid cell differentiation | 135 | 292 | 7.61e-03 |
GO:BP | GO:2000628 | regulation of miRNA metabolic process | 41 | 72 | 7.62e-03 |
GO:BP | GO:0048863 | stem cell differentiation | 93 | 191 | 7.66e-03 |
GO:BP | GO:0010605 | negative regulation of macromolecule metabolic process | 777 | 1951 | 7.69e-03 |
GO:BP | GO:0050769 | positive regulation of neurogenesis | 90 | 184 | 7.80e-03 |
GO:BP | GO:1905208 | negative regulation of cardiocyte differentiation | 10 | 11 | 7.80e-03 |
GO:BP | GO:0038180 | nerve growth factor signaling pathway | 10 | 11 | 7.80e-03 |
GO:BP | GO:0071560 | cellular response to transforming growth factor beta stimulus | 103 | 215 | 7.92e-03 |
GO:BP | GO:0046777 | protein autophosphorylation | 72 | 142 | 7.98e-03 |
GO:BP | GO:1903689 | regulation of wound healing, spreading of epidermal cells | 8 | 8 | 7.98e-03 |
GO:BP | GO:0060993 | kidney morphogenesis | 39 | 68 | 8.53e-03 |
GO:BP | GO:0060047 | heart contraction | 94 | 194 | 8.66e-03 |
GO:BP | GO:0018105 | peptidyl-serine phosphorylation | 80 | 161 | 8.69e-03 |
GO:BP | GO:0001952 | regulation of cell-matrix adhesion | 49 | 90 | 8.69e-03 |
GO:BP | GO:0010464 | regulation of mesenchymal cell proliferation | 19 | 27 | 8.72e-03 |
GO:BP | GO:0060325 | face morphogenesis | 19 | 27 | 8.72e-03 |
GO:BP | GO:0060998 | regulation of dendritic spine development | 30 | 49 | 8.73e-03 |
GO:BP | GO:0042063 | gliogenesis | 114 | 242 | 8.74e-03 |
GO:BP | GO:0030278 | regulation of ossification | 44 | 79 | 8.76e-03 |
GO:BP | GO:0007010 | cytoskeleton organization | 470 | 1146 | 8.83e-03 |
GO:BP | GO:0001570 | vasculogenesis | 38 | 66 | 8.90e-03 |
GO:BP | GO:0051017 | actin filament bundle assembly | 67 | 131 | 9.03e-03 |
GO:BP | GO:0043087 | regulation of GTPase activity | 82 | 166 | 9.17e-03 |
GO:BP | GO:0007044 | cell-substrate junction assembly | 48 | 88 | 9.17e-03 |
GO:BP | GO:0048565 | digestive tract development | 48 | 88 | 9.17e-03 |
GO:BP | GO:0098727 | maintenance of cell number | 73 | 145 | 9.21e-03 |
GO:BP | GO:0051174 | regulation of phosphorus metabolic process | 338 | 805 | 9.24e-03 |
GO:BP | GO:0060038 | cardiac muscle cell proliferation | 27 | 43 | 9.39e-03 |
GO:BP | GO:0006915 | apoptotic process | 558 | 1377 | 9.44e-03 |
GO:BP | GO:0010171 | body morphogenesis | 26 | 41 | 9.55e-03 |
GO:BP | GO:0021536 | diencephalon development | 25 | 39 | 9.68e-03 |
GO:BP | GO:0048511 | rhythmic process | 105 | 221 | 9.69e-03 |
GO:BP | GO:0008542 | visual learning | 23 | 35 | 9.69e-03 |
GO:BP | GO:0010594 | regulation of endothelial cell migration | 69 | 136 | 9.76e-03 |
GO:BP | GO:0010811 | positive regulation of cell-substrate adhesion | 51 | 95 | 9.95e-03 |
GO:BP | GO:0051234 | establishment of localization | 1257 | 3240 | 1.01e-02 |
GO:BP | GO:0008219 | cell death | 575 | 1423 | 1.03e-02 |
GO:BP | GO:0042472 | inner ear morphogenesis | 35 | 60 | 1.03e-02 |
GO:BP | GO:1902893 | regulation of miRNA transcription | 35 | 60 | 1.03e-02 |
GO:BP | GO:0071559 | response to transforming growth factor beta | 104 | 219 | 1.03e-02 |
GO:BP | GO:0060349 | bone morphogenesis | 41 | 73 | 1.04e-02 |
GO:BP | GO:0070374 | positive regulation of ERK1 and ERK2 cascade | 58 | 111 | 1.04e-02 |
GO:BP | GO:0032412 | regulation of monoatomic ion transmembrane transporter activity | 68 | 134 | 1.04e-02 |
GO:BP | GO:1904062 | regulation of monoatomic cation transmembrane transport | 91 | 188 | 1.04e-02 |
GO:BP | GO:0019220 | regulation of phosphate metabolic process | 337 | 804 | 1.05e-02 |
GO:BP | GO:0021987 | cerebral cortex development | 50 | 93 | 1.05e-02 |
GO:BP | GO:0051896 | regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction | 88 | 181 | 1.06e-02 |
GO:BP | GO:0051147 | regulation of muscle cell differentiation | 61 | 118 | 1.07e-02 |
GO:BP | GO:0007186 | G protein-coupled receptor signaling pathway | 172 | 386 | 1.10e-02 |
GO:BP | GO:0001934 | positive regulation of protein phosphorylation | 176 | 396 | 1.10e-02 |
GO:BP | GO:0061572 | actin filament bundle organization | 67 | 132 | 1.12e-02 |
GO:BP | GO:0043368 | positive T cell selection | 15 | 20 | 1.18e-02 |
GO:BP | GO:1903131 | mononuclear cell differentiation | 128 | 278 | 1.18e-02 |
GO:BP | GO:0022030 | telencephalon glial cell migration | 15 | 20 | 1.18e-02 |
GO:BP | GO:0099560 | synaptic membrane adhesion | 15 | 20 | 1.18e-02 |
GO:BP | GO:0021801 | cerebral cortex radial glia-guided migration | 15 | 20 | 1.18e-02 |
GO:BP | GO:0086065 | cell communication involved in cardiac conduction | 32 | 54 | 1.18e-02 |
GO:BP | GO:0042475 | odontogenesis of dentin-containing tooth | 32 | 54 | 1.18e-02 |
GO:BP | GO:0032956 | regulation of actin cytoskeleton organization | 121 | 261 | 1.18e-02 |
GO:BP | GO:0007398 | ectoderm development | 11 | 13 | 1.19e-02 |
GO:BP | GO:0031032 | actomyosin structure organization | 89 | 184 | 1.19e-02 |
GO:BP | GO:0006814 | sodium ion transport | 69 | 137 | 1.20e-02 |
GO:BP | GO:0002040 | sprouting angiogenesis | 52 | 98 | 1.20e-02 |
GO:BP | GO:0001837 | epithelial to mesenchymal transition | 69 | 137 | 1.20e-02 |
GO:BP | GO:0007015 | actin filament organization | 160 | 357 | 1.20e-02 |
GO:BP | GO:0045669 | positive regulation of osteoblast differentiation | 31 | 52 | 1.22e-02 |
GO:BP | GO:0003012 | muscle system process | 147 | 325 | 1.22e-02 |
GO:BP | GO:0048878 | chemical homeostasis | 284 | 670 | 1.23e-02 |
GO:BP | GO:0061035 | regulation of cartilage development | 30 | 50 | 1.28e-02 |
GO:BP | GO:0051148 | negative regulation of muscle cell differentiation | 30 | 50 | 1.28e-02 |
GO:BP | GO:0055123 | digestive system development | 51 | 96 | 1.28e-02 |
GO:BP | GO:0030178 | negative regulation of Wnt signaling pathway | 68 | 135 | 1.28e-02 |
GO:BP | GO:0003018 | vascular process in circulatory system | 93 | 194 | 1.29e-02 |
GO:BP | GO:0009890 | negative regulation of biosynthetic process | 654 | 1635 | 1.29e-02 |
GO:BP | GO:0022409 | positive regulation of cell-cell adhesion | 85 | 175 | 1.29e-02 |
GO:BP | GO:0003148 | outflow tract septum morphogenesis | 16 | 22 | 1.29e-02 |
GO:BP | GO:0012501 | programmed cell death | 572 | 1419 | 1.30e-02 |
GO:BP | GO:0048639 | positive regulation of developmental growth | 61 | 119 | 1.34e-02 |
GO:BP | GO:0032231 | regulation of actin filament bundle assembly | 46 | 85 | 1.35e-02 |
GO:BP | GO:0086001 | cardiac muscle cell action potential | 36 | 63 | 1.35e-02 |
GO:BP | GO:0045446 | endothelial cell differentiation | 46 | 85 | 1.35e-02 |
GO:BP | GO:0021761 | limbic system development | 46 | 85 | 1.35e-02 |
GO:BP | GO:0097061 | dendritic spine organization | 36 | 63 | 1.35e-02 |
GO:BP | GO:0035019 | somatic stem cell population maintenance | 28 | 46 | 1.36e-02 |
GO:BP | GO:0003407 | neural retina development | 28 | 46 | 1.36e-02 |
GO:BP | GO:0050954 | sensory perception of mechanical stimulus | 57 | 110 | 1.38e-02 |
GO:BP | GO:0030516 | regulation of axon extension | 41 | 74 | 1.38e-02 |
GO:BP | GO:0031644 | regulation of nervous system process | 41 | 74 | 1.38e-02 |
GO:BP | GO:0017145 | stem cell division | 17 | 24 | 1.38e-02 |
GO:BP | GO:0086002 | cardiac muscle cell action potential involved in contraction | 27 | 44 | 1.40e-02 |
GO:BP | GO:0061614 | miRNA transcription | 35 | 61 | 1.42e-02 |
GO:BP | GO:0060491 | regulation of cell projection assembly | 78 | 159 | 1.43e-02 |
GO:BP | GO:0042391 | regulation of membrane potential | 129 | 282 | 1.44e-02 |
GO:BP | GO:0007623 | circadian rhythm | 75 | 152 | 1.44e-02 |
GO:BP | GO:0086009 | membrane repolarization | 26 | 42 | 1.44e-02 |
GO:BP | GO:0051336 | regulation of hydrolase activity | 189 | 431 | 1.44e-02 |
GO:BP | GO:0045058 | T cell selection | 18 | 26 | 1.45e-02 |
GO:BP | GO:0031327 | negative regulation of cellular biosynthetic process | 649 | 1624 | 1.45e-02 |
GO:BP | GO:0060317 | cardiac epithelial to mesenchymal transition | 19 | 28 | 1.51e-02 |
GO:BP | GO:0120032 | regulation of plasma membrane bounded cell projection assembly | 77 | 157 | 1.53e-02 |
GO:BP | GO:0001759 | organ induction | 12 | 15 | 1.53e-02 |
GO:BP | GO:0038179 | neurotrophin signaling pathway | 23 | 36 | 1.53e-02 |
GO:BP | GO:0043369 | CD4-positive or CD8-positive, alpha-beta T cell lineage commitment | 12 | 15 | 1.53e-02 |
GO:BP | GO:0001937 | negative regulation of endothelial cell proliferation | 20 | 30 | 1.53e-02 |
GO:BP | GO:0032330 | regulation of chondrocyte differentiation | 22 | 34 | 1.54e-02 |
GO:BP | GO:0042325 | regulation of phosphorylation | 288 | 683 | 1.55e-02 |
GO:BP | GO:0010976 | positive regulation of neuron projection development | 65 | 129 | 1.55e-02 |
GO:BP | GO:0018209 | peptidyl-serine modification | 82 | 169 | 1.57e-02 |
GO:BP | GO:0046834 | lipid phosphorylation | 9 | 10 | 1.59e-02 |
GO:BP | GO:0060572 | morphogenesis of an epithelial bud | 9 | 10 | 1.59e-02 |
GO:BP | GO:0061458 | reproductive system development | 97 | 205 | 1.61e-02 |
GO:BP | GO:0048754 | branching morphogenesis of an epithelial tube | 58 | 113 | 1.62e-02 |
GO:BP | GO:0055085 | transmembrane transport | 380 | 921 | 1.64e-02 |
GO:BP | GO:0061387 | regulation of extent of cell growth | 47 | 88 | 1.64e-02 |
GO:BP | GO:0010959 | regulation of metal ion transport | 111 | 239 | 1.64e-02 |
GO:BP | GO:0007254 | JNK cascade | 64 | 127 | 1.67e-02 |
GO:BP | GO:0044089 | positive regulation of cellular component biogenesis | 172 | 390 | 1.73e-02 |
GO:BP | GO:0051492 | regulation of stress fiber assembly | 42 | 77 | 1.74e-02 |
GO:BP | GO:0048332 | mesoderm morphogenesis | 31 | 53 | 1.74e-02 |
GO:BP | GO:0045639 | positive regulation of myeloid cell differentiation | 37 | 66 | 1.75e-02 |
GO:BP | GO:0051153 | regulation of striated muscle cell differentiation | 37 | 66 | 1.75e-02 |
GO:BP | GO:0001558 | regulation of cell growth | 145 | 323 | 1.77e-02 |
GO:BP | GO:0043067 | regulation of programmed cell death | 433 | 1060 | 1.79e-02 |
GO:BP | GO:0042060 | wound healing | 132 | 291 | 1.79e-02 |
GO:BP | GO:0010558 | negative regulation of macromolecule biosynthetic process | 634 | 1588 | 1.79e-02 |
GO:BP | GO:0010977 | negative regulation of neuron projection development | 56 | 109 | 1.88e-02 |
GO:BP | GO:0045765 | regulation of angiogenesis | 92 | 194 | 1.92e-02 |
GO:BP | GO:0051641 | cellular localization | 1022 | 2623 | 1.95e-02 |
GO:BP | GO:0001932 | regulation of protein phosphorylation | 271 | 642 | 1.96e-02 |
GO:BP | GO:0003158 | endothelium development | 52 | 100 | 1.96e-02 |
GO:BP | GO:0043149 | stress fiber assembly | 48 | 91 | 2.01e-02 |
GO:BP | GO:0030038 | contractile actin filament bundle assembly | 48 | 91 | 2.01e-02 |
GO:BP | GO:0045600 | positive regulation of fat cell differentiation | 28 | 47 | 2.02e-02 |
GO:BP | GO:0030048 | actin filament-based movement | 55 | 107 | 2.02e-02 |
GO:BP | GO:0090066 | regulation of anatomical structure size | 167 | 379 | 2.08e-02 |
GO:BP | GO:0002360 | T cell lineage commitment | 14 | 19 | 2.09e-02 |
GO:BP | GO:0021772 | olfactory bulb development | 14 | 19 | 2.09e-02 |
GO:BP | GO:0060997 | dendritic spine morphogenesis | 27 | 45 | 2.09e-02 |
GO:BP | GO:0060512 | prostate gland morphogenesis | 14 | 19 | 2.09e-02 |
GO:BP | GO:2000647 | negative regulation of stem cell proliferation | 14 | 19 | 2.09e-02 |
GO:BP | GO:0048566 | embryonic digestive tract development | 14 | 19 | 2.09e-02 |
GO:BP | GO:0060740 | prostate gland epithelium morphogenesis | 14 | 19 | 2.09e-02 |
GO:BP | GO:0106027 | neuron projection organization | 39 | 71 | 2.10e-02 |
GO:BP | GO:0042981 | regulation of apoptotic process | 421 | 1031 | 2.10e-02 |
GO:BP | GO:0007162 | negative regulation of cell adhesion | 88 | 185 | 2.11e-02 |
GO:BP | GO:0048608 | reproductive structure development | 95 | 202 | 2.18e-02 |
GO:BP | GO:0048844 | artery morphogenesis | 33 | 58 | 2.22e-02 |
GO:BP | GO:0072028 | nephron morphogenesis | 33 | 58 | 2.22e-02 |
GO:BP | GO:0016192 | vesicle-mediated transport | 467 | 1152 | 2.22e-02 |
GO:BP | GO:0007605 | sensory perception of sound | 50 | 96 | 2.24e-02 |
GO:BP | GO:0061383 | trabecula morphogenesis | 25 | 41 | 2.26e-02 |
GO:BP | GO:0086011 | membrane repolarization during action potential | 15 | 21 | 2.27e-02 |
GO:BP | GO:0021983 | pituitary gland development | 15 | 21 | 2.27e-02 |
GO:BP | GO:0070252 | actin-mediated cell contraction | 46 | 87 | 2.29e-02 |
GO:BP | GO:0050773 | regulation of dendrite development | 42 | 78 | 2.30e-02 |
GO:BP | GO:0001763 | morphogenesis of a branching structure | 71 | 145 | 2.31e-02 |
GO:BP | GO:0003198 | epithelial to mesenchymal transition involved in endocardial cushion formation | 10 | 12 | 2.31e-02 |
GO:BP | GO:0045176 | apical protein localization | 10 | 12 | 2.31e-02 |
GO:BP | GO:0002088 | lens development in camera-type eye | 32 | 56 | 2.31e-02 |
GO:BP | GO:0045670 | regulation of osteoclast differentiation | 24 | 39 | 2.31e-02 |
GO:BP | GO:0032486 | Rap protein signal transduction | 10 | 12 | 2.31e-02 |
GO:BP | GO:0014009 | glial cell proliferation | 24 | 39 | 2.31e-02 |
GO:BP | GO:0048708 | astrocyte differentiation | 32 | 56 | 2.31e-02 |
GO:BP | GO:0001658 | branching involved in ureteric bud morphogenesis | 24 | 39 | 2.31e-02 |
GO:BP | GO:0051491 | positive regulation of filopodium assembly | 16 | 23 | 2.38e-02 |
GO:BP | GO:0043537 | negative regulation of blood vessel endothelial cell migration | 16 | 23 | 2.38e-02 |
GO:BP | GO:0045935 | positive regulation of nucleobase-containing compound metabolic process | 604 | 1514 | 2.42e-02 |
GO:BP | GO:0051963 | regulation of synapse assembly | 41 | 76 | 2.43e-02 |
GO:BP | GO:0048640 | negative regulation of developmental growth | 45 | 85 | 2.43e-02 |
GO:BP | GO:0001775 | cell activation | 264 | 627 | 2.51e-02 |
GO:BP | GO:0030857 | negative regulation of epithelial cell differentiation | 20 | 31 | 2.53e-02 |
GO:BP | GO:0099622 | cardiac muscle cell membrane repolarization | 20 | 31 | 2.53e-02 |
GO:BP | GO:0060563 | neuroepithelial cell differentiation | 19 | 29 | 2.53e-02 |
GO:BP | GO:0006810 | transport | 1154 | 2984 | 2.53e-02 |
GO:BP | GO:0051050 | positive regulation of transport | 242 | 571 | 2.57e-02 |
GO:BP | GO:0061180 | mammary gland epithelium development | 30 | 52 | 2.59e-02 |
GO:BP | GO:0001708 | cell fate specification | 30 | 52 | 2.59e-02 |
GO:BP | GO:0045927 | positive regulation of growth | 87 | 184 | 2.67e-02 |
GO:BP | GO:0007043 | cell-cell junction assembly | 54 | 106 | 2.70e-02 |
GO:BP | GO:0002011 | morphogenesis of an epithelial sheet | 29 | 50 | 2.74e-02 |
GO:BP | GO:0042490 | mechanoreceptor differentiation | 29 | 50 | 2.74e-02 |
GO:BP | GO:0030199 | collagen fibril organization | 29 | 50 | 2.74e-02 |
GO:BP | GO:0006936 | muscle contraction | 116 | 255 | 2.85e-02 |
GO:BP | GO:0035249 | synaptic transmission, glutamatergic | 34 | 61 | 2.87e-02 |
GO:BP | GO:0008306 | associative learning | 34 | 61 | 2.87e-02 |
GO:BP | GO:0001656 | metanephros development | 34 | 61 | 2.87e-02 |
GO:BP | GO:0060113 | inner ear receptor cell differentiation | 28 | 48 | 2.90e-02 |
GO:BP | GO:0071772 | response to BMP | 59 | 118 | 2.94e-02 |
GO:BP | GO:0071773 | cellular response to BMP stimulus | 59 | 118 | 2.94e-02 |
GO:BP | GO:0048485 | sympathetic nervous system development | 11 | 14 | 2.94e-02 |
GO:BP | GO:0010842 | retina layer formation | 11 | 14 | 2.94e-02 |
GO:BP | GO:0002363 | alpha-beta T cell lineage commitment | 11 | 14 | 2.94e-02 |
GO:BP | GO:0008347 | glial cell migration | 27 | 46 | 3.05e-02 |
GO:BP | GO:0072171 | mesonephric tubule morphogenesis | 27 | 46 | 3.05e-02 |
GO:BP | GO:0035725 | sodium ion transmembrane transport | 49 | 95 | 3.05e-02 |
GO:BP | GO:0043491 | phosphatidylinositol 3-kinase/protein kinase B signal transduction | 99 | 214 | 3.11e-02 |
GO:BP | GO:0090090 | negative regulation of canonical Wnt signaling pathway | 55 | 109 | 3.16e-02 |
GO:BP | GO:0098657 | import into cell | 261 | 622 | 3.19e-02 |
GO:BP | GO:0060324 | face development | 26 | 44 | 3.20e-02 |
GO:BP | GO:0002042 | cell migration involved in sprouting angiogenesis | 26 | 44 | 3.20e-02 |
GO:BP | GO:0014033 | neural crest cell differentiation | 41 | 77 | 3.22e-02 |
GO:BP | GO:0007600 | sensory perception | 114 | 251 | 3.23e-02 |
GO:BP | GO:0021954 | central nervous system neuron development | 32 | 57 | 3.24e-02 |
GO:BP | GO:0001954 | positive regulation of cell-matrix adhesion | 25 | 42 | 3.36e-02 |
GO:BP | GO:0060601 | lateral sprouting from an epithelium | 8 | 9 | 3.36e-02 |
GO:BP | GO:1901329 | regulation of odontoblast differentiation | 8 | 9 | 3.36e-02 |
GO:BP | GO:0045986 | negative regulation of smooth muscle contraction | 8 | 9 | 3.36e-02 |
GO:BP | GO:0008361 | regulation of cell size | 71 | 147 | 3.37e-02 |
GO:BP | GO:0006935 | chemotaxis | 111 | 244 | 3.39e-02 |
GO:BP | GO:0007498 | mesoderm development | 44 | 84 | 3.39e-02 |
GO:BP | GO:0042330 | taxis | 111 | 244 | 3.39e-02 |
GO:BP | GO:0055008 | cardiac muscle tissue morphogenesis | 31 | 55 | 3.44e-02 |
GO:BP | GO:0045668 | negative regulation of osteoblast differentiation | 23 | 38 | 3.68e-02 |
GO:BP | GO:0061001 | regulation of dendritic spine morphogenesis | 22 | 36 | 3.84e-02 |
GO:BP | GO:0003203 | endocardial cushion morphogenesis | 22 | 36 | 3.84e-02 |
GO:BP | GO:0048704 | embryonic skeletal system morphogenesis | 29 | 51 | 3.94e-02 |
GO:BP | GO:0001707 | mesoderm formation | 29 | 51 | 3.94e-02 |
GO:BP | GO:0051591 | response to cAMP | 34 | 62 | 3.95e-02 |
GO:BP | GO:0050865 | regulation of cell activation | 152 | 347 | 3.96e-02 |
GO:BP | GO:0030509 | BMP signaling pathway | 55 | 110 | 3.96e-02 |
GO:BP | GO:0007159 | leukocyte cell-cell adhesion | 100 | 218 | 3.96e-02 |
GO:BP | GO:0010629 | negative regulation of gene expression | 325 | 790 | 4.01e-02 |
GO:BP | GO:0045926 | negative regulation of growth | 86 | 184 | 4.02e-02 |
GO:BP | GO:0002053 | positive regulation of mesenchymal cell proliferation | 14 | 20 | 4.04e-02 |
GO:BP | GO:0021516 | dorsal spinal cord development | 6 | 6 | 4.04e-02 |
GO:BP | GO:0048617 | embryonic foregut morphogenesis | 6 | 6 | 4.04e-02 |
GO:BP | GO:1901289 | succinyl-CoA catabolic process | 6 | 6 | 4.04e-02 |
GO:BP | GO:0072178 | nephric duct morphogenesis | 6 | 6 | 4.04e-02 |
GO:BP | GO:0050861 | positive regulation of B cell receptor signaling pathway | 6 | 6 | 4.04e-02 |
GO:BP | GO:0021814 | cell motility involved in cerebral cortex radial glia guided migration | 6 | 6 | 4.04e-02 |
GO:BP | GO:0050982 | detection of mechanical stimulus | 20 | 32 | 4.05e-02 |
GO:BP | GO:0008154 | actin polymerization or depolymerization | 71 | 148 | 4.05e-02 |
GO:BP | GO:0032233 | positive regulation of actin filament bundle assembly | 28 | 49 | 4.13e-02 |
GO:BP | GO:0060914 | heart formation | 19 | 30 | 4.15e-02 |
GO:BP | GO:0033688 | regulation of osteoblast proliferation | 15 | 22 | 4.16e-02 |
GO:BP | GO:0048661 | positive regulation of smooth muscle cell proliferation | 33 | 60 | 4.16e-02 |
GO:BP | GO:0021675 | nerve development | 33 | 60 | 4.16e-02 |
GO:BP | GO:1902107 | positive regulation of leukocyte differentiation | 57 | 115 | 4.17e-02 |
GO:BP | GO:1903708 | positive regulation of hemopoiesis | 57 | 115 | 4.17e-02 |
GO:BP | GO:0072006 | nephron development | 57 | 115 | 4.17e-02 |
GO:BP | GO:0030510 | regulation of BMP signaling pathway | 41 | 78 | 4.17e-02 |
GO:BP | GO:0021799 | cerebral cortex radially oriented cell migration | 17 | 26 | 4.18e-02 |
GO:BP | GO:0071392 | cellular response to estradiol stimulus | 16 | 24 | 4.18e-02 |
GO:BP | GO:0048048 | embryonic eye morphogenesis | 16 | 24 | 4.18e-02 |
GO:BP | GO:0003181 | atrioventricular valve morphogenesis | 17 | 26 | 4.18e-02 |
GO:BP | GO:0040036 | regulation of fibroblast growth factor receptor signaling pathway | 16 | 24 | 4.18e-02 |
GO:BP | GO:0086064 | cell communication by electrical coupling involved in cardiac conduction | 17 | 26 | 4.18e-02 |
GO:BP | GO:0110110 | positive regulation of animal organ morphogenesis | 17 | 26 | 4.18e-02 |
GO:BP | GO:0035282 | segmentation | 37 | 69 | 4.18e-02 |
GO:BP | GO:0033687 | osteoblast proliferation | 17 | 26 | 4.18e-02 |
GO:BP | GO:0010721 | negative regulation of cell development | 85 | 182 | 4.19e-02 |
GO:BP | GO:0033135 | regulation of peptidyl-serine phosphorylation | 44 | 85 | 4.30e-02 |
GO:BP | GO:0050790 | regulation of catalytic activity | 364 | 893 | 4.37e-02 |
GO:BP | GO:0061333 | renal tubule morphogenesis | 32 | 58 | 4.38e-02 |
GO:BP | GO:0008543 | fibroblast growth factor receptor signaling pathway | 32 | 58 | 4.38e-02 |
GO:BP | GO:0071805 | potassium ion transmembrane transport | 59 | 120 | 4.38e-02 |
GO:BP | GO:0007188 | adenylate cyclase-modulating G protein-coupled receptor signaling pathway | 56 | 113 | 4.43e-02 |
GO:BP | GO:0055001 | muscle cell development | 77 | 163 | 4.43e-02 |
GO:BP | GO:0060675 | ureteric bud morphogenesis | 26 | 45 | 4.56e-02 |
GO:BP | GO:0035331 | negative regulation of hippo signaling | 9 | 11 | 4.61e-02 |
GO:BP | GO:0021895 | cerebral cortex neuron differentiation | 9 | 11 | 4.61e-02 |
GO:BP | GO:0090263 | positive regulation of canonical Wnt signaling pathway | 43 | 83 | 4.62e-02 |
GO:BP | GO:0072088 | nephron epithelium morphogenesis | 31 | 56 | 4.67e-02 |
GO:BP | GO:0003229 | ventricular cardiac muscle tissue development | 31 | 56 | 4.67e-02 |
GO:BP | GO:0046928 | regulation of neurotransmitter secretion | 31 | 56 | 4.67e-02 |
GO:BP | GO:0002682 | regulation of immune system process | 354 | 868 | 4.70e-02 |
GO:BP | GO:0110053 | regulation of actin filament organization | 97 | 212 | 4.70e-02 |
GO:BP | GO:0061326 | renal tubule development | 39 | 74 | 4.75e-02 |
GO:BP | GO:0048864 | stem cell development | 39 | 74 | 4.75e-02 |
GO:BP | GO:0030316 | osteoclast differentiation | 35 | 65 | 4.78e-02 |
GO:BP | GO:0051496 | positive regulation of stress fiber assembly | 25 | 43 | 4.78e-02 |
GO:BP | GO:0009880 | embryonic pattern specification | 25 | 43 | 4.78e-02 |
GO:BP | GO:0050679 | positive regulation of epithelial cell proliferation | 68 | 142 | 4.93e-02 |
GO:BP | GO:0019722 | calcium-mediated signaling | 60 | 123 | 4.97e-02 |
GO:BP | GO:0072078 | nephron tubule morphogenesis | 30 | 54 | 4.97e-02 |
EARnomtable %>%
filter(source=="KEGG", p_value < 0.05) %>%
mutate_at(.vars = 6, .funs = scientific_format()) %>%
kable(., caption = "KEGG terms found in EAR neargenes") %>%
kable_paper("striped", full_width = FALSE) %>%
kable_styling(
full_width = FALSE,
position = "left",
bootstrap_options = c("striped", "hover")
) %>%
scroll_box(width = "100%", height = "400px")
source | term_id | term_name | intersection_size | term_size | p_value |
---|---|---|---|---|---|
KEGG | KEGG:04510 | Focal adhesion | 97 | 169 | 6.03e-06 |
KEGG | KEGG:04015 | Rap1 signaling pathway | 90 | 162 | 7.47e-05 |
KEGG | KEGG:04360 | Axon guidance | 84 | 155 | 4.62e-04 |
KEGG | KEGG:04512 | ECM-receptor interaction | 42 | 66 | 5.12e-04 |
KEGG | KEGG:04520 | Adherens junction | 49 | 83 | 1.45e-03 |
KEGG | KEGG:04310 | Wnt signaling pathway | 71 | 133 | 2.44e-03 |
KEGG | KEGG:04024 | cAMP signaling pathway | 75 | 147 | 6.33e-03 |
KEGG | KEGG:04010 | MAPK signaling pathway | 111 | 231 | 6.33e-03 |
KEGG | KEGG:04726 | Serotonergic synapse | 35 | 58 | 6.33e-03 |
KEGG | KEGG:05200 | Pathways in cancer | 177 | 391 | 6.33e-03 |
KEGG | KEGG:05222 | Small cell lung cancer | 46 | 82 | 6.46e-03 |
KEGG | KEGG:04151 | PI3K-Akt signaling pathway | 118 | 250 | 7.19e-03 |
KEGG | KEGG:04014 | Ras signaling pathway | 81 | 164 | 9.91e-03 |
KEGG | KEGG:05202 | Transcriptional misregulation in cancer | 63 | 122 | 9.91e-03 |
KEGG | KEGG:05412 | Arrhythmogenic right ventricular cardiomyopathy | 38 | 67 | 1.24e-02 |
KEGG | KEGG:04350 | TGF-beta signaling pathway | 48 | 90 | 1.47e-02 |
KEGG | KEGG:04810 | Regulation of actin cytoskeleton | 82 | 169 | 1.47e-02 |
KEGG | KEGG:05205 | Proteoglycans in cancer | 79 | 162 | 1.47e-02 |
KEGG | KEGG:04514 | Cell adhesion molecules | 38 | 69 | 2.10e-02 |
KEGG | KEGG:04730 | Long-term depression | 24 | 39 | 2.10e-02 |
KEGG | KEGG:04390 | Hippo signaling pathway | 64 | 129 | 2.22e-02 |
KEGG | KEGG:04713 | Circadian entrainment | 37 | 68 | 2.80e-02 |
KEGG | KEGG:04928 | Parathyroid hormone synthesis, secretion and action | 41 | 78 | 3.73e-02 |
KEGG | KEGG:04068 | FoxO signaling pathway | 53 | 106 | 3.91e-02 |
KEGG | KEGG:04974 | Protein digestion and absorption | 31 | 56 | 3.97e-02 |
KEGG | KEGG:04072 | Phospholipase D signaling pathway | 53 | 107 | 4.66e-02 |
# ESR_resgenes <- gost(query = ESR_NG_list$ENTREZID,
# organism = "hsapiens",
# significant = FALSE,
# ordered_query = FALSE,
# domain_scope = "custom",
# measure_underrepresentation = FALSE,
# evcodes = FALSE,
# user_threshold = 0.05,
# correction_method = c("fdr"),
# custom_bg = background_df$ENTREZID,
# sources=c("GO:BP","KEGG"))
# saveRDS(ESR_resgenes,"data/GO_KEGG_analysis/ESR_resgenes.RDS")
ESRnom <- gostplot(ESR_resgenes, capped = FALSE, interactive = TRUE)
# ESRnom
ESRnomtable <- ESR_resgenes$result %>%
dplyr::select(c(source, term_id,
term_name,intersection_size,
term_size, p_value))# %>%
ESRnomtable %>%
filter(source=="GO:BP", p_value < 0.05) %>%
mutate_at(.vars = 6, .funs = scientific_format()) %>%
kable(.,caption = "GO:BP terms found in ESR neargenes" ) %>%
kable_paper("striped", full_width = FALSE) %>%
kable_styling(
full_width = FALSE,
position = "left",
bootstrap_options = c("striped", "hover")
) %>%
scroll_box(width = "100%", height = "400px")
source | term_id | term_name | intersection_size | term_size | p_value |
---|---|---|---|---|---|
GO:BP | GO:0032501 | multicellular organismal process | 2719 | 4504 | 6.19e-51 |
GO:BP | GO:0048856 | anatomical structure development | 2368 | 3867 | 1.05e-48 |
GO:BP | GO:0009653 | anatomical structure morphogenesis | 1237 | 1844 | 1.90e-47 |
GO:BP | GO:0032502 | developmental process | 2521 | 4179 | 2.35e-45 |
GO:BP | GO:0007275 | multicellular organism development | 1971 | 3170 | 2.02e-44 |
GO:BP | GO:0007154 | cell communication | 2411 | 3983 | 2.68e-44 |
GO:BP | GO:0023052 | signaling | 2374 | 3918 | 7.47e-44 |
GO:BP | GO:0048731 | system development | 1713 | 2719 | 3.79e-42 |
GO:BP | GO:0007165 | signal transduction | 2187 | 3611 | 9.13e-39 |
GO:BP | GO:0030154 | cell differentiation | 1746 | 2803 | 1.06e-38 |
GO:BP | GO:0048869 | cellular developmental process | 1746 | 2804 | 1.33e-38 |
GO:BP | GO:0050896 | response to stimulus | 3104 | 5379 | 5.22e-35 |
GO:BP | GO:0051716 | cellular response to stimulus | 2717 | 4640 | 6.46e-35 |
GO:BP | GO:0051239 | regulation of multicellular organismal process | 1237 | 1924 | 5.46e-34 |
GO:BP | GO:0009888 | tissue development | 904 | 1348 | 2.90e-33 |
GO:BP | GO:0048513 | animal organ development | 1279 | 2004 | 3.55e-33 |
GO:BP | GO:0048646 | anatomical structure formation involved in morphogenesis | 597 | 837 | 4.28e-32 |
GO:BP | GO:0007399 | nervous system development | 1136 | 1775 | 1.60e-29 |
GO:BP | GO:0007155 | cell adhesion | 651 | 941 | 7.22e-29 |
GO:BP | GO:0010646 | regulation of cell communication | 1503 | 2444 | 4.76e-28 |
GO:BP | GO:0007166 | cell surface receptor signaling pathway | 1142 | 1801 | 2.61e-27 |
GO:BP | GO:0023051 | regulation of signaling | 1496 | 2438 | 3.01e-27 |
GO:BP | GO:0035295 | tube development | 553 | 787 | 7.25e-27 |
GO:BP | GO:0072359 | circulatory system development | 599 | 864 | 8.41e-27 |
GO:BP | GO:0016477 | cell migration | 686 | 1011 | 9.57e-27 |
GO:BP | GO:0048468 | cell development | 1184 | 1886 | 5.73e-26 |
GO:BP | GO:0050793 | regulation of developmental process | 1076 | 1697 | 1.61e-25 |
GO:BP | GO:0048870 | cell motility | 745 | 1120 | 2.94e-25 |
GO:BP | GO:0035239 | tube morphogenesis | 458 | 638 | 3.31e-25 |
GO:BP | GO:0022008 | neurogenesis | 819 | 1251 | 9.61e-25 |
GO:BP | GO:0003008 | system process | 752 | 1139 | 4.38e-24 |
GO:BP | GO:0048729 | tissue morphogenesis | 340 | 453 | 6.87e-24 |
GO:BP | GO:0009887 | animal organ morphogenesis | 475 | 673 | 1.46e-23 |
GO:BP | GO:0051240 | positive regulation of multicellular organismal process | 692 | 1040 | 2.24e-23 |
GO:BP | GO:0048699 | generation of neurons | 711 | 1076 | 8.28e-23 |
GO:BP | GO:2000026 | regulation of multicellular organismal development | 637 | 951 | 1.83e-22 |
GO:BP | GO:0030182 | neuron differentiation | 671 | 1014 | 1.21e-21 |
GO:BP | GO:0141124 | intracellular signaling cassette | 842 | 1314 | 2.89e-21 |
GO:BP | GO:0007267 | cell-cell signaling | 709 | 1082 | 2.91e-21 |
GO:BP | GO:0009966 | regulation of signal transduction | 1316 | 2166 | 6.52e-21 |
GO:BP | GO:0007167 | enzyme-linked receptor protein signaling pathway | 493 | 717 | 1.33e-20 |
GO:BP | GO:0051094 | positive regulation of developmental process | 607 | 913 | 3.88e-20 |
GO:BP | GO:0030334 | regulation of cell migration | 461 | 668 | 1.15e-19 |
GO:BP | GO:0001944 | vasculature development | 391 | 552 | 1.24e-19 |
GO:BP | GO:0050789 | regulation of biological process | 4101 | 7516 | 3.07e-19 |
GO:BP | GO:0040011 | locomotion | 540 | 805 | 5.25e-19 |
GO:BP | GO:0048583 | regulation of response to stimulus | 1605 | 2717 | 7.46e-19 |
GO:BP | GO:2000145 | regulation of cell motility | 477 | 700 | 1.07e-18 |
GO:BP | GO:0001568 | blood vessel development | 372 | 525 | 1.07e-18 |
GO:BP | GO:0044057 | regulation of system process | 285 | 384 | 1.07e-18 |
GO:BP | GO:0065007 | biological regulation | 4205 | 7734 | 1.75e-18 |
GO:BP | GO:0022603 | regulation of anatomical structure morphogenesis | 422 | 609 | 1.86e-18 |
GO:BP | GO:0040012 | regulation of locomotion | 488 | 720 | 1.89e-18 |
GO:BP | GO:0060429 | epithelium development | 530 | 792 | 2.43e-18 |
GO:BP | GO:0034330 | cell junction organization | 383 | 545 | 2.60e-18 |
GO:BP | GO:0098609 | cell-cell adhesion | 394 | 564 | 3.80e-18 |
GO:BP | GO:0050794 | regulation of cellular process | 3906 | 7153 | 1.53e-17 |
GO:BP | GO:0048514 | blood vessel morphogenesis | 323 | 450 | 1.64e-17 |
GO:BP | GO:0030029 | actin filament-based process | 437 | 640 | 2.59e-17 |
GO:BP | GO:0002009 | morphogenesis of an epithelium | 272 | 369 | 3.69e-17 |
GO:BP | GO:0000902 | cell morphogenesis | 478 | 713 | 1.18e-16 |
GO:BP | GO:0009790 | embryo development | 541 | 821 | 1.22e-16 |
GO:BP | GO:0071495 | cellular response to endogenous stimulus | 664 | 1035 | 1.36e-16 |
GO:BP | GO:0035556 | intracellular signal transduction | 1175 | 1951 | 1.58e-16 |
GO:BP | GO:0045595 | regulation of cell differentiation | 685 | 1073 | 1.95e-16 |
GO:BP | GO:0045597 | positive regulation of cell differentiation | 405 | 591 | 2.08e-16 |
GO:BP | GO:0032989 | cellular anatomical entity morphogenesis | 403 | 588 | 2.42e-16 |
GO:BP | GO:0003013 | circulatory system process | 305 | 426 | 2.87e-16 |
GO:BP | GO:0048518 | positive regulation of biological process | 2429 | 4301 | 3.13e-16 |
GO:BP | GO:0060485 | mesenchyme development | 191 | 245 | 3.48e-16 |
GO:BP | GO:0048519 | negative regulation of biological process | 2146 | 3764 | 3.74e-16 |
GO:BP | GO:0048522 | positive regulation of cellular process | 2246 | 3954 | 3.89e-16 |
GO:BP | GO:0048598 | embryonic morphogenesis | 302 | 422 | 4.42e-16 |
GO:BP | GO:0030155 | regulation of cell adhesion | 354 | 508 | 5.26e-16 |
GO:BP | GO:0048523 | negative regulation of cellular process | 2030 | 3550 | 9.49e-16 |
GO:BP | GO:0070848 | response to growth factor | 376 | 547 | 1.55e-15 |
GO:BP | GO:0007507 | heart development | 347 | 499 | 1.86e-15 |
GO:BP | GO:0051128 | regulation of cellular component organization | 1120 | 1862 | 1.96e-15 |
GO:BP | GO:0008015 | blood circulation | 260 | 357 | 2.56e-15 |
GO:BP | GO:0065008 | regulation of biological quality | 1136 | 1893 | 2.94e-15 |
GO:BP | GO:0009719 | response to endogenous stimulus | 749 | 1197 | 4.69e-15 |
GO:BP | GO:0120036 | plasma membrane bounded cell projection organization | 722 | 1150 | 6.09e-15 |
GO:BP | GO:0048666 | neuron development | 544 | 838 | 7.15e-15 |
GO:BP | GO:0061061 | muscle structure development | 367 | 536 | 9.31e-15 |
GO:BP | GO:0030030 | cell projection organization | 739 | 1182 | 1.01e-14 |
GO:BP | GO:0071363 | cellular response to growth factor stimulus | 362 | 528 | 1.09e-14 |
GO:BP | GO:0031175 | neuron projection development | 488 | 743 | 1.35e-14 |
GO:BP | GO:0014706 | striated muscle tissue development | 167 | 213 | 1.47e-14 |
GO:BP | GO:0048762 | mesenchymal cell differentiation | 158 | 200 | 2.74e-14 |
GO:BP | GO:0048738 | cardiac muscle tissue development | 158 | 201 | 6.30e-14 |
GO:BP | GO:0030036 | actin cytoskeleton organization | 382 | 566 | 6.89e-14 |
GO:BP | GO:0042127 | regulation of cell population proliferation | 676 | 1077 | 6.96e-14 |
GO:BP | GO:0001525 | angiogenesis | 271 | 381 | 7.21e-14 |
GO:BP | GO:0120039 | plasma membrane bounded cell projection morphogenesis | 338 | 494 | 1.76e-13 |
GO:BP | GO:0007169 | transmembrane receptor protein tyrosine kinase signaling pathway | 315 | 456 | 2.20e-13 |
GO:BP | GO:0048858 | cell projection morphogenesis | 340 | 498 | 2.30e-13 |
GO:BP | GO:0008285 | negative regulation of cell population proliferation | 322 | 469 | 3.95e-13 |
GO:BP | GO:0051241 | negative regulation of multicellular organismal process | 460 | 706 | 7.81e-13 |
GO:BP | GO:0060562 | epithelial tube morphogenesis | 194 | 261 | 9.34e-13 |
GO:BP | GO:0010647 | positive regulation of cell communication | 749 | 1218 | 1.35e-12 |
GO:BP | GO:0023057 | negative regulation of signaling | 647 | 1036 | 1.35e-12 |
GO:BP | GO:0007423 | sensory organ development | 271 | 387 | 1.52e-12 |
GO:BP | GO:0023056 | positive regulation of signaling | 750 | 1221 | 1.80e-12 |
GO:BP | GO:0007010 | cytoskeleton organization | 708 | 1146 | 1.89e-12 |
GO:BP | GO:0051049 | regulation of transport | 681 | 1098 | 1.98e-12 |
GO:BP | GO:0008283 | cell population proliferation | 797 | 1306 | 1.99e-12 |
GO:BP | GO:0010648 | negative regulation of cell communication | 645 | 1034 | 2.00e-12 |
GO:BP | GO:0048812 | neuron projection morphogenesis | 325 | 479 | 3.29e-12 |
GO:BP | GO:0003012 | muscle system process | 232 | 325 | 4.33e-12 |
GO:BP | GO:0060537 | muscle tissue development | 240 | 339 | 6.98e-12 |
GO:BP | GO:0001667 | ameboidal-type cell migration | 243 | 344 | 7.18e-12 |
GO:BP | GO:0051093 | negative regulation of developmental process | 407 | 622 | 1.06e-11 |
GO:BP | GO:0042221 | response to chemical | 1336 | 2304 | 1.47e-11 |
GO:BP | GO:0006468 | protein phosphorylation | 598 | 958 | 1.59e-11 |
GO:BP | GO:0034329 | cell junction assembly | 229 | 323 | 1.99e-11 |
GO:BP | GO:0048667 | cell morphogenesis involved in neuron differentiation | 296 | 435 | 2.60e-11 |
GO:BP | GO:0120035 | regulation of plasma membrane bounded cell projection organization | 337 | 505 | 3.26e-11 |
GO:BP | GO:0098657 | import into cell | 405 | 622 | 3.52e-11 |
GO:BP | GO:0007417 | central nervous system development | 446 | 694 | 4.58e-11 |
GO:BP | GO:0048589 | developmental growth | 334 | 501 | 4.96e-11 |
GO:BP | GO:0072001 | renal system development | 179 | 244 | 6.49e-11 |
GO:BP | GO:0010720 | positive regulation of cell development | 219 | 309 | 6.74e-11 |
GO:BP | GO:0031344 | regulation of cell projection organization | 342 | 516 | 8.22e-11 |
GO:BP | GO:0048568 | embryonic organ development | 215 | 303 | 8.93e-11 |
GO:BP | GO:0048585 | negative regulation of response to stimulus | 725 | 1193 | 1.10e-10 |
GO:BP | GO:1902531 | regulation of intracellular signal transduction | 777 | 1289 | 1.75e-10 |
GO:BP | GO:0051960 | regulation of nervous system development | 236 | 339 | 1.76e-10 |
GO:BP | GO:0060322 | head development | 354 | 539 | 1.98e-10 |
GO:BP | GO:0072073 | kidney epithelium development | 92 | 111 | 2.23e-10 |
GO:BP | GO:0030001 | metal ion transport | 345 | 524 | 2.32e-10 |
GO:BP | GO:0009968 | negative regulation of signal transduction | 600 | 972 | 2.48e-10 |
GO:BP | GO:0009967 | positive regulation of signal transduction | 667 | 1093 | 3.12e-10 |
GO:BP | GO:0001501 | skeletal system development | 240 | 347 | 3.22e-10 |
GO:BP | GO:0003007 | heart morphogenesis | 161 | 218 | 3.42e-10 |
GO:BP | GO:0003206 | cardiac chamber morphogenesis | 91 | 110 | 3.49e-10 |
GO:BP | GO:0044087 | regulation of cellular component biogenesis | 478 | 757 | 3.61e-10 |
GO:BP | GO:0045165 | cell fate commitment | 118 | 151 | 4.59e-10 |
GO:BP | GO:0003205 | cardiac chamber development | 118 | 151 | 4.59e-10 |
GO:BP | GO:0090596 | sensory organ morphogenesis | 132 | 173 | 5.78e-10 |
GO:BP | GO:0007420 | brain development | 328 | 498 | 7.15e-10 |
GO:BP | GO:0001822 | kidney development | 172 | 237 | 7.36e-10 |
GO:BP | GO:0032879 | regulation of localization | 855 | 1439 | 9.26e-10 |
GO:BP | GO:0034762 | regulation of transmembrane transport | 209 | 298 | 9.79e-10 |
GO:BP | GO:0007186 | G protein-coupled receptor signaling pathway | 261 | 386 | 1.63e-09 |
GO:BP | GO:0001823 | mesonephros development | 65 | 74 | 1.79e-09 |
GO:BP | GO:0006936 | muscle contraction | 182 | 255 | 1.94e-09 |
GO:BP | GO:1903522 | regulation of blood circulation | 144 | 194 | 2.29e-09 |
GO:BP | GO:0003231 | cardiac ventricle development | 93 | 115 | 2.36e-09 |
GO:BP | GO:0010975 | regulation of neuron projection development | 242 | 355 | 2.45e-09 |
GO:BP | GO:0045596 | negative regulation of cell differentiation | 299 | 452 | 2.74e-09 |
GO:BP | GO:0072164 | mesonephric tubule development | 64 | 73 | 2.95e-09 |
GO:BP | GO:0072163 | mesonephric epithelium development | 64 | 73 | 2.95e-09 |
GO:BP | GO:0060284 | regulation of cell development | 367 | 570 | 3.33e-09 |
GO:BP | GO:0090287 | regulation of cellular response to growth factor stimulus | 177 | 248 | 3.47e-09 |
GO:BP | GO:0030335 | positive regulation of cell migration | 265 | 395 | 3.86e-09 |
GO:BP | GO:0016310 | phosphorylation | 689 | 1145 | 4.94e-09 |
GO:BP | GO:0001657 | ureteric bud development | 63 | 72 | 4.94e-09 |
GO:BP | GO:0016043 | cellular component organization | 2629 | 4802 | 5.18e-09 |
GO:BP | GO:0051179 | localization | 2071 | 3731 | 5.58e-09 |
GO:BP | GO:0030900 | forebrain development | 191 | 272 | 5.75e-09 |
GO:BP | GO:2000147 | positive regulation of cell motility | 272 | 408 | 5.80e-09 |
GO:BP | GO:0007264 | small GTPase-mediated signal transduction | 261 | 390 | 7.69e-09 |
GO:BP | GO:0090257 | regulation of muscle system process | 132 | 177 | 8.05e-09 |
GO:BP | GO:0045785 | positive regulation of cell adhesion | 208 | 301 | 8.37e-09 |
GO:BP | GO:0140352 | export from cell | 379 | 594 | 8.42e-09 |
GO:BP | GO:0060560 | developmental growth involved in morphogenesis | 140 | 190 | 9.34e-09 |
GO:BP | GO:0003151 | outflow tract morphogenesis | 59 | 67 | 1.06e-08 |
GO:BP | GO:0060411 | cardiac septum morphogenesis | 59 | 67 | 1.06e-08 |
GO:BP | GO:0007409 | axonogenesis | 229 | 337 | 1.18e-08 |
GO:BP | GO:0061448 | connective tissue development | 149 | 205 | 1.27e-08 |
GO:BP | GO:0043269 | regulation of monoatomic ion transport | 196 | 282 | 1.27e-08 |
GO:BP | GO:0001837 | epithelial to mesenchymal transition | 106 | 137 | 1.32e-08 |
GO:BP | GO:0044093 | positive regulation of molecular function | 485 | 783 | 1.39e-08 |
GO:BP | GO:0060047 | heart contraction | 142 | 194 | 1.46e-08 |
GO:BP | GO:0051216 | cartilage development | 111 | 145 | 1.55e-08 |
GO:BP | GO:0040017 | positive regulation of locomotion | 275 | 416 | 1.62e-08 |
GO:BP | GO:0030855 | epithelial cell differentiation | 282 | 428 | 1.62e-08 |
GO:BP | GO:0048880 | sensory system development | 186 | 266 | 1.62e-08 |
GO:BP | GO:0042692 | muscle cell differentiation | 220 | 323 | 1.82e-08 |
GO:BP | GO:0099177 | regulation of trans-synaptic signaling | 220 | 323 | 1.82e-08 |
GO:BP | GO:0061564 | axon development | 249 | 372 | 1.82e-08 |
GO:BP | GO:0001654 | eye development | 184 | 263 | 1.84e-08 |
GO:BP | GO:0006810 | transport | 1673 | 2984 | 1.89e-08 |
GO:BP | GO:0007188 | adenylate cyclase-modulating G protein-coupled receptor signaling pathway | 90 | 113 | 1.89e-08 |
GO:BP | GO:0070887 | cellular response to chemical stimulus | 1015 | 1751 | 2.12e-08 |
GO:BP | GO:0050808 | synapse organization | 228 | 337 | 2.23e-08 |
GO:BP | GO:0035265 | organ growth | 99 | 127 | 2.28e-08 |
GO:BP | GO:0099537 | trans-synaptic signaling | 304 | 467 | 2.31e-08 |
GO:BP | GO:0050804 | modulation of chemical synaptic transmission | 219 | 322 | 2.36e-08 |
GO:BP | GO:0009792 | embryo development ending in birth or egg hatching | 335 | 521 | 2.49e-08 |
GO:BP | GO:0009893 | positive regulation of metabolic process | 1480 | 2622 | 2.65e-08 |
GO:BP | GO:0002062 | chondrocyte differentiation | 73 | 88 | 2.66e-08 |
GO:BP | GO:0150063 | visual system development | 184 | 264 | 2.85e-08 |
GO:BP | GO:0051056 | regulation of small GTPase mediated signal transduction | 165 | 233 | 3.35e-08 |
GO:BP | GO:0045937 | positive regulation of phosphate metabolic process | 301 | 463 | 3.37e-08 |
GO:BP | GO:0010562 | positive regulation of phosphorus metabolic process | 301 | 463 | 3.37e-08 |
GO:BP | GO:0010810 | regulation of cell-substrate adhesion | 121 | 162 | 3.39e-08 |
GO:BP | GO:0003018 | vascular process in circulatory system | 141 | 194 | 3.39e-08 |
GO:BP | GO:0065009 | regulation of molecular function | 768 | 1299 | 3.42e-08 |
GO:BP | GO:0048863 | stem cell differentiation | 139 | 191 | 3.84e-08 |
GO:BP | GO:0003015 | heart process | 147 | 204 | 3.96e-08 |
GO:BP | GO:0060419 | heart growth | 61 | 71 | 4.05e-08 |
GO:BP | GO:0198738 | cell-cell signaling by wnt | 240 | 359 | 4.09e-08 |
GO:BP | GO:1901888 | regulation of cell junction assembly | 117 | 156 | 4.09e-08 |
GO:BP | GO:0040007 | growth | 434 | 697 | 4.15e-08 |
GO:BP | GO:0048584 | positive regulation of response to stimulus | 879 | 1504 | 4.15e-08 |
GO:BP | GO:0050767 | regulation of neurogenesis | 199 | 290 | 4.29e-08 |
GO:BP | GO:0097485 | neuron projection guidance | 127 | 172 | 4.29e-08 |
GO:BP | GO:0007411 | axon guidance | 127 | 172 | 4.29e-08 |
GO:BP | GO:0003279 | cardiac septum development | 82 | 102 | 4.35e-08 |
GO:BP | GO:0099536 | synaptic signaling | 312 | 483 | 4.35e-08 |
GO:BP | GO:0090130 | tissue migration | 173 | 247 | 4.71e-08 |
GO:BP | GO:0043062 | extracellular structure organization | 159 | 224 | 4.73e-08 |
GO:BP | GO:0045229 | external encapsulating structure organization | 159 | 224 | 4.73e-08 |
GO:BP | GO:0001775 | cell activation | 394 | 627 | 4.92e-08 |
GO:BP | GO:0016055 | Wnt signaling pathway | 239 | 358 | 5.11e-08 |
GO:BP | GO:0010959 | regulation of metal ion transport | 168 | 239 | 5.22e-08 |
GO:BP | GO:0046903 | secretion | 391 | 622 | 5.28e-08 |
GO:BP | GO:0007268 | chemical synaptic transmission | 300 | 463 | 5.48e-08 |
GO:BP | GO:0098916 | anterograde trans-synaptic signaling | 300 | 463 | 5.48e-08 |
GO:BP | GO:0071310 | cellular response to organic substance | 765 | 1297 | 6.20e-08 |
GO:BP | GO:0045216 | cell-cell junction organization | 114 | 152 | 6.21e-08 |
GO:BP | GO:0008284 | positive regulation of cell population proliferation | 381 | 605 | 6.21e-08 |
GO:BP | GO:0030198 | extracellular matrix organization | 158 | 223 | 6.36e-08 |
GO:BP | GO:0043009 | chordate embryonic development | 325 | 507 | 6.45e-08 |
GO:BP | GO:0010243 | response to organonitrogen compound | 426 | 685 | 6.91e-08 |
GO:BP | GO:0040013 | negative regulation of locomotion | 170 | 243 | 7.05e-08 |
GO:BP | GO:0090132 | epithelium migration | 170 | 243 | 7.05e-08 |
GO:BP | GO:0010631 | epithelial cell migration | 170 | 243 | 7.05e-08 |
GO:BP | GO:0043410 | positive regulation of MAPK cascade | 197 | 288 | 7.18e-08 |
GO:BP | GO:0031589 | cell-substrate adhesion | 179 | 258 | 7.25e-08 |
GO:BP | GO:0008016 | regulation of heart contraction | 122 | 165 | 7.25e-08 |
GO:BP | GO:0006897 | endocytosis | 316 | 492 | 7.78e-08 |
GO:BP | GO:0072006 | nephron development | 90 | 115 | 8.05e-08 |
GO:BP | GO:0010033 | response to organic substance | 1002 | 1736 | 8.14e-08 |
GO:BP | GO:0031401 | positive regulation of protein modification process | 349 | 550 | 8.55e-08 |
GO:BP | GO:0097435 | supramolecular fiber organization | 396 | 633 | 9.09e-08 |
GO:BP | GO:0006816 | calcium ion transport | 181 | 262 | 9.74e-08 |
GO:BP | GO:0051146 | striated muscle cell differentiation | 164 | 234 | 1.07e-07 |
GO:BP | GO:0006811 | monoatomic ion transport | 444 | 719 | 1.11e-07 |
GO:BP | GO:0010604 | positive regulation of macromolecule metabolic process | 1364 | 2415 | 1.12e-07 |
GO:BP | GO:0003208 | cardiac ventricle morphogenesis | 54 | 62 | 1.14e-07 |
GO:BP | GO:0022407 | regulation of cell-cell adhesion | 190 | 278 | 1.48e-07 |
GO:BP | GO:0016331 | morphogenesis of embryonic epithelium | 94 | 122 | 1.48e-07 |
GO:BP | GO:0043010 | camera-type eye development | 161 | 230 | 1.68e-07 |
GO:BP | GO:0050877 | nervous system process | 376 | 600 | 1.71e-07 |
GO:BP | GO:0051962 | positive regulation of nervous system development | 150 | 212 | 1.77e-07 |
GO:BP | GO:0051130 | positive regulation of cellular component organization | 516 | 850 | 1.79e-07 |
GO:BP | GO:0006915 | apoptotic process | 805 | 1377 | 1.93e-07 |
GO:BP | GO:0060348 | bone development | 109 | 146 | 2.00e-07 |
GO:BP | GO:0035148 | tube formation | 95 | 124 | 2.01e-07 |
GO:BP | GO:0010632 | regulation of epithelial cell migration | 135 | 188 | 2.28e-07 |
GO:BP | GO:0061035 | regulation of cartilage development | 45 | 50 | 2.39e-07 |
GO:BP | GO:0071417 | cellular response to organonitrogen compound | 285 | 442 | 2.61e-07 |
GO:BP | GO:0050673 | epithelial cell proliferation | 202 | 300 | 3.06e-07 |
GO:BP | GO:0032940 | secretion by cell | 347 | 551 | 3.08e-07 |
GO:BP | GO:0043408 | regulation of MAPK cascade | 276 | 427 | 3.18e-07 |
GO:BP | GO:1901698 | response to nitrogen compound | 451 | 736 | 3.30e-07 |
GO:BP | GO:0070588 | calcium ion transmembrane transport | 148 | 210 | 3.30e-07 |
GO:BP | GO:0051234 | establishment of localization | 1795 | 3240 | 3.40e-07 |
GO:BP | GO:0008219 | cell death | 828 | 1423 | 3.56e-07 |
GO:BP | GO:0031399 | regulation of protein modification process | 548 | 911 | 3.60e-07 |
GO:BP | GO:0034220 | monoatomic ion transmembrane transport | 367 | 587 | 3.67e-07 |
GO:BP | GO:0033002 | muscle cell proliferation | 112 | 152 | 4.19e-07 |
GO:BP | GO:0012501 | programmed cell death | 825 | 1419 | 4.62e-07 |
GO:BP | GO:0023061 | signal release | 210 | 315 | 5.25e-07 |
GO:BP | GO:1901700 | response to oxygen-containing compound | 647 | 1093 | 5.44e-07 |
GO:BP | GO:0009605 | response to external stimulus | 900 | 1559 | 5.67e-07 |
GO:BP | GO:0061138 | morphogenesis of a branching epithelium | 101 | 135 | 5.72e-07 |
GO:BP | GO:0071773 | cellular response to BMP stimulus | 90 | 118 | 7.05e-07 |
GO:BP | GO:0071772 | response to BMP | 90 | 118 | 7.05e-07 |
GO:BP | GO:0034765 | regulation of monoatomic ion transmembrane transport | 147 | 210 | 7.29e-07 |
GO:BP | GO:0031325 | positive regulation of cellular metabolic process | 1313 | 2333 | 7.32e-07 |
GO:BP | GO:0001763 | morphogenesis of a branching structure | 107 | 145 | 7.56e-07 |
GO:BP | GO:0006937 | regulation of muscle contraction | 95 | 126 | 7.75e-07 |
GO:BP | GO:0098660 | inorganic ion transmembrane transport | 328 | 521 | 7.90e-07 |
GO:BP | GO:0061326 | renal tubule development | 61 | 74 | 8.38e-07 |
GO:BP | GO:0007178 | transmembrane receptor protein serine/threonine kinase signaling pathway | 191 | 284 | 8.38e-07 |
GO:BP | GO:0051046 | regulation of secretion | 256 | 396 | 1.02e-06 |
GO:BP | GO:0072175 | epithelial tube formation | 89 | 117 | 1.03e-06 |
GO:BP | GO:0055017 | cardiac muscle tissue growth | 54 | 64 | 1.10e-06 |
GO:BP | GO:0001503 | ossification | 201 | 302 | 1.24e-06 |
GO:BP | GO:1901342 | regulation of vasculature development | 139 | 198 | 1.29e-06 |
GO:BP | GO:0045664 | regulation of neuron differentiation | 97 | 130 | 1.33e-06 |
GO:BP | GO:0010717 | regulation of epithelial to mesenchymal transition | 68 | 85 | 1.35e-06 |
GO:BP | GO:0007159 | leukocyte cell-cell adhesion | 151 | 218 | 1.36e-06 |
GO:BP | GO:0007162 | negative regulation of cell adhesion | 131 | 185 | 1.38e-06 |
GO:BP | GO:0060038 | cardiac muscle cell proliferation | 39 | 43 | 1.41e-06 |
GO:BP | GO:0030336 | negative regulation of cell migration | 146 | 210 | 1.55e-06 |
GO:BP | GO:0007610 | behavior | 269 | 420 | 1.57e-06 |
GO:BP | GO:0048562 | embryonic organ morphogenesis | 129 | 182 | 1.58e-06 |
GO:BP | GO:0042472 | inner ear morphogenesis | 51 | 60 | 1.58e-06 |
GO:BP | GO:0009611 | response to wounding | 247 | 382 | 1.68e-06 |
GO:BP | GO:0035051 | cardiocyte differentiation | 98 | 132 | 1.68e-06 |
GO:BP | GO:0007369 | gastrulation | 103 | 140 | 1.69e-06 |
GO:BP | GO:0007389 | pattern specification process | 191 | 286 | 1.78e-06 |
GO:BP | GO:2000146 | negative regulation of cell motility | 150 | 217 | 1.79e-06 |
GO:BP | GO:0050769 | positive regulation of neurogenesis | 130 | 184 | 1.86e-06 |
GO:BP | GO:1901701 | cellular response to oxygen-containing compound | 480 | 796 | 1.86e-06 |
GO:BP | GO:0055085 | transmembrane transport | 549 | 921 | 1.86e-06 |
GO:BP | GO:0030048 | actin filament-based movement | 82 | 107 | 1.90e-06 |
GO:BP | GO:0006935 | chemotaxis | 166 | 244 | 1.95e-06 |
GO:BP | GO:0042330 | taxis | 166 | 244 | 1.95e-06 |
GO:BP | GO:0003281 | ventricular septum development | 57 | 69 | 1.95e-06 |
GO:BP | GO:0007189 | adenylate cyclase-activating G protein-coupled receptor signaling pathway | 61 | 75 | 2.05e-06 |
GO:BP | GO:0030510 | regulation of BMP signaling pathway | 63 | 78 | 2.05e-06 |
GO:BP | GO:0045321 | leukocyte activation | 331 | 530 | 2.06e-06 |
GO:BP | GO:0046777 | protein autophosphorylation | 104 | 142 | 2.07e-06 |
GO:BP | GO:0043085 | positive regulation of catalytic activity | 340 | 546 | 2.08e-06 |
GO:BP | GO:0006796 | phosphate-containing compound metabolic process | 1069 | 1883 | 2.08e-06 |
GO:BP | GO:0003229 | ventricular cardiac muscle tissue development | 48 | 56 | 2.17e-06 |
GO:BP | GO:0007015 | actin filament organization | 232 | 357 | 2.19e-06 |
GO:BP | GO:0044089 | positive regulation of cellular component biogenesis | 251 | 390 | 2.24e-06 |
GO:BP | GO:0006812 | monoatomic cation transport | 378 | 614 | 2.31e-06 |
GO:BP | GO:2000027 | regulation of animal organ morphogenesis | 50 | 59 | 2.45e-06 |
GO:BP | GO:0150115 | cell-substrate junction organization | 74 | 95 | 2.46e-06 |
GO:BP | GO:0051174 | regulation of phosphorus metabolic process | 484 | 805 | 2.62e-06 |
GO:BP | GO:0042327 | positive regulation of phosphorylation | 265 | 415 | 2.69e-06 |
GO:BP | GO:0098662 | inorganic cation transmembrane transport | 302 | 480 | 2.78e-06 |
GO:BP | GO:0007517 | muscle organ development | 179 | 267 | 2.87e-06 |
GO:BP | GO:0048839 | inner ear development | 98 | 133 | 2.92e-06 |
GO:BP | GO:0060993 | kidney morphogenesis | 56 | 68 | 2.99e-06 |
GO:BP | GO:0048645 | animal organ formation | 45 | 52 | 2.99e-06 |
GO:BP | GO:0051247 | positive regulation of protein metabolic process | 542 | 911 | 3.04e-06 |
GO:BP | GO:0090092 | regulation of transmembrane receptor protein serine/threonine kinase signaling pathway | 145 | 210 | 3.05e-06 |
GO:BP | GO:0019220 | regulation of phosphate metabolic process | 483 | 804 | 3.05e-06 |
GO:BP | GO:0014033 | neural crest cell differentiation | 62 | 77 | 3.06e-06 |
GO:BP | GO:1902533 | positive regulation of intracellular signal transduction | 433 | 714 | 3.17e-06 |
GO:BP | GO:0051050 | positive regulation of transport | 353 | 571 | 3.29e-06 |
GO:BP | GO:0043583 | ear development | 109 | 151 | 3.37e-06 |
GO:BP | GO:0055008 | cardiac muscle tissue morphogenesis | 47 | 55 | 3.45e-06 |
GO:BP | GO:0098655 | monoatomic cation transmembrane transport | 310 | 495 | 3.46e-06 |
GO:BP | GO:0006793 | phosphorus metabolic process | 1078 | 1904 | 3.53e-06 |
GO:BP | GO:0001704 | formation of primary germ layer | 73 | 94 | 3.59e-06 |
GO:BP | GO:0042592 | homeostatic process | 665 | 1137 | 3.62e-06 |
GO:BP | GO:0030111 | regulation of Wnt signaling pathway | 175 | 261 | 3.77e-06 |
GO:BP | GO:0072028 | nephron morphogenesis | 49 | 58 | 3.81e-06 |
GO:BP | GO:0061333 | renal tubule morphogenesis | 49 | 58 | 3.81e-06 |
GO:BP | GO:0048844 | artery morphogenesis | 49 | 58 | 3.81e-06 |
GO:BP | GO:0045765 | regulation of angiogenesis | 135 | 194 | 3.94e-06 |
GO:BP | GO:0007044 | cell-substrate junction assembly | 69 | 88 | 3.99e-06 |
GO:BP | GO:0051924 | regulation of calcium ion transport | 110 | 153 | 4.04e-06 |
GO:BP | GO:0060415 | muscle tissue morphogenesis | 51 | 61 | 4.12e-06 |
GO:BP | GO:0061337 | cardiac conduction | 67 | 85 | 4.17e-06 |
GO:BP | GO:0048644 | muscle organ morphogenesis | 53 | 64 | 4.37e-06 |
GO:BP | GO:0072080 | nephron tubule development | 57 | 70 | 4.61e-06 |
GO:BP | GO:0042391 | regulation of membrane potential | 187 | 282 | 4.61e-06 |
GO:BP | GO:0030509 | BMP signaling pathway | 83 | 110 | 4.62e-06 |
GO:BP | GO:0071840 | cellular component organization or biogenesis | 2690 | 4988 | 5.01e-06 |
GO:BP | GO:0022612 | gland morphogenesis | 72 | 93 | 5.24e-06 |
GO:BP | GO:1901699 | cellular response to nitrogen compound | 300 | 479 | 5.24e-06 |
GO:BP | GO:0042060 | wound healing | 192 | 291 | 5.39e-06 |
GO:BP | GO:0048167 | regulation of synaptic plasticity | 101 | 139 | 5.46e-06 |
GO:BP | GO:0001952 | regulation of cell-matrix adhesion | 70 | 90 | 5.56e-06 |
GO:BP | GO:0000165 | MAPK cascade | 314 | 504 | 5.56e-06 |
GO:BP | GO:0022409 | positive regulation of cell-cell adhesion | 123 | 175 | 5.72e-06 |
GO:BP | GO:0070252 | actin-mediated cell contraction | 68 | 87 | 5.90e-06 |
GO:BP | GO:0060070 | canonical Wnt signaling pathway | 163 | 242 | 6.11e-06 |
GO:BP | GO:0072009 | nephron epithelium development | 66 | 84 | 6.22e-06 |
GO:BP | GO:0014070 | response to organic cyclic compound | 371 | 606 | 6.31e-06 |
GO:BP | GO:0060412 | ventricular septum morphogenesis | 36 | 40 | 6.35e-06 |
GO:BP | GO:0060421 | positive regulation of heart growth | 27 | 28 | 6.52e-06 |
GO:BP | GO:0001932 | regulation of protein phosphorylation | 391 | 642 | 6.52e-06 |
GO:BP | GO:0009987 | cellular process | 5561 | 10686 | 6.84e-06 |
GO:BP | GO:0021915 | neural tube development | 97 | 133 | 6.88e-06 |
GO:BP | GO:0090288 | negative regulation of cellular response to growth factor stimulus | 60 | 75 | 6.88e-06 |
GO:BP | GO:0006941 | striated muscle contraction | 105 | 146 | 7.11e-06 |
GO:BP | GO:0001838 | embryonic epithelial tube formation | 80 | 106 | 7.20e-06 |
GO:BP | GO:0031214 | biomineral tissue development | 80 | 106 | 7.20e-06 |
GO:BP | GO:0018212 | peptidyl-tyrosine modification | 116 | 164 | 7.20e-06 |
GO:BP | GO:0051336 | regulation of hydrolase activity | 272 | 431 | 7.29e-06 |
GO:BP | GO:0001934 | positive regulation of protein phosphorylation | 252 | 396 | 7.41e-06 |
GO:BP | GO:0090100 | positive regulation of transmembrane receptor protein serine/threonine kinase signaling pathway | 67 | 86 | 8.72e-06 |
GO:BP | GO:0050803 | regulation of synapse structure or activity | 123 | 176 | 9.02e-06 |
GO:BP | GO:0072088 | nephron epithelium morphogenesis | 47 | 56 | 9.52e-06 |
GO:BP | GO:0060048 | cardiac muscle contraction | 86 | 116 | 9.88e-06 |
GO:BP | GO:0050807 | regulation of synapse organization | 121 | 173 | 1.04e-05 |
GO:BP | GO:0002521 | leukocyte differentiation | 237 | 371 | 1.07e-05 |
GO:BP | GO:1904062 | regulation of monoatomic cation transmembrane transport | 130 | 188 | 1.07e-05 |
GO:BP | GO:0032970 | regulation of actin filament-based process | 196 | 300 | 1.09e-05 |
GO:BP | GO:1903530 | regulation of secretion by cell | 234 | 366 | 1.14e-05 |
GO:BP | GO:0141091 | transforming growth factor beta receptor superfamily signaling pathway | 172 | 259 | 1.15e-05 |
GO:BP | GO:0009628 | response to abiotic stimulus | 483 | 811 | 1.16e-05 |
GO:BP | GO:0035108 | limb morphogenesis | 82 | 110 | 1.22e-05 |
GO:BP | GO:0035107 | appendage morphogenesis | 82 | 110 | 1.22e-05 |
GO:BP | GO:0060420 | regulation of heart growth | 42 | 49 | 1.23e-05 |
GO:BP | GO:0098742 | cell-cell adhesion via plasma-membrane adhesion molecules | 108 | 152 | 1.24e-05 |
GO:BP | GO:0060045 | positive regulation of cardiac muscle cell proliferation | 22 | 22 | 1.24e-05 |
GO:BP | GO:0003148 | outflow tract septum morphogenesis | 22 | 22 | 1.24e-05 |
GO:BP | GO:0009612 | response to mechanical stimulus | 108 | 152 | 1.24e-05 |
GO:BP | GO:0060840 | artery development | 66 | 85 | 1.28e-05 |
GO:BP | GO:0042325 | regulation of phosphorylation | 412 | 683 | 1.28e-05 |
GO:BP | GO:0018108 | peptidyl-tyrosine phosphorylation | 114 | 162 | 1.32e-05 |
GO:BP | GO:0060043 | regulation of cardiac muscle cell proliferation | 29 | 31 | 1.32e-05 |
GO:BP | GO:0002065 | columnar/cuboidal epithelial cell differentiation | 64 | 82 | 1.35e-05 |
GO:BP | GO:0051173 | positive regulation of nitrogen compound metabolic process | 1222 | 2186 | 1.35e-05 |
GO:BP | GO:1903037 | regulation of leukocyte cell-cell adhesion | 135 | 197 | 1.39e-05 |
GO:BP | GO:0003179 | heart valve morphogenesis | 46 | 55 | 1.49e-05 |
GO:BP | GO:0060395 | SMAD protein signal transduction | 60 | 76 | 1.50e-05 |
GO:BP | GO:0098771 | inorganic ion homeostasis | 223 | 348 | 1.58e-05 |
GO:BP | GO:0007160 | cell-matrix adhesion | 118 | 169 | 1.58e-05 |
GO:BP | GO:0048588 | developmental cell growth | 124 | 179 | 1.61e-05 |
GO:BP | GO:0055074 | calcium ion homeostasis | 146 | 216 | 1.71e-05 |
GO:BP | GO:0090090 | negative regulation of canonical Wnt signaling pathway | 81 | 109 | 1.72e-05 |
GO:BP | GO:0007498 | mesoderm development | 65 | 84 | 1.90e-05 |
GO:BP | GO:0032409 | regulation of transporter activity | 105 | 148 | 1.92e-05 |
GO:BP | GO:0097553 | calcium ion transmembrane import into cytosol | 89 | 122 | 1.92e-05 |
GO:BP | GO:0050806 | positive regulation of synaptic transmission | 79 | 106 | 1.92e-05 |
GO:BP | GO:0110110 | positive regulation of animal organ morphogenesis | 25 | 26 | 2.07e-05 |
GO:BP | GO:0043270 | positive regulation of monoatomic ion transport | 92 | 127 | 2.10e-05 |
GO:BP | GO:0032330 | regulation of chondrocyte differentiation | 31 | 34 | 2.12e-05 |
GO:BP | GO:0003161 | cardiac conduction system development | 31 | 34 | 2.12e-05 |
GO:BP | GO:0050678 | regulation of epithelial cell proliferation | 165 | 249 | 2.25e-05 |
GO:BP | GO:0090066 | regulation of anatomical structure size | 240 | 379 | 2.29e-05 |
GO:BP | GO:1905314 | semi-lunar valve development | 36 | 41 | 2.29e-05 |
GO:BP | GO:0035924 | cellular response to vascular endothelial growth factor stimulus | 45 | 54 | 2.33e-05 |
GO:BP | GO:0072078 | nephron tubule morphogenesis | 45 | 54 | 2.33e-05 |
GO:BP | GO:0014910 | regulation of smooth muscle cell migration | 45 | 54 | 2.33e-05 |
GO:BP | GO:0010817 | regulation of hormone levels | 205 | 318 | 2.33e-05 |
GO:BP | GO:0048660 | regulation of smooth muscle cell proliferation | 73 | 97 | 2.61e-05 |
GO:BP | GO:0048732 | gland development | 199 | 308 | 2.64e-05 |
GO:BP | GO:0006874 | intracellular calcium ion homeostasis | 137 | 202 | 2.70e-05 |
GO:BP | GO:0046879 | hormone secretion | 137 | 202 | 2.70e-05 |
GO:BP | GO:0048771 | tissue remodeling | 83 | 113 | 2.73e-05 |
GO:BP | GO:0048754 | branching morphogenesis of an epithelial tube | 83 | 113 | 2.73e-05 |
GO:BP | GO:0055010 | ventricular cardiac muscle tissue morphogenesis | 38 | 44 | 2.74e-05 |
GO:BP | GO:0022898 | regulation of transmembrane transporter activity | 99 | 139 | 2.85e-05 |
GO:BP | GO:0031346 | positive regulation of cell projection organization | 186 | 286 | 3.07e-05 |
GO:BP | GO:0048041 | focal adhesion assembly | 60 | 77 | 3.18e-05 |
GO:BP | GO:0050865 | regulation of cell activation | 221 | 347 | 3.25e-05 |
GO:BP | GO:0099003 | vesicle-mediated transport in synapse | 117 | 169 | 3.29e-05 |
GO:BP | GO:0001649 | osteoblast differentiation | 120 | 174 | 3.29e-05 |
GO:BP | GO:0015833 | peptide transport | 123 | 179 | 3.29e-05 |
GO:BP | GO:0031644 | regulation of nervous system process | 58 | 74 | 3.33e-05 |
GO:BP | GO:0048864 | stem cell development | 58 | 74 | 3.33e-05 |
GO:BP | GO:0042471 | ear morphogenesis | 58 | 74 | 3.33e-05 |
GO:BP | GO:0046649 | lymphocyte activation | 276 | 444 | 3.36e-05 |
GO:BP | GO:0048592 | eye morphogenesis | 79 | 107 | 3.41e-05 |
GO:BP | GO:0055023 | positive regulation of cardiac muscle tissue growth | 24 | 25 | 3.65e-05 |
GO:BP | GO:0003170 | heart valve development | 52 | 65 | 3.77e-05 |
GO:BP | GO:0043087 | regulation of GTPase activity | 115 | 166 | 3.77e-05 |
GO:BP | GO:0035296 | regulation of tube diameter | 75 | 101 | 4.29e-05 |
GO:BP | GO:0007163 | establishment or maintenance of cell polarity | 125 | 183 | 4.29e-05 |
GO:BP | GO:0035150 | regulation of tube size | 75 | 101 | 4.29e-05 |
GO:BP | GO:0097746 | blood vessel diameter maintenance | 75 | 101 | 4.29e-05 |
GO:BP | GO:0030178 | negative regulation of Wnt signaling pathway | 96 | 135 | 4.45e-05 |
GO:BP | GO:0006813 | potassium ion transport | 96 | 135 | 4.45e-05 |
GO:BP | GO:0003002 | regionalization | 169 | 258 | 4.65e-05 |
GO:BP | GO:0010634 | positive regulation of epithelial cell migration | 91 | 127 | 4.83e-05 |
GO:BP | GO:0050878 | regulation of body fluid levels | 152 | 229 | 4.83e-05 |
GO:BP | GO:0009914 | hormone transport | 139 | 207 | 5.02e-05 |
GO:BP | GO:0072171 | mesonephric tubule morphogenesis | 39 | 46 | 5.02e-05 |
GO:BP | GO:0048878 | chemical homeostasis | 401 | 670 | 5.04e-05 |
GO:BP | GO:0048638 | regulation of developmental growth | 160 | 243 | 5.41e-05 |
GO:BP | GO:0043491 | phosphatidylinositol 3-kinase/protein kinase B signal transduction | 143 | 214 | 5.43e-05 |
GO:BP | GO:0071407 | cellular response to organic cyclic compound | 238 | 379 | 5.89e-05 |
GO:BP | GO:0072091 | regulation of stem cell proliferation | 49 | 61 | 5.89e-05 |
GO:BP | GO:0009891 | positive regulation of biosynthetic process | 1040 | 1856 | 6.19e-05 |
GO:BP | GO:0030097 | hemopoiesis | 375 | 624 | 6.22e-05 |
GO:BP | GO:0060078 | regulation of postsynaptic membrane potential | 60 | 78 | 6.44e-05 |
GO:BP | GO:0031032 | actomyosin structure organization | 125 | 184 | 6.44e-05 |
GO:BP | GO:0003272 | endocardial cushion formation | 23 | 24 | 6.53e-05 |
GO:BP | GO:0051345 | positive regulation of hydrolase activity | 173 | 266 | 6.68e-05 |
GO:BP | GO:0010628 | positive regulation of gene expression | 442 | 746 | 6.76e-05 |
GO:BP | GO:0048736 | appendage development | 96 | 136 | 7.25e-05 |
GO:BP | GO:0060173 | limb development | 96 | 136 | 7.25e-05 |
GO:BP | GO:0014812 | muscle cell migration | 56 | 72 | 7.43e-05 |
GO:BP | GO:0031328 | positive regulation of cellular biosynthetic process | 1031 | 1841 | 7.75e-05 |
GO:BP | GO:0003184 | pulmonary valve morphogenesis | 19 | 19 | 7.75e-05 |
GO:BP | GO:0014032 | neural crest cell development | 54 | 69 | 7.88e-05 |
GO:BP | GO:0006939 | smooth muscle contraction | 54 | 69 | 7.88e-05 |
GO:BP | GO:0060675 | ureteric bud morphogenesis | 38 | 45 | 8.03e-05 |
GO:BP | GO:1902107 | positive regulation of leukocyte differentiation | 83 | 115 | 8.09e-05 |
GO:BP | GO:1903708 | positive regulation of hemopoiesis | 83 | 115 | 8.09e-05 |
GO:BP | GO:0042110 | T cell activation | 195 | 305 | 8.59e-05 |
GO:BP | GO:0010718 | positive regulation of epithelial to mesenchymal transition | 40 | 48 | 8.60e-05 |
GO:BP | GO:0021953 | central nervous system neuron differentiation | 73 | 99 | 8.60e-05 |
GO:BP | GO:0071805 | potassium ion transmembrane transport | 86 | 120 | 8.61e-05 |
GO:BP | GO:0055001 | muscle cell development | 112 | 163 | 8.88e-05 |
GO:BP | GO:0001707 | mesoderm formation | 42 | 51 | 8.89e-05 |
GO:BP | GO:0014909 | smooth muscle cell migration | 48 | 60 | 8.89e-05 |
GO:BP | GO:0072132 | mesenchyme morphogenesis | 42 | 51 | 8.89e-05 |
GO:BP | GO:0045666 | positive regulation of neuron differentiation | 46 | 57 | 9.01e-05 |
GO:BP | GO:0043067 | regulation of programmed cell death | 612 | 1060 | 9.15e-05 |
GO:BP | GO:0070372 | regulation of ERK1 and ERK2 cascade | 119 | 175 | 9.88e-05 |
GO:BP | GO:0006949 | syncytium formation | 33 | 38 | 1.00e-04 |
GO:BP | GO:0031345 | negative regulation of cell projection organization | 101 | 145 | 1.01e-04 |
GO:BP | GO:0050790 | regulation of catalytic activity | 521 | 893 | 1.02e-04 |
GO:BP | GO:0008544 | epidermis development | 139 | 209 | 1.04e-04 |
GO:BP | GO:0008150 | biological_process | 5821 | 11244 | 1.13e-04 |
GO:BP | GO:0061036 | positive regulation of cartilage development | 22 | 23 | 1.15e-04 |
GO:BP | GO:0002063 | chondrocyte development | 22 | 23 | 1.15e-04 |
GO:BP | GO:0070371 | ERK1 and ERK2 cascade | 130 | 194 | 1.16e-04 |
GO:BP | GO:0060541 | respiratory system development | 111 | 162 | 1.17e-04 |
GO:BP | GO:0048639 | positive regulation of developmental growth | 85 | 119 | 1.18e-04 |
GO:BP | GO:0045667 | regulation of osteoblast differentiation | 72 | 98 | 1.21e-04 |
GO:BP | GO:0030010 | establishment of cell polarity | 88 | 124 | 1.24e-04 |
GO:BP | GO:0055021 | regulation of cardiac muscle tissue growth | 37 | 44 | 1.27e-04 |
GO:BP | GO:0060976 | coronary vasculature development | 37 | 44 | 1.27e-04 |
GO:BP | GO:0042981 | regulation of apoptotic process | 595 | 1031 | 1.31e-04 |
GO:BP | GO:0032412 | regulation of monoatomic ion transmembrane transporter activity | 94 | 134 | 1.31e-04 |
GO:BP | GO:0046883 | regulation of hormone secretion | 112 | 164 | 1.33e-04 |
GO:BP | GO:0014855 | striated muscle cell proliferation | 47 | 59 | 1.34e-04 |
GO:BP | GO:0060828 | regulation of canonical Wnt signaling pathway | 135 | 203 | 1.39e-04 |
GO:BP | GO:0048332 | mesoderm morphogenesis | 43 | 53 | 1.39e-04 |
GO:BP | GO:0051249 | regulation of lymphocyte activation | 179 | 279 | 1.47e-04 |
GO:BP | GO:0003158 | endothelium development | 73 | 100 | 1.50e-04 |
GO:BP | GO:0002790 | peptide secretion | 113 | 166 | 1.52e-04 |
GO:BP | GO:0010594 | regulation of endothelial cell migration | 95 | 136 | 1.54e-04 |
GO:BP | GO:1903039 | positive regulation of leukocyte cell-cell adhesion | 101 | 146 | 1.57e-04 |
GO:BP | GO:0010557 | positive regulation of macromolecule biosynthetic process | 1001 | 1791 | 1.61e-04 |
GO:BP | GO:0003176 | aortic valve development | 32 | 37 | 1.63e-04 |
GO:BP | GO:0055007 | cardiac muscle cell differentiation | 76 | 105 | 1.63e-04 |
GO:BP | GO:0050708 | regulation of protein secretion | 120 | 178 | 1.64e-04 |
GO:BP | GO:0021537 | telencephalon development | 130 | 195 | 1.66e-04 |
GO:BP | GO:0019722 | calcium-mediated signaling | 87 | 123 | 1.67e-04 |
GO:BP | GO:0030513 | positive regulation of BMP signaling pathway | 27 | 30 | 1.72e-04 |
GO:BP | GO:0048705 | skeletal system morphogenesis | 102 | 148 | 1.81e-04 |
GO:BP | GO:0002694 | regulation of leukocyte activation | 198 | 313 | 1.85e-04 |
GO:BP | GO:0050770 | regulation of axonogenesis | 88 | 125 | 2.00e-04 |
GO:BP | GO:0048663 | neuron fate commitment | 24 | 26 | 2.04e-04 |
GO:BP | GO:0010092 | specification of animal organ identity | 24 | 26 | 2.04e-04 |
GO:BP | GO:0003177 | pulmonary valve development | 21 | 22 | 2.04e-04 |
GO:BP | GO:0050870 | positive regulation of T cell activation | 94 | 135 | 2.07e-04 |
GO:BP | GO:0051893 | regulation of focal adhesion assembly | 44 | 55 | 2.09e-04 |
GO:BP | GO:0003197 | endocardial cushion development | 38 | 46 | 2.09e-04 |
GO:BP | GO:0090109 | regulation of cell-substrate junction assembly | 44 | 55 | 2.09e-04 |
GO:BP | GO:0060390 | regulation of SMAD protein signal transduction | 40 | 49 | 2.13e-04 |
GO:BP | GO:1902105 | regulation of leukocyte differentiation | 129 | 194 | 2.14e-04 |
GO:BP | GO:0071692 | protein localization to extracellular region | 165 | 256 | 2.18e-04 |
GO:BP | GO:2000648 | positive regulation of stem cell proliferation | 29 | 33 | 2.21e-04 |
GO:BP | GO:0003180 | aortic valve morphogenesis | 29 | 33 | 2.21e-04 |
GO:BP | GO:0061572 | actin filament bundle organization | 92 | 132 | 2.37e-04 |
GO:BP | GO:0002573 | myeloid leukocyte differentiation | 104 | 152 | 2.37e-04 |
GO:BP | GO:0070482 | response to oxygen levels | 170 | 265 | 2.39e-04 |
GO:BP | GO:0048565 | digestive tract development | 65 | 88 | 2.39e-04 |
GO:BP | GO:0001935 | endothelial cell proliferation | 81 | 114 | 2.51e-04 |
GO:BP | GO:0036211 | protein modification process | 1263 | 2291 | 2.54e-04 |
GO:BP | GO:0048659 | smooth muscle cell proliferation | 73 | 101 | 2.55e-04 |
GO:BP | GO:0060445 | branching involved in salivary gland morphogenesis | 17 | 17 | 2.58e-04 |
GO:BP | GO:0061351 | neural precursor cell proliferation | 84 | 119 | 2.60e-04 |
GO:BP | GO:0140253 | cell-cell fusion | 31 | 36 | 2.61e-04 |
GO:BP | GO:0038084 | vascular endothelial growth factor signaling pathway | 31 | 36 | 2.61e-04 |
GO:BP | GO:0000768 | syncytium formation by plasma membrane fusion | 31 | 36 | 2.61e-04 |
GO:BP | GO:0010463 | mesenchymal cell proliferation | 31 | 36 | 2.61e-04 |
GO:BP | GO:0045446 | endothelial cell differentiation | 63 | 85 | 2.66e-04 |
GO:BP | GO:0007492 | endoderm development | 49 | 63 | 2.68e-04 |
GO:BP | GO:0007043 | cell-cell junction assembly | 76 | 106 | 2.70e-04 |
GO:BP | GO:1990138 | neuron projection extension | 93 | 134 | 2.72e-04 |
GO:BP | GO:0150116 | regulation of cell-substrate junction organization | 47 | 60 | 2.85e-04 |
GO:BP | GO:1902893 | regulation of miRNA transcription | 47 | 60 | 2.85e-04 |
GO:BP | GO:0002040 | sprouting angiogenesis | 71 | 98 | 2.87e-04 |
GO:BP | GO:0001658 | branching involved in ureteric bud morphogenesis | 33 | 39 | 2.90e-04 |
GO:BP | GO:0071774 | response to fibroblast growth factor | 61 | 82 | 2.96e-04 |
GO:BP | GO:0051283 | negative regulation of sequestering of calcium ion | 66 | 90 | 2.96e-04 |
GO:BP | GO:0071559 | response to transforming growth factor beta | 143 | 219 | 2.97e-04 |
GO:BP | GO:1903131 | mononuclear cell differentiation | 177 | 278 | 2.97e-04 |
GO:BP | GO:0006954 | inflammatory response | 260 | 425 | 3.08e-04 |
GO:BP | GO:0032835 | glomerulus development | 43 | 54 | 3.11e-04 |
GO:BP | GO:0086065 | cell communication involved in cardiac conduction | 43 | 54 | 3.11e-04 |
GO:BP | GO:0051017 | actin filament bundle assembly | 91 | 131 | 3.11e-04 |
GO:BP | GO:1903169 | regulation of calcium ion transmembrane transport | 77 | 108 | 3.23e-04 |
GO:BP | GO:0042476 | odontogenesis | 59 | 79 | 3.27e-04 |
GO:BP | GO:0044344 | cellular response to fibroblast growth factor stimulus | 59 | 79 | 3.27e-04 |
GO:BP | GO:0048593 | camera-type eye morphogenesis | 64 | 87 | 3.30e-04 |
GO:BP | GO:0014020 | primary neural tube formation | 64 | 87 | 3.30e-04 |
GO:BP | GO:0030326 | embryonic limb morphogenesis | 64 | 87 | 3.30e-04 |
GO:BP | GO:0035113 | embryonic appendage morphogenesis | 64 | 87 | 3.30e-04 |
GO:BP | GO:0032956 | regulation of actin cytoskeleton organization | 167 | 261 | 3.35e-04 |
GO:BP | GO:0050863 | regulation of T cell activation | 134 | 204 | 3.45e-04 |
GO:BP | GO:1902532 | negative regulation of intracellular signal transduction | 263 | 431 | 3.51e-04 |
GO:BP | GO:0002064 | epithelial cell development | 101 | 148 | 3.51e-04 |
GO:BP | GO:0050730 | regulation of peptidyl-tyrosine phosphorylation | 95 | 138 | 3.58e-04 |
GO:BP | GO:0001841 | neural tube formation | 67 | 92 | 3.63e-04 |
GO:BP | GO:0010721 | negative regulation of cell development | 121 | 182 | 3.74e-04 |
GO:BP | GO:0060349 | bone morphogenesis | 55 | 73 | 4.03e-04 |
GO:BP | GO:0051209 | release of sequestered calcium ion into cytosol | 65 | 89 | 4.13e-04 |
GO:BP | GO:0006942 | regulation of striated muscle contraction | 60 | 81 | 4.16e-04 |
GO:BP | GO:0045860 | positive regulation of protein kinase activity | 122 | 184 | 4.16e-04 |
GO:BP | GO:0046622 | positive regulation of organ growth | 30 | 35 | 4.16e-04 |
GO:BP | GO:0030072 | peptide hormone secretion | 109 | 162 | 4.32e-04 |
GO:BP | GO:0071560 | cellular response to transforming growth factor beta stimulus | 140 | 215 | 4.32e-04 |
GO:BP | GO:0045444 | fat cell differentiation | 119 | 179 | 4.33e-04 |
GO:BP | GO:0098659 | inorganic cation import across plasma membrane | 53 | 70 | 4.40e-04 |
GO:BP | GO:0016049 | cell growth | 235 | 382 | 4.40e-04 |
GO:BP | GO:0099565 | chemical synaptic transmission, postsynaptic | 53 | 70 | 4.40e-04 |
GO:BP | GO:0099587 | inorganic ion import across plasma membrane | 53 | 70 | 4.40e-04 |
GO:BP | GO:0043616 | keratinocyte proliferation | 32 | 38 | 4.56e-04 |
GO:BP | GO:0099173 | postsynapse organization | 100 | 147 | 4.61e-04 |
GO:BP | GO:0050679 | positive regulation of epithelial cell proliferation | 97 | 142 | 4.69e-04 |
GO:BP | GO:2000463 | positive regulation of excitatory postsynaptic potential | 25 | 28 | 4.70e-04 |
GO:BP | GO:0098739 | import across plasma membrane | 85 | 122 | 4.70e-04 |
GO:BP | GO:0030073 | insulin secretion | 94 | 137 | 4.72e-04 |
GO:BP | GO:0098815 | modulation of excitatory postsynaptic potential | 34 | 41 | 4.78e-04 |
GO:BP | GO:1905330 | regulation of morphogenesis of an epithelium | 34 | 41 | 4.78e-04 |
GO:BP | GO:0048010 | vascular endothelial growth factor receptor signaling pathway | 40 | 50 | 4.78e-04 |
GO:BP | GO:0034332 | adherens junction organization | 36 | 44 | 4.89e-04 |
GO:BP | GO:0007156 | homophilic cell adhesion via plasma membrane adhesion molecules | 66 | 91 | 5.02e-04 |
GO:BP | GO:0034767 | positive regulation of monoatomic ion transmembrane transport | 66 | 91 | 5.02e-04 |
GO:BP | GO:0009306 | protein secretion | 161 | 252 | 5.06e-04 |
GO:BP | GO:0035592 | establishment of protein localization to extracellular region | 161 | 252 | 5.06e-04 |
GO:BP | GO:0086003 | cardiac muscle cell contraction | 49 | 64 | 5.24e-04 |
GO:BP | GO:0016358 | dendrite development | 121 | 183 | 5.26e-04 |
GO:BP | GO:0030324 | lung development | 98 | 144 | 5.28e-04 |
GO:BP | GO:0055123 | digestive system development | 69 | 96 | 5.36e-04 |
GO:BP | GO:0061614 | miRNA transcription | 47 | 61 | 5.69e-04 |
GO:BP | GO:0042063 | gliogenesis | 155 | 242 | 5.80e-04 |
GO:BP | GO:0051251 | positive regulation of lymphocyte activation | 122 | 185 | 5.82e-04 |
GO:BP | GO:0030098 | lymphocyte differentiation | 159 | 249 | 5.83e-04 |
GO:BP | GO:0042886 | amide transport | 133 | 204 | 6.02e-04 |
GO:BP | GO:0043069 | negative regulation of programmed cell death | 378 | 642 | 6.10e-04 |
GO:BP | GO:0016192 | vesicle-mediated transport | 654 | 1152 | 6.14e-04 |
GO:BP | GO:1904018 | positive regulation of vasculature development | 81 | 116 | 6.18e-04 |
GO:BP | GO:0007416 | synapse assembly | 93 | 136 | 6.18e-04 |
GO:BP | GO:0051051 | negative regulation of transport | 180 | 286 | 6.18e-04 |
GO:BP | GO:0051235 | maintenance of location | 160 | 251 | 6.25e-04 |
GO:BP | GO:0032526 | response to retinoic acid | 57 | 77 | 6.51e-04 |
GO:BP | GO:0001666 | response to hypoxia | 149 | 232 | 6.58e-04 |
GO:BP | GO:0006898 | receptor-mediated endocytosis | 120 | 182 | 6.71e-04 |
GO:BP | GO:0030323 | respiratory tube development | 100 | 148 | 6.76e-04 |
GO:BP | GO:0001708 | cell fate specification | 41 | 52 | 6.91e-04 |
GO:BP | GO:0001570 | vasculogenesis | 50 | 66 | 6.93e-04 |
GO:BP | GO:0050796 | regulation of insulin secretion | 79 | 113 | 7.12e-04 |
GO:BP | GO:0050920 | regulation of chemotaxis | 91 | 133 | 7.15e-04 |
GO:BP | GO:0030100 | regulation of endocytosis | 128 | 196 | 7.32e-04 |
GO:BP | GO:0071526 | semaphorin-plexin signaling pathway | 35 | 43 | 7.54e-04 |
GO:BP | GO:0036293 | response to decreased oxygen levels | 155 | 243 | 7.73e-04 |
GO:BP | GO:0050801 | monoatomic ion homeostasis | 247 | 406 | 7.73e-04 |
GO:BP | GO:0007215 | glutamate receptor signaling pathway | 24 | 27 | 7.79e-04 |
GO:BP | GO:0032870 | cellular response to hormone stimulus | 262 | 433 | 7.82e-04 |
GO:BP | GO:0043542 | endothelial cell migration | 115 | 174 | 8.14e-04 |
GO:BP | GO:0006836 | neurotransmitter transport | 92 | 135 | 8.15e-04 |
GO:BP | GO:0002761 | regulation of myeloid leukocyte differentiation | 58 | 79 | 8.16e-04 |
GO:BP | GO:0071375 | cellular response to peptide hormone stimulus | 148 | 231 | 8.16e-04 |
GO:BP | GO:0009410 | response to xenobiotic stimulus | 172 | 273 | 8.17e-04 |
GO:BP | GO:0034764 | positive regulation of transmembrane transport | 89 | 130 | 8.22e-04 |
GO:BP | GO:0051897 | positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction | 86 | 125 | 8.28e-04 |
GO:BP | GO:0050731 | positive regulation of peptidyl-tyrosine phosphorylation | 66 | 92 | 8.36e-04 |
GO:BP | GO:0051282 | regulation of sequestering of calcium ion | 66 | 92 | 8.36e-04 |
GO:BP | GO:0001759 | organ induction | 15 | 15 | 8.36e-04 |
GO:BP | GO:0022604 | regulation of cell morphogenesis | 126 | 193 | 8.37e-04 |
GO:BP | GO:0010001 | glial cell differentiation | 119 | 181 | 8.45e-04 |
GO:BP | GO:0051896 | regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction | 119 | 181 | 8.45e-04 |
GO:BP | GO:0060606 | tube closure | 61 | 84 | 8.84e-04 |
GO:BP | GO:0035270 | endocrine system development | 61 | 84 | 8.84e-04 |
GO:BP | GO:0010876 | lipid localization | 186 | 298 | 8.84e-04 |
GO:BP | GO:0043434 | response to peptide hormone | 195 | 314 | 8.99e-04 |
GO:BP | GO:0051129 | negative regulation of cellular component organization | 329 | 555 | 9.01e-04 |
GO:BP | GO:0051963 | regulation of synapse assembly | 56 | 76 | 9.06e-04 |
GO:BP | GO:1901890 | positive regulation of cell junction assembly | 56 | 76 | 9.06e-04 |
GO:BP | GO:0060914 | heart formation | 26 | 30 | 9.27e-04 |
GO:BP | GO:0002791 | regulation of peptide secretion | 90 | 132 | 9.27e-04 |
GO:BP | GO:0042475 | odontogenesis of dentin-containing tooth | 42 | 54 | 9.55e-04 |
GO:BP | GO:0055117 | regulation of cardiac muscle contraction | 49 | 65 | 9.86e-04 |
GO:BP | GO:0060079 | excitatory postsynaptic potential | 49 | 65 | 9.86e-04 |
GO:BP | GO:0033674 | positive regulation of kinase activity | 128 | 197 | 9.95e-04 |
GO:BP | GO:0051047 | positive regulation of secretion | 132 | 204 | 1.02e-03 |
GO:BP | GO:0030031 | cell projection assembly | 269 | 447 | 1.03e-03 |
GO:BP | GO:1901652 | response to peptide | 225 | 368 | 1.03e-03 |
GO:BP | GO:0032924 | activin receptor signaling pathway | 28 | 33 | 1.04e-03 |
GO:BP | GO:0003156 | regulation of animal organ formation | 18 | 19 | 1.06e-03 |
GO:BP | GO:0001764 | neuron migration | 88 | 129 | 1.07e-03 |
GO:BP | GO:0001755 | neural crest cell migration | 38 | 48 | 1.07e-03 |
GO:BP | GO:0051058 | negative regulation of small GTPase mediated signal transduction | 38 | 48 | 1.07e-03 |
GO:BP | GO:0140115 | export across plasma membrane | 38 | 48 | 1.07e-03 |
GO:BP | GO:0051961 | negative regulation of nervous system development | 76 | 109 | 1.08e-03 |
GO:BP | GO:0070167 | regulation of biomineral tissue development | 47 | 62 | 1.08e-03 |
GO:BP | GO:0099504 | synaptic vesicle cycle | 101 | 151 | 1.08e-03 |
GO:BP | GO:0045766 | positive regulation of angiogenesis | 79 | 114 | 1.08e-03 |
GO:BP | GO:0003203 | endocardial cushion morphogenesis | 30 | 36 | 1.10e-03 |
GO:BP | GO:0002376 | immune system process | 789 | 1410 | 1.12e-03 |
GO:BP | GO:0046632 | alpha-beta T cell differentiation | 52 | 70 | 1.13e-03 |
GO:BP | GO:0046620 | regulation of organ growth | 52 | 70 | 1.13e-03 |
GO:BP | GO:0040008 | regulation of growth | 277 | 462 | 1.13e-03 |
GO:BP | GO:0060627 | regulation of vesicle-mediated transport | 228 | 374 | 1.17e-03 |
GO:BP | GO:0001936 | regulation of endothelial cell proliferation | 68 | 96 | 1.18e-03 |
GO:BP | GO:0055080 | monoatomic cation homeostasis | 243 | 401 | 1.19e-03 |
GO:BP | GO:0120031 | plasma membrane bounded cell projection assembly | 263 | 437 | 1.19e-03 |
GO:BP | GO:0051641 | cellular localization | 1428 | 2623 | 1.19e-03 |
GO:BP | GO:0007611 | learning or memory | 123 | 189 | 1.20e-03 |
GO:BP | GO:0001843 | neural tube closure | 60 | 83 | 1.20e-03 |
GO:BP | GO:0002027 | regulation of heart rate | 60 | 83 | 1.20e-03 |
GO:BP | GO:0070374 | positive regulation of ERK1 and ERK2 cascade | 77 | 111 | 1.24e-03 |
GO:BP | GO:0043066 | negative regulation of apoptotic process | 363 | 619 | 1.24e-03 |
GO:BP | GO:2000181 | negative regulation of blood vessel morphogenesis | 50 | 67 | 1.25e-03 |
GO:BP | GO:0051588 | regulation of neurotransmitter transport | 50 | 67 | 1.25e-03 |
GO:BP | GO:1901343 | negative regulation of vasculature development | 50 | 67 | 1.25e-03 |
GO:BP | GO:0014896 | muscle hypertrophy | 55 | 75 | 1.25e-03 |
GO:BP | GO:0050867 | positive regulation of cell activation | 131 | 203 | 1.25e-03 |
GO:BP | GO:0045927 | positive regulation of growth | 120 | 184 | 1.26e-03 |
GO:BP | GO:0046928 | regulation of neurotransmitter secretion | 43 | 56 | 1.27e-03 |
GO:BP | GO:2000628 | regulation of miRNA metabolic process | 53 | 72 | 1.42e-03 |
GO:BP | GO:0014902 | myotube differentiation | 61 | 85 | 1.47e-03 |
GO:BP | GO:1902414 | protein localization to cell junction | 61 | 85 | 1.47e-03 |
GO:BP | GO:0060563 | neuroepithelial cell differentiation | 25 | 29 | 1.48e-03 |
GO:BP | GO:0007520 | myoblast fusion | 25 | 29 | 1.48e-03 |
GO:BP | GO:0090497 | mesenchymal cell migration | 39 | 50 | 1.49e-03 |
GO:BP | GO:0023019 | signal transduction involved in regulation of gene expression | 14 | 14 | 1.50e-03 |
GO:BP | GO:0009991 | response to extracellular stimulus | 229 | 377 | 1.51e-03 |
GO:BP | GO:0090276 | regulation of peptide hormone secretion | 88 | 130 | 1.57e-03 |
GO:BP | GO:0046888 | negative regulation of hormone secretion | 37 | 47 | 1.58e-03 |
GO:BP | GO:0031667 | response to nutrient levels | 216 | 354 | 1.61e-03 |
GO:BP | GO:1905207 | regulation of cardiocyte differentiation | 20 | 22 | 1.61e-03 |
GO:BP | GO:0048333 | mesodermal cell differentiation | 20 | 22 | 1.61e-03 |
GO:BP | GO:1903779 | regulation of cardiac conduction | 20 | 22 | 1.61e-03 |
GO:BP | GO:1902284 | neuron projection extension involved in neuron projection guidance | 27 | 32 | 1.63e-03 |
GO:BP | GO:0048846 | axon extension involved in axon guidance | 27 | 32 | 1.63e-03 |
GO:BP | GO:0086002 | cardiac muscle cell action potential involved in contraction | 35 | 44 | 1.66e-03 |
GO:BP | GO:0002696 | positive regulation of leukocyte activation | 127 | 197 | 1.67e-03 |
GO:BP | GO:0032414 | positive regulation of ion transmembrane transporter activity | 44 | 58 | 1.70e-03 |
GO:BP | GO:0010812 | negative regulation of cell-substrate adhesion | 33 | 41 | 1.71e-03 |
GO:BP | GO:0006814 | sodium ion transport | 92 | 137 | 1.71e-03 |
GO:BP | GO:0048168 | regulation of neuronal synaptic plasticity | 31 | 38 | 1.72e-03 |
GO:BP | GO:0048013 | ephrin receptor signaling pathway | 31 | 38 | 1.72e-03 |
GO:BP | GO:0000082 | G1/S transition of mitotic cell cycle | 120 | 185 | 1.72e-03 |
GO:BP | GO:0007613 | memory | 62 | 87 | 1.74e-03 |
GO:BP | GO:0014897 | striated muscle hypertrophy | 54 | 74 | 1.74e-03 |
GO:BP | GO:0016525 | negative regulation of angiogenesis | 49 | 66 | 1.76e-03 |
GO:BP | GO:0018105 | peptidyl-serine phosphorylation | 106 | 161 | 1.78e-03 |
GO:BP | GO:0001816 | cytokine production | 264 | 441 | 1.82e-03 |
GO:BP | GO:0031099 | regeneration | 96 | 144 | 1.83e-03 |
GO:BP | GO:0050890 | cognition | 136 | 213 | 1.83e-03 |
GO:BP | GO:0007009 | plasma membrane organization | 74 | 107 | 1.89e-03 |
GO:BP | GO:1903706 | regulation of hemopoiesis | 161 | 257 | 1.91e-03 |
GO:BP | GO:0043535 | regulation of blood vessel endothelial cell migration | 52 | 71 | 1.97e-03 |
GO:BP | GO:0090087 | regulation of peptide transport | 90 | 134 | 1.97e-03 |
GO:BP | GO:0072089 | stem cell proliferation | 60 | 84 | 1.99e-03 |
GO:BP | GO:0043500 | muscle adaptation | 63 | 89 | 2.08e-03 |
GO:BP | GO:0010595 | positive regulation of endothelial cell migration | 63 | 89 | 2.08e-03 |
GO:BP | GO:0051246 | regulation of protein metabolic process | 884 | 1595 | 2.08e-03 |
GO:BP | GO:0006470 | protein dephosphorylation | 115 | 177 | 2.11e-03 |
GO:BP | GO:0006869 | lipid transport | 163 | 261 | 2.16e-03 |
GO:BP | GO:0007266 | Rho protein signal transduction | 75 | 109 | 2.18e-03 |
GO:BP | GO:0045685 | regulation of glial cell differentiation | 38 | 49 | 2.18e-03 |
GO:BP | GO:1903053 | regulation of extracellular matrix organization | 38 | 49 | 2.18e-03 |
GO:BP | GO:0099175 | regulation of postsynapse organization | 58 | 81 | 2.28e-03 |
GO:BP | GO:1904064 | positive regulation of cation transmembrane transport | 58 | 81 | 2.28e-03 |
GO:BP | GO:0060350 | endochondral bone morphogenesis | 36 | 46 | 2.34e-03 |
GO:BP | GO:0097120 | receptor localization to synapse | 36 | 46 | 2.34e-03 |
GO:BP | GO:0030947 | regulation of vascular endothelial growth factor receptor signaling pathway | 24 | 28 | 2.38e-03 |
GO:BP | GO:0001817 | regulation of cytokine production | 261 | 437 | 2.39e-03 |
GO:BP | GO:0009952 | anterior/posterior pattern specification | 82 | 121 | 2.41e-03 |
GO:BP | GO:0003300 | cardiac muscle hypertrophy | 53 | 73 | 2.43e-03 |
GO:BP | GO:0051208 | sequestering of calcium ion | 67 | 96 | 2.49e-03 |
GO:BP | GO:0048813 | dendrite morphogenesis | 76 | 111 | 2.49e-03 |
GO:BP | GO:0035023 | regulation of Rho protein signal transduction | 48 | 65 | 2.50e-03 |
GO:BP | GO:0010644 | cell communication by electrical coupling | 26 | 31 | 2.56e-03 |
GO:BP | GO:0071634 | regulation of transforming growth factor beta production | 26 | 31 | 2.56e-03 |
GO:BP | GO:0050900 | leukocyte migration | 125 | 195 | 2.57e-03 |
GO:BP | GO:0018209 | peptidyl-serine modification | 110 | 169 | 2.57e-03 |
GO:BP | GO:0050795 | regulation of behavior | 32 | 40 | 2.58e-03 |
GO:BP | GO:0055006 | cardiac cell development | 56 | 78 | 2.58e-03 |
GO:BP | GO:0071868 | cellular response to monoamine stimulus | 28 | 34 | 2.64e-03 |
GO:BP | GO:0071870 | cellular response to catecholamine stimulus | 28 | 34 | 2.64e-03 |
GO:BP | GO:0061037 | negative regulation of cartilage development | 19 | 21 | 2.68e-03 |
GO:BP | GO:0014912 | negative regulation of smooth muscle cell migration | 19 | 21 | 2.68e-03 |
GO:BP | GO:0046631 | alpha-beta T cell activation | 62 | 88 | 2.81e-03 |
GO:BP | GO:0043547 | positive regulation of GTPase activity | 77 | 113 | 2.83e-03 |
GO:BP | GO:0045598 | regulation of fat cell differentiation | 65 | 93 | 2.86e-03 |
GO:BP | GO:0050680 | negative regulation of epithelial cell proliferation | 68 | 98 | 2.89e-03 |
GO:BP | GO:0050768 | negative regulation of neurogenesis | 71 | 103 | 2.89e-03 |
GO:BP | GO:0033993 | response to lipid | 335 | 573 | 2.91e-03 |
GO:BP | GO:0045893 | positive regulation of DNA-templated transcription | 689 | 1231 | 2.92e-03 |
GO:BP | GO:0019935 | cyclic-nucleotide-mediated signaling | 39 | 51 | 2.93e-03 |
GO:BP | GO:1901653 | cellular response to peptide | 169 | 273 | 3.01e-03 |
GO:BP | GO:0009725 | response to hormone | 355 | 610 | 3.06e-03 |
GO:BP | GO:0140747 | regulation of ncRNA transcription | 57 | 80 | 3.10e-03 |
GO:BP | GO:2001257 | regulation of cation channel activity | 49 | 67 | 3.10e-03 |
GO:BP | GO:0060977 | coronary vasculature morphogenesis | 16 | 17 | 3.13e-03 |
GO:BP | GO:0034505 | tooth mineralization | 16 | 17 | 3.13e-03 |
GO:BP | GO:0003215 | cardiac right ventricle morphogenesis | 16 | 17 | 3.13e-03 |
GO:BP | GO:0033135 | regulation of peptidyl-serine phosphorylation | 60 | 85 | 3.21e-03 |
GO:BP | GO:0071396 | cellular response to lipid | 233 | 388 | 3.24e-03 |
GO:BP | GO:0071496 | cellular response to external stimulus | 166 | 268 | 3.24e-03 |
GO:BP | GO:0001890 | placenta development | 75 | 110 | 3.25e-03 |
GO:BP | GO:1902680 | positive regulation of RNA biosynthetic process | 690 | 1234 | 3.30e-03 |
GO:BP | GO:0032878 | regulation of establishment or maintenance of cell polarity | 21 | 24 | 3.33e-03 |
GO:BP | GO:0003401 | axis elongation | 21 | 24 | 3.33e-03 |
GO:BP | GO:1905332 | positive regulation of morphogenesis of an epithelium | 21 | 24 | 3.33e-03 |
GO:BP | GO:0033036 | macromolecule localization | 1257 | 2309 | 3.34e-03 |
GO:BP | GO:0019229 | regulation of vasoconstriction | 33 | 42 | 3.70e-03 |
GO:BP | GO:0045944 | positive regulation of transcription by RNA polymerase II | 497 | 874 | 3.70e-03 |
GO:BP | GO:0010927 | cellular component assembly involved in morphogenesis | 73 | 107 | 3.78e-03 |
GO:BP | GO:0010586 | miRNA metabolic process | 61 | 87 | 3.79e-03 |
GO:BP | GO:0001508 | action potential | 70 | 102 | 3.81e-03 |
GO:BP | GO:0120162 | positive regulation of cold-induced thermogenesis | 50 | 69 | 3.81e-03 |
GO:BP | GO:0099643 | signal release from synapse | 70 | 102 | 3.81e-03 |
GO:BP | GO:0007269 | neurotransmitter secretion | 70 | 102 | 3.81e-03 |
GO:BP | GO:0060021 | roof of mouth development | 50 | 69 | 3.81e-03 |
GO:BP | GO:0043534 | blood vessel endothelial cell migration | 64 | 92 | 3.81e-03 |
GO:BP | GO:0021536 | diencephalon development | 31 | 39 | 3.87e-03 |
GO:BP | GO:0003006 | developmental process involved in reproduction | 334 | 573 | 3.88e-03 |
GO:BP | GO:0035249 | synaptic transmission, glutamatergic | 45 | 61 | 3.92e-03 |
GO:BP | GO:0001656 | metanephros development | 45 | 61 | 3.92e-03 |
GO:BP | GO:1903532 | positive regulation of secretion by cell | 123 | 193 | 3.92e-03 |
GO:BP | GO:0048662 | negative regulation of smooth muscle cell proliferation | 29 | 36 | 3.99e-03 |
GO:BP | GO:0071869 | response to catecholamine | 29 | 36 | 3.99e-03 |
GO:BP | GO:0071867 | response to monoamine | 29 | 36 | 3.99e-03 |
GO:BP | GO:0097306 | cellular response to alcohol | 53 | 74 | 4.02e-03 |
GO:BP | GO:0002792 | negative regulation of peptide secretion | 27 | 33 | 4.05e-03 |
GO:BP | GO:2000630 | positive regulation of miRNA metabolic process | 38 | 50 | 4.22e-03 |
GO:BP | GO:0010660 | regulation of muscle cell apoptotic process | 38 | 50 | 4.22e-03 |
GO:BP | GO:0048008 | platelet-derived growth factor receptor signaling pathway | 38 | 50 | 4.22e-03 |
GO:BP | GO:0010977 | negative regulation of neuron projection development | 74 | 109 | 4.24e-03 |
GO:BP | GO:0051250 | negative regulation of lymphocyte activation | 59 | 84 | 4.31e-03 |
GO:BP | GO:0051048 | negative regulation of secretion | 71 | 104 | 4.32e-03 |
GO:BP | GO:0008543 | fibroblast growth factor receptor signaling pathway | 43 | 58 | 4.39e-03 |
GO:BP | GO:0002028 | regulation of sodium ion transport | 43 | 58 | 4.39e-03 |
GO:BP | GO:0055082 | intracellular chemical homeostasis | 286 | 486 | 4.44e-03 |
GO:BP | GO:1902547 | regulation of cellular response to vascular endothelial growth factor stimulus | 18 | 20 | 4.46e-03 |
GO:BP | GO:2000116 | regulation of cysteine-type endopeptidase activity | 81 | 121 | 4.50e-03 |
GO:BP | GO:0002067 | glandular epithelial cell differentiation | 36 | 47 | 4.63e-03 |
GO:BP | GO:0086001 | cardiac muscle cell action potential | 46 | 63 | 4.88e-03 |
GO:BP | GO:0032411 | positive regulation of transporter activity | 46 | 63 | 4.88e-03 |
GO:BP | GO:0036302 | atrioventricular canal development | 12 | 12 | 4.89e-03 |
GO:BP | GO:0032332 | positive regulation of chondrocyte differentiation | 12 | 12 | 4.89e-03 |
GO:BP | GO:0099505 | regulation of presynaptic membrane potential | 12 | 12 | 4.89e-03 |
GO:BP | GO:0048871 | multicellular organismal-level homeostasis | 313 | 536 | 4.89e-03 |
GO:BP | GO:0008360 | regulation of cell shape | 72 | 106 | 4.89e-03 |
GO:BP | GO:0003198 | epithelial to mesenchymal transition involved in endocardial cushion formation | 12 | 12 | 4.89e-03 |
GO:BP | GO:0007405 | neuroblast proliferation | 41 | 55 | 4.89e-03 |
GO:BP | GO:0045651 | positive regulation of macrophage differentiation | 12 | 12 | 4.89e-03 |
GO:BP | GO:0010657 | muscle cell apoptotic process | 41 | 55 | 4.89e-03 |
GO:BP | GO:0038066 | p38MAPK cascade | 34 | 44 | 4.99e-03 |
GO:BP | GO:0002042 | cell migration involved in sprouting angiogenesis | 34 | 44 | 4.99e-03 |
GO:BP | GO:1902895 | positive regulation of miRNA transcription | 34 | 44 | 4.99e-03 |
GO:BP | GO:0034103 | regulation of tissue remodeling | 34 | 44 | 4.99e-03 |
GO:BP | GO:2000177 | regulation of neural precursor cell proliferation | 49 | 68 | 5.20e-03 |
GO:BP | GO:0030162 | regulation of proteolysis | 247 | 416 | 5.29e-03 |
GO:BP | GO:0032331 | negative regulation of chondrocyte differentiation | 15 | 16 | 5.36e-03 |
GO:BP | GO:0001709 | cell fate determination | 20 | 23 | 5.36e-03 |
GO:BP | GO:0043537 | negative regulation of blood vessel endothelial cell migration | 20 | 23 | 5.36e-03 |
GO:BP | GO:0050919 | negative chemotaxis | 32 | 41 | 5.36e-03 |
GO:BP | GO:0070168 | negative regulation of biomineral tissue development | 15 | 16 | 5.36e-03 |
GO:BP | GO:0061383 | trabecula morphogenesis | 32 | 41 | 5.36e-03 |
GO:BP | GO:0031128 | developmental induction | 20 | 23 | 5.36e-03 |
GO:BP | GO:0014888 | striated muscle adaptation | 32 | 41 | 5.36e-03 |
GO:BP | GO:0060037 | pharyngeal system development | 20 | 23 | 5.36e-03 |
GO:BP | GO:0045669 | positive regulation of osteoblast differentiation | 39 | 52 | 5.42e-03 |
GO:BP | GO:0021675 | nerve development | 44 | 60 | 5.42e-03 |
GO:BP | GO:0051254 | positive regulation of RNA metabolic process | 751 | 1354 | 5.54e-03 |
GO:BP | GO:0030282 | bone mineralization | 55 | 78 | 5.62e-03 |
GO:BP | GO:0051480 | regulation of cytosolic calcium ion concentration | 30 | 38 | 5.72e-03 |
GO:BP | GO:0042752 | regulation of circadian rhythm | 61 | 88 | 5.78e-03 |
GO:BP | GO:0030099 | myeloid cell differentiation | 178 | 292 | 5.78e-03 |
GO:BP | GO:0060291 | long-term synaptic potentiation | 47 | 65 | 5.89e-03 |
GO:BP | GO:0003209 | cardiac atrium morphogenesis | 22 | 26 | 5.90e-03 |
GO:BP | GO:0086064 | cell communication by electrical coupling involved in cardiac conduction | 22 | 26 | 5.90e-03 |
GO:BP | GO:0046651 | lymphocyte proliferation | 98 | 151 | 5.93e-03 |
GO:BP | GO:0086091 | regulation of heart rate by cardiac conduction | 28 | 35 | 5.97e-03 |
GO:BP | GO:0019933 | cAMP-mediated signaling | 28 | 35 | 5.97e-03 |
GO:BP | GO:0090278 | negative regulation of peptide hormone secretion | 26 | 32 | 6.11e-03 |
GO:BP | GO:0010656 | negative regulation of muscle cell apoptotic process | 26 | 32 | 6.11e-03 |
GO:BP | GO:0007157 | heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules | 24 | 29 | 6.11e-03 |
GO:BP | GO:0010837 | regulation of keratinocyte proliferation | 26 | 32 | 6.11e-03 |
GO:BP | GO:0021954 | central nervous system neuron development | 42 | 57 | 6.11e-03 |
GO:BP | GO:0071604 | transforming growth factor beta production | 26 | 32 | 6.11e-03 |
GO:BP | GO:0060041 | retina development in camera-type eye | 71 | 105 | 6.30e-03 |
GO:BP | GO:0043068 | positive regulation of programmed cell death | 231 | 388 | 6.31e-03 |
GO:BP | GO:0045859 | regulation of protein kinase activity | 200 | 332 | 6.36e-03 |
GO:BP | GO:0030856 | regulation of epithelial cell differentiation | 68 | 100 | 6.44e-03 |
GO:BP | GO:0035725 | sodium ion transmembrane transport | 65 | 95 | 6.55e-03 |
GO:BP | GO:0016311 | dephosphorylation | 144 | 232 | 6.55e-03 |
GO:BP | GO:0010811 | positive regulation of cell-substrate adhesion | 65 | 95 | 6.55e-03 |
GO:BP | GO:0050866 | negative regulation of cell activation | 78 | 117 | 6.59e-03 |
GO:BP | GO:0035019 | somatic stem cell population maintenance | 35 | 46 | 6.59e-03 |
GO:BP | GO:0006950 | response to stress | 1373 | 2540 | 6.68e-03 |
GO:BP | GO:0034109 | homotypic cell-cell adhesion | 48 | 67 | 7.09e-03 |
GO:BP | GO:0001892 | embryonic placenta development | 48 | 67 | 7.09e-03 |
GO:BP | GO:0030217 | T cell differentiation | 116 | 183 | 7.20e-03 |
GO:BP | GO:0045665 | negative regulation of neuron differentiation | 33 | 43 | 7.26e-03 |
GO:BP | GO:0032944 | regulation of mononuclear cell proliferation | 79 | 119 | 7.35e-03 |
GO:BP | GO:0062009 | secondary palate development | 17 | 19 | 7.35e-03 |
GO:BP | GO:0055013 | cardiac muscle cell development | 51 | 72 | 7.37e-03 |
GO:BP | GO:0045995 | regulation of embryonic development | 51 | 72 | 7.37e-03 |
GO:BP | GO:0002695 | negative regulation of leukocyte activation | 66 | 97 | 7.45e-03 |
GO:BP | GO:0032943 | mononuclear cell proliferation | 101 | 157 | 7.54e-03 |
GO:BP | GO:0051279 | regulation of release of sequestered calcium ion into cytosol | 43 | 59 | 7.54e-03 |
GO:BP | GO:0046849 | bone remodeling | 43 | 59 | 7.54e-03 |
GO:BP | GO:0045621 | positive regulation of lymphocyte differentiation | 57 | 82 | 7.63e-03 |
GO:BP | GO:0010633 | negative regulation of epithelial cell migration | 38 | 51 | 7.67e-03 |
GO:BP | GO:0045936 | negative regulation of phosphate metabolic process | 175 | 288 | 7.70e-03 |
GO:BP | GO:0060326 | cell chemotaxis | 98 | 152 | 8.05e-03 |
GO:BP | GO:0032101 | regulation of response to external stimulus | 375 | 654 | 8.47e-03 |
GO:BP | GO:0062013 | positive regulation of small molecule metabolic process | 67 | 99 | 8.47e-03 |
GO:BP | GO:0050670 | regulation of lymphocyte proliferation | 77 | 116 | 8.52e-03 |
GO:BP | GO:0044843 | cell cycle G1/S phase transition | 127 | 203 | 8.58e-03 |
GO:BP | GO:0021700 | developmental maturation | 127 | 203 | 8.58e-03 |
GO:BP | GO:0071300 | cellular response to retinoic acid | 36 | 48 | 8.60e-03 |
GO:BP | GO:0002021 | response to dietary excess | 19 | 22 | 8.64e-03 |
GO:BP | GO:0097150 | neuronal stem cell population maintenance | 19 | 22 | 8.64e-03 |
GO:BP | GO:0031623 | receptor internalization | 61 | 89 | 8.77e-03 |
GO:BP | GO:0045637 | regulation of myeloid cell differentiation | 88 | 135 | 8.85e-03 |
GO:BP | GO:0070661 | leukocyte proliferation | 111 | 175 | 8.86e-03 |
GO:BP | GO:0043114 | regulation of vascular permeability | 27 | 34 | 8.99e-03 |
GO:BP | GO:0003230 | cardiac atrium development | 27 | 34 | 8.99e-03 |
GO:BP | GO:0060571 | morphogenesis of an epithelial fold | 14 | 15 | 9.15e-03 |
GO:BP | GO:0014047 | glutamate secretion | 14 | 15 | 9.15e-03 |
GO:BP | GO:0071636 | positive regulation of transforming growth factor beta production | 14 | 15 | 9.15e-03 |
GO:BP | GO:0055012 | ventricular cardiac muscle cell differentiation | 14 | 15 | 9.15e-03 |
GO:BP | GO:0035567 | non-canonical Wnt signaling pathway | 44 | 61 | 9.19e-03 |
GO:BP | GO:0099072 | regulation of postsynaptic membrane neurotransmitter receptor levels | 44 | 61 | 9.19e-03 |
GO:BP | GO:0030857 | negative regulation of epithelial cell differentiation | 25 | 31 | 9.28e-03 |
GO:BP | GO:1900744 | regulation of p38MAPK cascade | 25 | 31 | 9.28e-03 |
GO:BP | GO:0070663 | regulation of leukocyte proliferation | 85 | 130 | 9.28e-03 |
GO:BP | GO:0090049 | regulation of cell migration involved in sprouting angiogenesis | 25 | 31 | 9.28e-03 |
GO:BP | GO:1903351 | cellular response to dopamine | 25 | 31 | 9.28e-03 |
GO:BP | GO:0060391 | positive regulation of SMAD protein signal transduction | 25 | 31 | 9.28e-03 |
GO:BP | GO:0002274 | myeloid leukocyte activation | 78 | 118 | 9.29e-03 |
GO:BP | GO:0009913 | epidermal cell differentiation | 78 | 118 | 9.29e-03 |
GO:BP | GO:0048483 | autonomic nervous system development | 23 | 28 | 9.40e-03 |
GO:BP | GO:0048841 | regulation of axon extension involved in axon guidance | 23 | 28 | 9.40e-03 |
GO:BP | GO:0010563 | negative regulation of phosphorus metabolic process | 175 | 289 | 9.41e-03 |
GO:BP | GO:0045639 | positive regulation of myeloid cell differentiation | 47 | 66 | 9.59e-03 |
GO:BP | GO:0022408 | negative regulation of cell-cell adhesion | 75 | 113 | 9.72e-03 |
GO:BP | GO:0043254 | regulation of protein-containing complex assembly | 196 | 327 | 9.73e-03 |
GO:BP | GO:0051928 | positive regulation of calcium ion transport | 50 | 71 | 9.88e-03 |
GO:BP | GO:1903038 | negative regulation of leukocyte cell-cell adhesion | 50 | 71 | 9.88e-03 |
GO:BP | GO:0001819 | positive regulation of cytokine production | 157 | 257 | 9.96e-03 |
GO:BP | GO:0007229 | integrin-mediated signaling pathway | 59 | 86 | 1.00e-02 |
GO:BP | GO:0071887 | leukocyte apoptotic process | 53 | 76 | 1.00e-02 |
GO:BP | GO:0048608 | reproductive structure development | 126 | 202 | 1.03e-02 |
GO:BP | GO:0045123 | cellular extravasation | 32 | 42 | 1.04e-02 |
GO:BP | GO:0006873 | intracellular monoatomic ion homeostasis | 214 | 360 | 1.05e-02 |
GO:BP | GO:0045862 | positive regulation of proteolysis | 150 | 245 | 1.12e-02 |
GO:BP | GO:0042098 | T cell proliferation | 73 | 110 | 1.13e-02 |
GO:BP | GO:0030177 | positive regulation of Wnt signaling pathway | 73 | 110 | 1.13e-02 |
GO:BP | GO:0043502 | regulation of muscle adaptation | 48 | 68 | 1.14e-02 |
GO:BP | GO:0055002 | striated muscle cell development | 48 | 68 | 1.14e-02 |
GO:BP | GO:0030003 | intracellular monoatomic cation homeostasis | 211 | 355 | 1.14e-02 |
GO:BP | GO:0050922 | negative regulation of chemotaxis | 30 | 39 | 1.15e-02 |
GO:BP | GO:0003014 | renal system process | 51 | 73 | 1.16e-02 |
GO:BP | GO:0034763 | negative regulation of transmembrane transport | 57 | 83 | 1.16e-02 |
GO:BP | GO:2001056 | positive regulation of cysteine-type endopeptidase activity | 57 | 83 | 1.16e-02 |
GO:BP | GO:0010976 | positive regulation of neuron projection development | 84 | 129 | 1.17e-02 |
GO:BP | GO:0008217 | regulation of blood pressure | 70 | 105 | 1.17e-02 |
GO:BP | GO:0042310 | vasoconstriction | 40 | 55 | 1.18e-02 |
GO:BP | GO:0038094 | Fc-gamma receptor signaling pathway | 16 | 18 | 1.20e-02 |
GO:BP | GO:0051968 | positive regulation of synaptic transmission, glutamatergic | 16 | 18 | 1.20e-02 |
GO:BP | GO:1903319 | positive regulation of protein maturation | 16 | 18 | 1.20e-02 |
GO:BP | GO:0055093 | response to hyperoxia | 16 | 18 | 1.20e-02 |
GO:BP | GO:0045649 | regulation of macrophage differentiation | 16 | 18 | 1.20e-02 |
GO:BP | GO:0003228 | atrial cardiac muscle tissue development | 16 | 18 | 1.20e-02 |
GO:BP | GO:1900746 | regulation of vascular endothelial growth factor signaling pathway | 16 | 18 | 1.20e-02 |
GO:BP | GO:0002763 | positive regulation of myeloid leukocyte differentiation | 28 | 36 | 1.24e-02 |
GO:BP | GO:0060443 | mammary gland morphogenesis | 28 | 36 | 1.24e-02 |
GO:BP | GO:0120032 | regulation of plasma membrane bounded cell projection assembly | 100 | 157 | 1.24e-02 |
GO:BP | GO:0051493 | regulation of cytoskeleton organization | 242 | 412 | 1.25e-02 |
GO:BP | GO:0048675 | axon extension | 64 | 95 | 1.25e-02 |
GO:BP | GO:0071214 | cellular response to abiotic stimulus | 153 | 251 | 1.28e-02 |
GO:BP | GO:0104004 | cellular response to environmental stimulus | 153 | 251 | 1.28e-02 |
GO:BP | GO:0008366 | axon ensheathment | 78 | 119 | 1.30e-02 |
GO:BP | GO:0007272 | ensheathment of neurons | 78 | 119 | 1.30e-02 |
GO:BP | GO:0048640 | negative regulation of developmental growth | 58 | 85 | 1.31e-02 |
GO:BP | GO:0032231 | regulation of actin filament bundle assembly | 58 | 85 | 1.31e-02 |
GO:BP | GO:0060491 | regulation of cell projection assembly | 101 | 159 | 1.32e-02 |
GO:BP | GO:0022414 | reproductive process | 491 | 874 | 1.36e-02 |
GO:BP | GO:0021983 | pituitary gland development | 18 | 21 | 1.37e-02 |
GO:BP | GO:0060384 | innervation | 18 | 21 | 1.37e-02 |
GO:BP | GO:0031324 | negative regulation of cellular metabolic process | 1051 | 1934 | 1.37e-02 |
GO:BP | GO:0061458 | reproductive system development | 127 | 205 | 1.38e-02 |
GO:BP | GO:0043412 | macromolecule modification | 1341 | 2489 | 1.39e-02 |
GO:BP | GO:0001937 | negative regulation of endothelial cell proliferation | 24 | 30 | 1.39e-02 |
GO:BP | GO:0046676 | negative regulation of insulin secretion | 24 | 30 | 1.39e-02 |
GO:BP | GO:0048546 | digestive tract morphogenesis | 24 | 30 | 1.39e-02 |
GO:BP | GO:0048512 | circadian behavior | 24 | 30 | 1.39e-02 |
GO:BP | GO:0007616 | long-term memory | 24 | 30 | 1.39e-02 |
GO:BP | GO:0046850 | regulation of bone remodeling | 24 | 30 | 1.39e-02 |
GO:BP | GO:0050817 | coagulation | 94 | 147 | 1.40e-02 |
GO:BP | GO:0008361 | regulation of cell size | 94 | 147 | 1.40e-02 |
GO:BP | GO:1990845 | adaptive thermogenesis | 79 | 121 | 1.41e-02 |
GO:BP | GO:0071260 | cellular response to mechanical stimulus | 41 | 57 | 1.42e-02 |
GO:BP | GO:0032147 | activation of protein kinase activity | 41 | 57 | 1.42e-02 |
GO:BP | GO:0051899 | membrane depolarization | 41 | 57 | 1.42e-02 |
GO:BP | GO:0014898 | cardiac muscle hypertrophy in response to stress | 20 | 24 | 1.42e-02 |
GO:BP | GO:0003299 | muscle hypertrophy in response to stress | 20 | 24 | 1.42e-02 |
GO:BP | GO:1990573 | potassium ion import across plasma membrane | 22 | 27 | 1.42e-02 |
GO:BP | GO:0010464 | regulation of mesenchymal cell proliferation | 22 | 27 | 1.42e-02 |
GO:BP | GO:0045124 | regulation of bone resorption | 20 | 24 | 1.42e-02 |
GO:BP | GO:0002431 | Fc receptor mediated stimulatory signaling pathway | 20 | 24 | 1.42e-02 |
GO:BP | GO:0031279 | regulation of cyclase activity | 22 | 27 | 1.42e-02 |
GO:BP | GO:0014887 | cardiac muscle adaptation | 20 | 24 | 1.42e-02 |
GO:BP | GO:0043065 | positive regulation of apoptotic process | 224 | 380 | 1.42e-02 |
GO:BP | GO:0045926 | negative regulation of growth | 115 | 184 | 1.44e-02 |
GO:BP | GO:0034446 | substrate adhesion-dependent cell spreading | 59 | 87 | 1.46e-02 |
GO:BP | GO:0030168 | platelet activation | 59 | 87 | 1.46e-02 |
GO:BP | GO:0030902 | hindbrain development | 69 | 104 | 1.47e-02 |
GO:BP | GO:0045582 | positive regulation of T cell differentiation | 50 | 72 | 1.52e-02 |
GO:BP | GO:0021533 | cell differentiation in hindbrain | 13 | 14 | 1.53e-02 |
GO:BP | GO:0043217 | myelin maintenance | 13 | 14 | 1.53e-02 |
GO:BP | GO:0010002 | cardioblast differentiation | 13 | 14 | 1.53e-02 |
GO:BP | GO:0009892 | negative regulation of metabolic process | 1137 | 2100 | 1.54e-02 |
GO:BP | GO:1902285 | semaphorin-plexin signaling pathway involved in neuron projection guidance | 10 | 10 | 1.54e-02 |
GO:BP | GO:0072497 | mesenchymal stem cell differentiation | 10 | 10 | 1.54e-02 |
GO:BP | GO:0045906 | negative regulation of vasoconstriction | 10 | 10 | 1.54e-02 |
GO:BP | GO:0022410 | circadian sleep/wake cycle process | 10 | 10 | 1.54e-02 |
GO:BP | GO:0099149 | regulation of postsynaptic neurotransmitter receptor internalization | 10 | 10 | 1.54e-02 |
GO:BP | GO:1902287 | semaphorin-plexin signaling pathway involved in axon guidance | 10 | 10 | 1.54e-02 |
GO:BP | GO:0030431 | sleep | 10 | 10 | 1.54e-02 |
GO:BP | GO:0043549 | regulation of kinase activity | 211 | 357 | 1.59e-02 |
GO:BP | GO:1903531 | negative regulation of secretion by cell | 63 | 94 | 1.59e-02 |
GO:BP | GO:0007596 | blood coagulation | 92 | 144 | 1.59e-02 |
GO:BP | GO:0050918 | positive chemotaxis | 29 | 38 | 1.62e-02 |
GO:BP | GO:0002066 | columnar/cuboidal epithelial cell development | 29 | 38 | 1.62e-02 |
GO:BP | GO:0014074 | response to purine-containing compound | 70 | 106 | 1.62e-02 |
GO:BP | GO:0007200 | phospholipase C-activating G protein-coupled receptor signaling pathway | 29 | 38 | 1.62e-02 |
GO:BP | GO:0045103 | intermediate filament-based process | 29 | 38 | 1.62e-02 |
GO:BP | GO:0001706 | endoderm formation | 34 | 46 | 1.67e-02 |
GO:BP | GO:0033043 | regulation of organelle organization | 532 | 953 | 1.68e-02 |
GO:BP | GO:0030278 | regulation of ossification | 54 | 79 | 1.72e-02 |
GO:BP | GO:0010038 | response to metal ion | 151 | 249 | 1.76e-02 |
GO:BP | GO:0051347 | positive regulation of transferase activity | 156 | 258 | 1.76e-02 |
GO:BP | GO:0007605 | sensory perception of sound | 64 | 96 | 1.77e-02 |
GO:BP | GO:0008038 | neuron recognition | 27 | 35 | 1.78e-02 |
GO:BP | GO:0001933 | negative regulation of protein phosphorylation | 137 | 224 | 1.78e-02 |
GO:BP | GO:0042593 | glucose homeostasis | 106 | 169 | 1.80e-02 |
GO:BP | GO:0051223 | regulation of protein transport | 193 | 325 | 1.81e-02 |
GO:BP | GO:0042733 | embryonic digit morphogenesis | 37 | 51 | 1.82e-02 |
GO:BP | GO:0007599 | hemostasis | 94 | 148 | 1.84e-02 |
GO:BP | GO:0009880 | embryonic pattern specification | 32 | 43 | 1.89e-02 |
GO:BP | GO:0042129 | regulation of T cell proliferation | 58 | 86 | 1.91e-02 |
GO:BP | GO:0019725 | cellular homeostasis | 323 | 564 | 1.91e-02 |
GO:BP | GO:0098884 | postsynaptic neurotransmitter receptor internalization | 15 | 17 | 1.92e-02 |
GO:BP | GO:0038096 | Fc-gamma receptor signaling pathway involved in phagocytosis | 15 | 17 | 1.92e-02 |
GO:BP | GO:0051590 | positive regulation of neurotransmitter transport | 15 | 17 | 1.92e-02 |
GO:BP | GO:0010954 | positive regulation of protein processing | 15 | 17 | 1.92e-02 |
GO:BP | GO:0002433 | immune response-regulating cell surface receptor signaling pathway involved in phagocytosis | 15 | 17 | 1.92e-02 |
GO:BP | GO:0007622 | rhythmic behavior | 25 | 32 | 1.92e-02 |
GO:BP | GO:0140239 | postsynaptic endocytosis | 15 | 17 | 1.92e-02 |
GO:BP | GO:0048169 | regulation of long-term neuronal synaptic plasticity | 15 | 17 | 1.92e-02 |
GO:BP | GO:1903350 | response to dopamine | 25 | 32 | 1.92e-02 |
GO:BP | GO:0060711 | labyrinthine layer development | 25 | 32 | 1.92e-02 |
GO:BP | GO:0007612 | learning | 72 | 110 | 1.95e-02 |
GO:BP | GO:0030879 | mammary gland development | 65 | 98 | 1.95e-02 |
GO:BP | GO:0001701 | in utero embryonic development | 196 | 331 | 1.98e-02 |
GO:BP | GO:0110053 | regulation of actin filament organization | 130 | 212 | 1.98e-02 |
GO:BP | GO:0030239 | myofibril assembly | 46 | 66 | 2.00e-02 |
GO:BP | GO:0106027 | neuron projection organization | 49 | 71 | 2.00e-02 |
GO:BP | GO:0035710 | CD4-positive, alpha-beta T cell activation | 46 | 66 | 2.00e-02 |
GO:BP | GO:0042552 | myelination | 76 | 117 | 2.01e-02 |
GO:BP | GO:0061384 | heart trabecula morphogenesis | 23 | 29 | 2.04e-02 |
GO:BP | GO:0042326 | negative regulation of phosphorylation | 145 | 239 | 2.04e-02 |
GO:BP | GO:0097106 | postsynaptic density organization | 23 | 29 | 2.04e-02 |
GO:BP | GO:0042491 | inner ear auditory receptor cell differentiation | 23 | 29 | 2.04e-02 |
GO:BP | GO:0086019 | cell-cell signaling involved in cardiac conduction | 23 | 29 | 2.04e-02 |
GO:BP | GO:0031102 | neuron projection regeneration | 35 | 48 | 2.05e-02 |
GO:BP | GO:0030500 | regulation of bone mineralization | 35 | 48 | 2.05e-02 |
GO:BP | GO:0048286 | lung alveolus development | 30 | 40 | 2.09e-02 |
GO:BP | GO:1902905 | positive regulation of supramolecular fiber organization | 88 | 138 | 2.09e-02 |
GO:BP | GO:0031281 | positive regulation of cyclase activity | 17 | 20 | 2.11e-02 |
GO:BP | GO:2000114 | regulation of establishment of cell polarity | 17 | 20 | 2.11e-02 |
GO:BP | GO:0048710 | regulation of astrocyte differentiation | 17 | 20 | 2.11e-02 |
GO:BP | GO:0048730 | epidermis morphogenesis | 17 | 20 | 2.11e-02 |
GO:BP | GO:0043588 | skin development | 109 | 175 | 2.12e-02 |
GO:BP | GO:0048806 | genitalia development | 21 | 26 | 2.13e-02 |
GO:BP | GO:1903055 | positive regulation of extracellular matrix organization | 21 | 26 | 2.13e-02 |
GO:BP | GO:0007212 | dopamine receptor signaling pathway | 21 | 26 | 2.13e-02 |
GO:BP | GO:1902656 | calcium ion import into cytosol | 21 | 26 | 2.13e-02 |
GO:BP | GO:0010765 | positive regulation of sodium ion transport | 19 | 23 | 2.15e-02 |
GO:BP | GO:0010827 | regulation of glucose transmembrane transport | 38 | 53 | 2.15e-02 |
GO:BP | GO:0003416 | endochondral bone growth | 19 | 23 | 2.15e-02 |
GO:BP | GO:0072012 | glomerulus vasculature development | 19 | 23 | 2.15e-02 |
GO:BP | GO:1904752 | regulation of vascular associated smooth muscle cell migration | 19 | 23 | 2.15e-02 |
GO:BP | GO:0043367 | CD4-positive, alpha-beta T cell differentiation | 38 | 53 | 2.15e-02 |
GO:BP | GO:0045834 | positive regulation of lipid metabolic process | 56 | 83 | 2.15e-02 |
GO:BP | GO:0045761 | regulation of adenylate cyclase activity | 19 | 23 | 2.15e-02 |
GO:BP | GO:0019216 | regulation of lipid metabolic process | 132 | 216 | 2.15e-02 |
GO:BP | GO:0010469 | regulation of signaling receptor activity | 41 | 58 | 2.24e-02 |
GO:BP | GO:0048706 | embryonic skeletal system development | 50 | 73 | 2.26e-02 |
GO:BP | GO:0048145 | regulation of fibroblast proliferation | 50 | 73 | 2.26e-02 |
GO:BP | GO:0097581 | lamellipodium organization | 50 | 73 | 2.26e-02 |
GO:BP | GO:0033500 | carbohydrate homeostasis | 106 | 170 | 2.27e-02 |
GO:BP | GO:0097061 | dendritic spine organization | 44 | 63 | 2.27e-02 |
GO:BP | GO:1903115 | regulation of actin filament-based movement | 28 | 37 | 2.29e-02 |
GO:BP | GO:0045104 | intermediate filament cytoskeleton organization | 28 | 37 | 2.29e-02 |
GO:BP | GO:0045747 | positive regulation of Notch signaling pathway | 28 | 37 | 2.29e-02 |
GO:BP | GO:0010658 | striated muscle cell apoptotic process | 28 | 37 | 2.29e-02 |
GO:BP | GO:0001818 | negative regulation of cytokine production | 102 | 163 | 2.30e-02 |
GO:BP | GO:0010761 | fibroblast migration | 36 | 50 | 2.48e-02 |
GO:BP | GO:0048814 | regulation of dendrite morphogenesis | 36 | 50 | 2.48e-02 |
GO:BP | GO:0042490 | mechanoreceptor differentiation | 36 | 50 | 2.48e-02 |
GO:BP | GO:0062012 | regulation of small molecule metabolic process | 140 | 231 | 2.48e-02 |
GO:BP | GO:1901655 | cellular response to ketone | 54 | 80 | 2.50e-02 |
GO:BP | GO:0032535 | regulation of cellular component size | 171 | 287 | 2.51e-02 |
GO:BP | GO:0008104 | protein localization | 1081 | 2000 | 2.51e-02 |
GO:BP | GO:0000122 | negative regulation of transcription by RNA polymerase II | 397 | 704 | 2.51e-02 |
GO:BP | GO:0010662 | regulation of striated muscle cell apoptotic process | 26 | 34 | 2.52e-02 |
GO:BP | GO:0071895 | odontoblast differentiation | 12 | 13 | 2.52e-02 |
GO:BP | GO:0010659 | cardiac muscle cell apoptotic process | 26 | 34 | 2.52e-02 |
GO:BP | GO:0048665 | neuron fate specification | 12 | 13 | 2.52e-02 |
GO:BP | GO:0099084 | postsynaptic specialization organization | 26 | 34 | 2.52e-02 |
GO:BP | GO:0046579 | positive regulation of Ras protein signal transduction | 12 | 13 | 2.52e-02 |
GO:BP | GO:1900153 | positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay | 12 | 13 | 2.52e-02 |
GO:BP | GO:0060841 | venous blood vessel development | 12 | 13 | 2.52e-02 |
GO:BP | GO:0000003 | reproduction | 492 | 882 | 2.52e-02 |
GO:BP | GO:0030033 | microvillus assembly | 12 | 13 | 2.52e-02 |
GO:BP | GO:0035315 | hair cell differentiation | 26 | 34 | 2.52e-02 |
GO:BP | GO:0009954 | proximal/distal pattern formation | 12 | 13 | 2.52e-02 |
GO:BP | GO:0001956 | positive regulation of neurotransmitter secretion | 12 | 13 | 2.52e-02 |
GO:BP | GO:0043281 | regulation of cysteine-type endopeptidase activity involved in apoptotic process | 68 | 104 | 2.54e-02 |
GO:BP | GO:0070509 | calcium ion import | 39 | 55 | 2.54e-02 |
GO:BP | GO:0003073 | regulation of systemic arterial blood pressure | 39 | 55 | 2.54e-02 |
GO:BP | GO:0001954 | positive regulation of cell-matrix adhesion | 31 | 42 | 2.58e-02 |
GO:BP | GO:0048146 | positive regulation of fibroblast proliferation | 31 | 42 | 2.58e-02 |
GO:BP | GO:0051966 | regulation of synaptic transmission, glutamatergic | 31 | 42 | 2.58e-02 |
GO:BP | GO:0001938 | positive regulation of endothelial cell proliferation | 48 | 70 | 2.58e-02 |
GO:BP | GO:0048661 | positive regulation of smooth muscle cell proliferation | 42 | 60 | 2.59e-02 |
GO:BP | GO:0035418 | protein localization to synapse | 42 | 60 | 2.59e-02 |
GO:BP | GO:0030316 | osteoclast differentiation | 45 | 65 | 2.59e-02 |
GO:BP | GO:0001942 | hair follicle development | 45 | 65 | 2.59e-02 |
GO:BP | GO:0010605 | negative regulation of macromolecule metabolic process | 1055 | 1951 | 2.60e-02 |
GO:BP | GO:0110020 | regulation of actomyosin structure organization | 58 | 87 | 2.65e-02 |
GO:BP | GO:0051147 | regulation of muscle cell differentiation | 76 | 118 | 2.65e-02 |
GO:BP | GO:0050714 | positive regulation of protein secretion | 65 | 99 | 2.67e-02 |
GO:BP | GO:0046629 | gamma-delta T cell activation | 9 | 9 | 2.68e-02 |
GO:BP | GO:2000288 | positive regulation of myoblast proliferation | 9 | 9 | 2.68e-02 |
GO:BP | GO:0002024 | diet induced thermogenesis | 9 | 9 | 2.68e-02 |
GO:BP | GO:0050802 | circadian sleep/wake cycle, sleep | 9 | 9 | 2.68e-02 |
GO:BP | GO:0010838 | positive regulation of keratinocyte proliferation | 9 | 9 | 2.68e-02 |
GO:BP | GO:0099509 | regulation of presynaptic cytosolic calcium ion concentration | 9 | 9 | 2.68e-02 |
GO:BP | GO:0032060 | bleb assembly | 9 | 9 | 2.68e-02 |
GO:BP | GO:1902679 | negative regulation of RNA biosynthetic process | 540 | 973 | 2.68e-02 |
GO:BP | GO:2000739 | regulation of mesenchymal stem cell differentiation | 9 | 9 | 2.68e-02 |
GO:BP | GO:0048845 | venous blood vessel morphogenesis | 9 | 9 | 2.68e-02 |
GO:BP | GO:0001768 | establishment of T cell polarity | 9 | 9 | 2.68e-02 |
GO:BP | GO:0032906 | transforming growth factor beta2 production | 9 | 9 | 2.68e-02 |
GO:BP | GO:0032909 | regulation of transforming growth factor beta2 production | 9 | 9 | 2.68e-02 |
GO:BP | GO:0051643 | endoplasmic reticulum localization | 9 | 9 | 2.68e-02 |
GO:BP | GO:0061626 | pharyngeal arch artery morphogenesis | 9 | 9 | 2.68e-02 |
GO:BP | GO:0010665 | regulation of cardiac muscle cell apoptotic process | 24 | 31 | 2.72e-02 |
GO:BP | GO:0060688 | regulation of morphogenesis of a branching structure | 24 | 31 | 2.72e-02 |
GO:BP | GO:0034405 | response to fluid shear stress | 24 | 31 | 2.72e-02 |
GO:BP | GO:0070664 | negative regulation of leukocyte proliferation | 34 | 47 | 2.74e-02 |
GO:BP | GO:0014743 | regulation of muscle hypertrophy | 34 | 47 | 2.74e-02 |
GO:BP | GO:0045600 | positive regulation of fat cell differentiation | 34 | 47 | 2.74e-02 |
GO:BP | GO:1903317 | regulation of protein maturation | 34 | 47 | 2.74e-02 |
GO:BP | GO:0007584 | response to nutrient | 73 | 113 | 2.79e-02 |
GO:BP | GO:0061024 | membrane organization | 354 | 625 | 2.81e-02 |
GO:BP | GO:0007179 | transforming growth factor beta receptor signaling pathway | 106 | 171 | 2.82e-02 |
GO:BP | GO:0045619 | regulation of lymphocyte differentiation | 81 | 127 | 2.85e-02 |
GO:BP | GO:0042311 | vasodilation | 29 | 39 | 2.86e-02 |
GO:BP | GO:0051965 | positive regulation of synapse assembly | 29 | 39 | 2.86e-02 |
GO:BP | GO:0035904 | aorta development | 37 | 52 | 2.87e-02 |
GO:BP | GO:1904427 | positive regulation of calcium ion transmembrane transport | 37 | 52 | 2.87e-02 |
GO:BP | GO:0070727 | cellular macromolecule localization | 1085 | 2010 | 2.87e-02 |
GO:BP | GO:0003171 | atrioventricular valve development | 22 | 28 | 2.92e-02 |
GO:BP | GO:0022405 | hair cycle process | 46 | 67 | 2.92e-02 |
GO:BP | GO:0022404 | molting cycle process | 46 | 67 | 2.92e-02 |
GO:BP | GO:0048713 | regulation of oligodendrocyte differentiation | 22 | 28 | 2.92e-02 |
GO:BP | GO:0060317 | cardiac epithelial to mesenchymal transition | 22 | 28 | 2.92e-02 |
GO:BP | GO:0044331 | cell-cell adhesion mediated by cadherin | 22 | 28 | 2.92e-02 |
GO:BP | GO:0031503 | protein-containing complex localization | 98 | 157 | 2.93e-02 |
GO:BP | GO:0086014 | atrial cardiac muscle cell action potential | 14 | 16 | 2.99e-02 |
GO:BP | GO:0086026 | atrial cardiac muscle cell to AV node cell signaling | 14 | 16 | 2.99e-02 |
GO:BP | GO:0021846 | cell proliferation in forebrain | 14 | 16 | 2.99e-02 |
GO:BP | GO:0003128 | heart field specification | 14 | 16 | 2.99e-02 |
GO:BP | GO:0086066 | atrial cardiac muscle cell to AV node cell communication | 14 | 16 | 2.99e-02 |
GO:BP | GO:1900274 | regulation of phospholipase C activity | 14 | 16 | 2.99e-02 |
GO:BP | GO:0045762 | positive regulation of adenylate cyclase activity | 14 | 16 | 2.99e-02 |
GO:BP | GO:0019827 | stem cell population maintenance | 90 | 143 | 3.00e-02 |
GO:BP | GO:0045892 | negative regulation of DNA-templated transcription | 535 | 965 | 3.01e-02 |
GO:BP | GO:1904738 | vascular associated smooth muscle cell migration | 20 | 25 | 3.09e-02 |
GO:BP | GO:0061437 | renal system vasculature development | 20 | 25 | 3.09e-02 |
GO:BP | GO:0007435 | salivary gland morphogenesis | 20 | 25 | 3.09e-02 |
GO:BP | GO:0061440 | kidney vasculature development | 20 | 25 | 3.09e-02 |
GO:BP | GO:0098703 | calcium ion import across plasma membrane | 20 | 25 | 3.09e-02 |
GO:BP | GO:0007623 | circadian rhythm | 95 | 152 | 3.15e-02 |
GO:BP | GO:0030038 | contractile actin filament bundle assembly | 60 | 91 | 3.17e-02 |
GO:BP | GO:0043149 | stress fiber assembly | 60 | 91 | 3.17e-02 |
GO:BP | GO:0038179 | neurotrophin signaling pathway | 27 | 36 | 3.17e-02 |
GO:BP | GO:0035306 | positive regulation of dephosphorylation | 27 | 36 | 3.17e-02 |
GO:BP | GO:0060512 | prostate gland morphogenesis | 16 | 19 | 3.17e-02 |
GO:BP | GO:0098810 | neurotransmitter reuptake | 16 | 19 | 3.17e-02 |
GO:BP | GO:1990806 | ligand-gated ion channel signaling pathway | 16 | 19 | 3.17e-02 |
GO:BP | GO:0099590 | neurotransmitter receptor internalization | 16 | 19 | 3.17e-02 |
GO:BP | GO:0060740 | prostate gland epithelium morphogenesis | 16 | 19 | 3.17e-02 |
GO:BP | GO:1901201 | regulation of extracellular matrix assembly | 16 | 19 | 3.17e-02 |
GO:BP | GO:0042092 | type 2 immune response | 16 | 19 | 3.17e-02 |
GO:BP | GO:0003338 | metanephros morphogenesis | 16 | 19 | 3.17e-02 |
GO:BP | GO:0097529 | myeloid leukocyte migration | 71 | 110 | 3.17e-02 |
GO:BP | GO:0055075 | potassium ion homeostasis | 18 | 22 | 3.18e-02 |
GO:BP | GO:0030279 | negative regulation of ossification | 18 | 22 | 3.18e-02 |
GO:BP | GO:0031400 | negative regulation of protein modification process | 191 | 325 | 3.18e-02 |
GO:BP | GO:1904705 | regulation of vascular associated smooth muscle cell proliferation | 35 | 49 | 3.24e-02 |
GO:BP | GO:0018107 | peptidyl-threonine phosphorylation | 47 | 69 | 3.28e-02 |
GO:BP | GO:1990778 | protein localization to cell periphery | 170 | 287 | 3.34e-02 |
GO:BP | GO:0016239 | positive regulation of macroautophagy | 44 | 64 | 3.34e-02 |
GO:BP | GO:0050868 | negative regulation of T cell activation | 44 | 64 | 3.34e-02 |
GO:BP | GO:0050772 | positive regulation of axonogenesis | 44 | 64 | 3.34e-02 |
GO:BP | GO:0140238 | presynaptic endocytosis | 41 | 59 | 3.36e-02 |
GO:BP | GO:2000045 | regulation of G1/S transition of mitotic cell cycle | 88 | 140 | 3.41e-02 |
GO:BP | GO:0106106 | cold-induced thermogenesis | 72 | 112 | 3.42e-02 |
GO:BP | GO:1903034 | regulation of response to wounding | 76 | 119 | 3.45e-02 |
GO:BP | GO:0046683 | response to organophosphorus | 61 | 93 | 3.46e-02 |
GO:BP | GO:0010171 | body morphogenesis | 30 | 41 | 3.49e-02 |
GO:BP | GO:0045453 | bone resorption | 30 | 41 | 3.49e-02 |
GO:BP | GO:0007600 | sensory perception | 150 | 251 | 3.50e-02 |
GO:BP | GO:1902692 | regulation of neuroblast proliferation | 25 | 33 | 3.51e-02 |
GO:BP | GO:0038093 | Fc receptor signaling pathway | 25 | 33 | 3.51e-02 |
GO:BP | GO:0018210 | peptidyl-threonine modification | 51 | 76 | 3.58e-02 |
GO:BP | GO:0060996 | dendritic spine development | 51 | 76 | 3.58e-02 |
GO:BP | GO:0007219 | Notch signaling pathway | 89 | 142 | 3.63e-02 |
GO:BP | GO:0030595 | leukocyte chemotaxis | 69 | 107 | 3.65e-02 |
GO:BP | GO:0032880 | regulation of protein localization | 388 | 691 | 3.70e-02 |
GO:BP | GO:0001655 | urogenital system development | 33 | 46 | 3.71e-02 |
GO:BP | GO:0010611 | regulation of cardiac muscle hypertrophy | 33 | 46 | 3.71e-02 |
GO:BP | GO:0006919 | activation of cysteine-type endopeptidase activity involved in apoptotic process | 33 | 46 | 3.71e-02 |
GO:BP | GO:0062014 | negative regulation of small molecule metabolic process | 48 | 71 | 3.71e-02 |
GO:BP | GO:1904036 | negative regulation of epithelial cell apoptotic process | 33 | 46 | 3.71e-02 |
GO:BP | GO:0007265 | Ras protein signal transduction | 62 | 95 | 3.78e-02 |
GO:BP | GO:0051153 | regulation of striated muscle cell differentiation | 45 | 66 | 3.80e-02 |
GO:BP | GO:0006887 | exocytosis | 142 | 237 | 3.83e-02 |
GO:BP | GO:0050771 | negative regulation of axonogenesis | 36 | 51 | 3.83e-02 |
GO:BP | GO:0043266 | regulation of potassium ion transport | 42 | 61 | 3.85e-02 |
GO:BP | GO:0031668 | cellular response to extracellular stimulus | 132 | 219 | 3.85e-02 |
GO:BP | GO:0033273 | response to vitamin | 42 | 61 | 3.85e-02 |
GO:BP | GO:0002088 | lens development in camera-type eye | 39 | 56 | 3.87e-02 |
GO:BP | GO:1904019 | epithelial cell apoptotic process | 66 | 102 | 3.87e-02 |
GO:BP | GO:0052652 | cyclic purine nucleotide metabolic process | 23 | 30 | 3.88e-02 |
GO:BP | GO:0014911 | positive regulation of smooth muscle cell migration | 23 | 30 | 3.88e-02 |
GO:BP | GO:0001659 | temperature homeostasis | 82 | 130 | 3.93e-02 |
GO:BP | GO:2001222 | regulation of neuron migration | 28 | 38 | 3.94e-02 |
GO:BP | GO:0006940 | regulation of smooth muscle contraction | 28 | 38 | 3.94e-02 |
GO:BP | GO:0045668 | negative regulation of osteoblast differentiation | 28 | 38 | 3.94e-02 |
GO:BP | GO:0061005 | cell differentiation involved in kidney development | 28 | 38 | 3.94e-02 |
GO:BP | GO:0052548 | regulation of endopeptidase activity | 95 | 153 | 3.97e-02 |
GO:BP | GO:0050773 | regulation of dendrite development | 52 | 78 | 3.97e-02 |
GO:BP | GO:0046942 | carboxylic acid transport | 123 | 203 | 3.98e-02 |
GO:BP | GO:0072578 | neurotransmitter-gated ion channel clustering | 11 | 12 | 4.07e-02 |
GO:BP | GO:0045780 | positive regulation of bone resorption | 11 | 12 | 4.07e-02 |
GO:BP | GO:0048368 | lateral mesoderm development | 11 | 12 | 4.07e-02 |
GO:BP | GO:0003222 | ventricular trabecula myocardium morphogenesis | 11 | 12 | 4.07e-02 |
GO:BP | GO:0061154 | endothelial tube morphogenesis | 11 | 12 | 4.07e-02 |
GO:BP | GO:0003207 | cardiac chamber formation | 11 | 12 | 4.07e-02 |
GO:BP | GO:0055057 | neuroblast division | 11 | 12 | 4.07e-02 |
GO:BP | GO:0003159 | morphogenesis of an endothelium | 11 | 12 | 4.07e-02 |
GO:BP | GO:0030539 | male genitalia development | 11 | 12 | 4.07e-02 |
GO:BP | GO:0031669 | cellular response to nutrient levels | 119 | 196 | 4.12e-02 |
GO:BP | GO:0001558 | regulation of cell growth | 189 | 323 | 4.13e-02 |
GO:BP | GO:0038127 | ERBB signaling pathway | 67 | 104 | 4.16e-02 |
GO:BP | GO:0051651 | maintenance of location in cell | 105 | 171 | 4.16e-02 |
GO:BP | GO:0051253 | negative regulation of RNA metabolic process | 587 | 1067 | 4.18e-02 |
GO:BP | GO:0120161 | regulation of cold-induced thermogenesis | 71 | 111 | 4.18e-02 |
GO:BP | GO:1901021 | positive regulation of calcium ion transmembrane transporter activity | 21 | 27 | 4.18e-02 |
GO:BP | GO:0120033 | negative regulation of plasma membrane bounded cell projection assembly | 21 | 27 | 4.18e-02 |
GO:BP | GO:0010517 | regulation of phospholipase activity | 21 | 27 | 4.18e-02 |
GO:BP | GO:0035909 | aorta morphogenesis | 21 | 27 | 4.18e-02 |
GO:BP | GO:0031333 | negative regulation of protein-containing complex assembly | 75 | 118 | 4.18e-02 |
GO:BP | GO:0002294 | CD4-positive, alpha-beta T cell differentiation involved in immune response | 31 | 43 | 4.18e-02 |
GO:BP | GO:0030514 | negative regulation of BMP signaling pathway | 31 | 43 | 4.18e-02 |
GO:BP | GO:0042093 | T-helper cell differentiation | 31 | 43 | 4.18e-02 |
GO:BP | GO:0070570 | regulation of neuron projection regeneration | 21 | 27 | 4.18e-02 |
GO:BP | GO:0032945 | negative regulation of mononuclear cell proliferation | 31 | 43 | 4.18e-02 |
GO:BP | GO:0002293 | alpha-beta T cell differentiation involved in immune response | 31 | 43 | 4.18e-02 |
GO:BP | GO:0050672 | negative regulation of lymphocyte proliferation | 31 | 43 | 4.18e-02 |
GO:BP | GO:0002287 | alpha-beta T cell activation involved in immune response | 31 | 43 | 4.18e-02 |
GO:BP | GO:0150104 | transport across blood-brain barrier | 46 | 68 | 4.20e-02 |
GO:BP | GO:0010232 | vascular transport | 46 | 68 | 4.20e-02 |
GO:BP | GO:0060249 | anatomical structure homeostasis | 101 | 164 | 4.24e-02 |
GO:BP | GO:0001894 | tissue homeostasis | 101 | 164 | 4.24e-02 |
GO:BP | GO:0010629 | negative regulation of gene expression | 440 | 790 | 4.24e-02 |
GO:BP | GO:0060113 | inner ear receptor cell differentiation | 34 | 48 | 4.32e-02 |
GO:BP | GO:0048488 | synaptic vesicle endocytosis | 40 | 58 | 4.38e-02 |
GO:BP | GO:0033138 | positive regulation of peptidyl-serine phosphorylation | 40 | 58 | 4.38e-02 |
GO:BP | GO:0007193 | adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway | 26 | 35 | 4.38e-02 |
GO:BP | GO:0034113 | heterotypic cell-cell adhesion | 26 | 35 | 4.38e-02 |
GO:BP | GO:0010508 | positive regulation of autophagy | 80 | 127 | 4.43e-02 |
GO:BP | GO:0098781 | ncRNA transcription | 76 | 120 | 4.47e-02 |
GO:BP | GO:0040036 | regulation of fibroblast growth factor receptor signaling pathway | 19 | 24 | 4.49e-02 |
GO:BP | GO:0033280 | response to vitamin D | 19 | 24 | 4.49e-02 |
GO:BP | GO:0010882 | regulation of cardiac muscle contraction by calcium ion signaling | 19 | 24 | 4.49e-02 |
GO:BP | GO:0022011 | myelination in peripheral nervous system | 19 | 24 | 4.49e-02 |
GO:BP | GO:0032292 | peripheral nervous system axon ensheathment | 19 | 24 | 4.49e-02 |
GO:BP | GO:0001958 | endochondral ossification | 19 | 24 | 4.49e-02 |
GO:BP | GO:0098868 | bone growth | 19 | 24 | 4.49e-02 |
GO:BP | GO:0036075 | replacement ossification | 19 | 24 | 4.49e-02 |
GO:BP | GO:0030534 | adult behavior | 57 | 87 | 4.50e-02 |
GO:BP | GO:0042303 | molting cycle | 50 | 75 | 4.50e-02 |
GO:BP | GO:0007204 | positive regulation of cytosolic calcium ion concentration | 50 | 75 | 4.50e-02 |
GO:BP | GO:0042633 | hair cycle | 50 | 75 | 4.50e-02 |
GO:BP | GO:0097152 | mesenchymal cell apoptotic process | 8 | 8 | 4.56e-02 |
GO:BP | GO:0045187 | regulation of circadian sleep/wake cycle, sleep | 8 | 8 | 4.56e-02 |
GO:BP | GO:0036462 | TRAIL-activated apoptotic signaling pathway | 8 | 8 | 4.56e-02 |
GO:BP | GO:0071389 | cellular response to mineralocorticoid stimulus | 8 | 8 | 4.56e-02 |
GO:BP | GO:0040034 | regulation of development, heterochronic | 8 | 8 | 4.56e-02 |
GO:BP | GO:0060982 | coronary artery morphogenesis | 8 | 8 | 4.56e-02 |
GO:BP | GO:0048505 | regulation of timing of cell differentiation | 8 | 8 | 4.56e-02 |
GO:BP | GO:0048715 | negative regulation of oligodendrocyte differentiation | 8 | 8 | 4.56e-02 |
GO:BP | GO:0003190 | atrioventricular valve formation | 8 | 8 | 4.56e-02 |
GO:BP | GO:0032674 | regulation of interleukin-5 production | 8 | 8 | 4.56e-02 |
GO:BP | GO:0060896 | neural plate pattern specification | 8 | 8 | 4.56e-02 |
GO:BP | GO:0032634 | interleukin-5 production | 8 | 8 | 4.56e-02 |
GO:BP | GO:2000651 | positive regulation of sodium ion transmembrane transporter activity | 8 | 8 | 4.56e-02 |
GO:BP | GO:1900116 | extracellular negative regulation of signal transduction | 8 | 8 | 4.56e-02 |
GO:BP | GO:0099624 | atrial cardiac muscle cell membrane repolarization | 8 | 8 | 4.56e-02 |
GO:BP | GO:1900115 | extracellular regulation of signal transduction | 8 | 8 | 4.56e-02 |
GO:BP | GO:0003149 | membranous septum morphogenesis | 8 | 8 | 4.56e-02 |
GO:BP | GO:0003418 | growth plate cartilage chondrocyte differentiation | 8 | 8 | 4.56e-02 |
GO:BP | GO:0018193 | peptidyl-amino acid modification | 314 | 555 | 4.56e-02 |
GO:BP | GO:0002828 | regulation of type 2 immune response | 13 | 15 | 4.58e-02 |
GO:BP | GO:0051546 | keratinocyte migration | 13 | 15 | 4.58e-02 |
GO:BP | GO:1902932 | positive regulation of alcohol biosynthetic process | 13 | 15 | 4.58e-02 |
GO:BP | GO:0072170 | metanephric tubule development | 13 | 15 | 4.58e-02 |
GO:BP | GO:0060413 | atrial septum morphogenesis | 13 | 15 | 4.58e-02 |
GO:BP | GO:1902683 | regulation of receptor localization to synapse | 13 | 15 | 4.58e-02 |
GO:BP | GO:0070571 | negative regulation of neuron projection regeneration | 13 | 15 | 4.58e-02 |
GO:BP | GO:0032891 | negative regulation of organic acid transport | 13 | 15 | 4.58e-02 |
GO:BP | GO:0016079 | synaptic vesicle exocytosis | 47 | 70 | 4.60e-02 |
GO:BP | GO:1900745 | positive regulation of p38MAPK cascade | 17 | 21 | 4.66e-02 |
GO:BP | GO:2000178 | negative regulation of neural precursor cell proliferation | 17 | 21 | 4.66e-02 |
GO:BP | GO:0031327 | negative regulation of cellular biosynthetic process | 879 | 1624 | 4.67e-02 |
GO:BP | GO:0015849 | organic acid transport | 123 | 204 | 4.71e-02 |
GO:BP | GO:0051495 | positive regulation of cytoskeleton organization | 90 | 145 | 4.71e-02 |
GO:BP | GO:0098727 | maintenance of cell number | 90 | 145 | 4.71e-02 |
GO:BP | GO:0032869 | cellular response to insulin stimulus | 99 | 161 | 4.71e-02 |
GO:BP | GO:0032925 | regulation of activin receptor signaling pathway | 15 | 18 | 4.74e-02 |
GO:BP | GO:0071880 | adenylate cyclase-activating adrenergic receptor signaling pathway | 15 | 18 | 4.74e-02 |
GO:BP | GO:0031069 | hair follicle morphogenesis | 15 | 18 | 4.74e-02 |
GO:BP | GO:0033032 | regulation of myeloid cell apoptotic process | 15 | 18 | 4.74e-02 |
GO:BP | GO:0007187 | G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger | 15 | 18 | 4.74e-02 |
GO:BP | GO:1902903 | regulation of supramolecular fiber organization | 178 | 304 | 4.77e-02 |
GO:BP | GO:0030501 | positive regulation of bone mineralization | 24 | 32 | 4.78e-02 |
GO:BP | GO:0042220 | response to cocaine | 24 | 32 | 4.78e-02 |
GO:BP | GO:0062237 | protein localization to postsynapse | 24 | 32 | 4.78e-02 |
GO:BP | GO:0070884 | regulation of calcineurin-NFAT signaling cascade | 24 | 32 | 4.78e-02 |
GO:BP | GO:0106056 | regulation of calcineurin-mediated signaling | 24 | 32 | 4.78e-02 |
GO:BP | GO:1903539 | protein localization to postsynaptic membrane | 24 | 32 | 4.78e-02 |
GO:BP | GO:0086004 | regulation of cardiac muscle cell contraction | 24 | 32 | 4.78e-02 |
GO:BP | GO:0050709 | negative regulation of protein secretion | 32 | 45 | 4.80e-02 |
GO:BP | GO:0002292 | T cell differentiation involved in immune response | 32 | 45 | 4.80e-02 |
GO:BP | GO:0060071 | Wnt signaling pathway, planar cell polarity pathway | 32 | 45 | 4.80e-02 |
GO:BP | GO:0007548 | sex differentiation | 109 | 179 | 4.80e-02 |
GO:BP | GO:0060997 | dendritic spine morphogenesis | 32 | 45 | 4.80e-02 |
GO:BP | GO:0046486 | glycerolipid metabolic process | 167 | 284 | 4.81e-02 |
GO:BP | GO:0051492 | regulation of stress fiber assembly | 51 | 77 | 4.85e-02 |
GO:BP | GO:0010950 | positive regulation of endopeptidase activity | 62 | 96 | 4.88e-02 |
GO:BP | GO:0070527 | platelet aggregation | 35 | 50 | 4.88e-02 |
GO:BP | GO:0051145 | smooth muscle cell differentiation | 38 | 55 | 4.88e-02 |
GO:BP | GO:1901019 | regulation of calcium ion transmembrane transporter activity | 35 | 50 | 4.88e-02 |
GO:BP | GO:0031016 | pancreas development | 35 | 50 | 4.88e-02 |
GO:BP | GO:0030041 | actin filament polymerization | 78 | 124 | 4.90e-02 |
GO:BP | GO:0046718 | symbiont entry into host cell | 66 | 103 | 4.94e-02 |
GO:BP | GO:0050954 | sensory perception of mechanical stimulus | 70 | 110 | 4.96e-02 |
ESRnomtable %>%
filter(source=="KEGG", p_value < 0.05) %>%
mutate_at(.vars = 6, .funs = scientific_format()) %>%
kable(., caption = "KEGG terms found in ESR neargenes") %>%
kable_paper("striped", full_width = FALSE) %>%
kable_styling(
full_width = FALSE,
position = "left",
bootstrap_options = c("striped", "hover")
) %>%
scroll_box(width = "100%", height = "400px")
source | term_id | term_name | intersection_size | term_size | p_value |
---|---|---|---|---|---|
KEGG | KEGG:04510 | Focal adhesion | 128 | 169 | 4.34e-09 |
KEGG | KEGG:05200 | Pathways in cancer | 263 | 391 | 4.34e-09 |
KEGG | KEGG:04020 | Calcium signaling pathway | 123 | 161 | 4.34e-09 |
KEGG | KEGG:04015 | Rap1 signaling pathway | 121 | 162 | 3.73e-08 |
KEGG | KEGG:04925 | Aldosterone synthesis and secretion | 64 | 75 | 3.73e-08 |
KEGG | KEGG:04024 | cAMP signaling pathway | 111 | 147 | 5.35e-08 |
KEGG | KEGG:04360 | Axon guidance | 114 | 155 | 3.91e-07 |
KEGG | KEGG:04310 | Wnt signaling pathway | 98 | 133 | 3.28e-06 |
KEGG | KEGG:04911 | Insulin secretion | 51 | 62 | 1.25e-05 |
KEGG | KEGG:05414 | Dilated cardiomyopathy | 64 | 82 | 1.36e-05 |
KEGG | KEGG:05205 | Proteoglycans in cancer | 114 | 162 | 1.36e-05 |
KEGG | KEGG:04970 | Salivary secretion | 45 | 54 | 2.12e-05 |
KEGG | KEGG:04261 | Adrenergic signaling in cardiomyocytes | 90 | 124 | 2.12e-05 |
KEGG | KEGG:04022 | cGMP-PKG signaling pathway | 93 | 129 | 2.14e-05 |
KEGG | KEGG:04520 | Adherens junction | 64 | 83 | 2.19e-05 |
KEGG | KEGG:04724 | Glutamatergic synapse | 58 | 74 | 2.54e-05 |
KEGG | KEGG:04927 | Cortisol synthesis and secretion | 39 | 46 | 3.73e-05 |
KEGG | KEGG:04014 | Ras signaling pathway | 113 | 164 | 4.85e-05 |
KEGG | KEGG:04512 | ECM-receptor interaction | 52 | 66 | 5.79e-05 |
KEGG | KEGG:04971 | Gastric acid secretion | 42 | 51 | 6.00e-05 |
KEGG | KEGG:04010 | MAPK signaling pathway | 152 | 231 | 6.12e-05 |
KEGG | KEGG:04151 | PI3K-Akt signaling pathway | 163 | 250 | 6.12e-05 |
KEGG | KEGG:04390 | Hippo signaling pathway | 91 | 129 | 7.77e-05 |
KEGG | KEGG:04924 | Renin secretion | 41 | 50 | 8.12e-05 |
KEGG | KEGG:04919 | Thyroid hormone signaling pathway | 76 | 105 | 9.35e-05 |
KEGG | KEGG:05412 | Arrhythmogenic right ventricular cardiomyopathy | 52 | 67 | 9.52e-05 |
KEGG | KEGG:04810 | Regulation of actin cytoskeleton | 114 | 169 | 1.36e-04 |
KEGG | KEGG:05410 | Hypertrophic cardiomyopathy | 58 | 77 | 1.36e-04 |
KEGG | KEGG:04934 | Cushing syndrome | 84 | 119 | 1.36e-04 |
KEGG | KEGG:04972 | Pancreatic secretion | 45 | 57 | 1.50e-04 |
KEGG | KEGG:04725 | Cholinergic synapse | 61 | 82 | 1.50e-04 |
KEGG | KEGG:04921 | Oxytocin signaling pathway | 80 | 113 | 1.66e-04 |
KEGG | KEGG:04974 | Protein digestion and absorption | 44 | 56 | 2.20e-04 |
KEGG | KEGG:04611 | Platelet activation | 64 | 88 | 2.84e-04 |
KEGG | KEGG:04713 | Circadian entrainment | 51 | 68 | 4.58e-04 |
KEGG | KEGG:04670 | Leukocyte transendothelial migration | 56 | 76 | 4.58e-04 |
KEGG | KEGG:04750 | Inflammatory mediator regulation of TRP channels | 53 | 72 | 7.33e-04 |
KEGG | KEGG:05224 | Breast cancer | 78 | 113 | 7.33e-04 |
KEGG | KEGG:04514 | Cell adhesion molecules | 51 | 69 | 8.01e-04 |
KEGG | KEGG:04923 | Regulation of lipolysis in adipocytes | 33 | 41 | 8.50e-04 |
KEGG | KEGG:04072 | Phospholipase D signaling pathway | 74 | 107 | 9.33e-04 |
KEGG | KEGG:04928 | Parathyroid hormone synthesis, secretion and action | 56 | 78 | 1.27e-03 |
KEGG | KEGG:04961 | Endocrine and other factor-regulated calcium reabsorption | 32 | 40 | 1.27e-03 |
KEGG | KEGG:05032 | Morphine addiction | 41 | 54 | 1.28e-03 |
KEGG | KEGG:05226 | Gastric cancer | 77 | 113 | 1.33e-03 |
KEGG | KEGG:04916 | Melanogenesis | 54 | 75 | 1.37e-03 |
KEGG | KEGG:04148 | Efferocytosis | 81 | 120 | 1.41e-03 |
KEGG | KEGG:05225 | Hepatocellular carcinoma | 91 | 137 | 1.41e-03 |
KEGG | KEGG:05218 | Melanoma | 42 | 56 | 1.55e-03 |
KEGG | KEGG:04728 | Dopaminergic synapse | 67 | 97 | 1.66e-03 |
KEGG | KEGG:04270 | Vascular smooth muscle contraction | 64 | 92 | 1.66e-03 |
KEGG | KEGG:04726 | Serotonergic synapse | 43 | 58 | 1.91e-03 |
KEGG | KEGG:04550 | Signaling pathways regulating pluripotency of stem cells | 69 | 101 | 2.16e-03 |
KEGG | KEGG:05202 | Transcriptional misregulation in cancer | 81 | 122 | 2.82e-03 |
KEGG | KEGG:04371 | Apelin signaling pathway | 70 | 104 | 3.70e-03 |
KEGG | KEGG:04935 | Growth hormone synthesis, secretion and action | 65 | 96 | 4.41e-03 |
KEGG | KEGG:05165 | Human papillomavirus infection | 154 | 252 | 4.67e-03 |
KEGG | KEGG:04213 | Longevity regulating pathway - multiple species | 37 | 50 | 4.67e-03 |
KEGG | KEGG:04929 | GnRH secretion | 37 | 50 | 4.67e-03 |
KEGG | KEGG:05163 | Human cytomegalovirus infection | 102 | 160 | 4.67e-03 |
KEGG | KEGG:04926 | Relaxin signaling pathway | 67 | 100 | 5.25e-03 |
KEGG | KEGG:04915 | Estrogen signaling pathway | 61 | 90 | 5.53e-03 |
KEGG | KEGG:04727 | GABAergic synapse | 38 | 52 | 5.68e-03 |
KEGG | KEGG:04976 | Bile secretion | 31 | 41 | 6.23e-03 |
KEGG | KEGG:04340 | Hedgehog signaling pathway | 36 | 49 | 6.23e-03 |
KEGG | KEGG:04933 | AGE-RAGE signaling pathway in diabetic complications | 59 | 87 | 6.23e-03 |
KEGG | KEGG:04530 | Tight junction | 83 | 129 | 8.32e-03 |
KEGG | KEGG:04540 | Gap junction | 49 | 71 | 8.54e-03 |
KEGG | KEGG:04742 | Taste transduction | 17 | 20 | 9.03e-03 |
KEGG | KEGG:05230 | Central carbon metabolism in cancer | 41 | 58 | 9.57e-03 |
KEGG | KEGG:04380 | Osteoclast differentiation | 61 | 92 | 1.11e-02 |
KEGG | KEGG:05214 | Glioma | 45 | 65 | 1.12e-02 |
KEGG | KEGG:04060 | Cytokine-cytokine receptor interaction | 62 | 94 | 1.21e-02 |
KEGG | KEGG:04152 | AMPK signaling pathway | 66 | 101 | 1.25e-02 |
KEGG | KEGG:05146 | Amoebiasis | 43 | 62 | 1.27e-02 |
KEGG | KEGG:04931 | Insulin resistance | 60 | 91 | 1.37e-02 |
KEGG | KEGG:05210 | Colorectal cancer | 54 | 81 | 1.50e-02 |
KEGG | KEGG:05206 | MicroRNAs in cancer | 90 | 144 | 1.65e-02 |
KEGG | KEGG:04720 | Long-term potentiation | 36 | 51 | 1.65e-02 |
KEGG | KEGG:04922 | Glucagon signaling pathway | 52 | 78 | 1.68e-02 |
KEGG | KEGG:04350 | TGF-beta signaling pathway | 59 | 90 | 1.68e-02 |
KEGG | KEGG:04012 | ErbB signaling pathway | 50 | 75 | 1.96e-02 |
KEGG | KEGG:05222 | Small cell lung cancer | 54 | 82 | 2.04e-02 |
KEGG | KEGG:01522 | Endocrine resistance | 54 | 82 | 2.04e-02 |
KEGG | KEGG:05031 | Amphetamine addiction | 32 | 45 | 2.11e-02 |
KEGG | KEGG:04071 | Sphingolipid signaling pathway | 66 | 103 | 2.16e-02 |
KEGG | KEGG:01521 | EGFR tyrosine kinase inhibitor resistance | 48 | 72 | 2.19e-02 |
KEGG | KEGG:04973 | Carbohydrate digestion and absorption | 22 | 29 | 2.30e-02 |
KEGG | KEGG:04066 | HIF-1 signaling pathway | 56 | 86 | 2.36e-02 |
KEGG | KEGG:00000 | KEGG root term | 2855 | 5451 | 2.47e-02 |
KEGG | KEGG:00051 | Fructose and mannose metabolism | 20 | 26 | 2.47e-02 |
KEGG | KEGG:04913 | Ovarian steroidogenesis | 20 | 26 | 2.47e-02 |
KEGG | KEGG:04730 | Long-term depression | 28 | 39 | 2.65e-02 |
KEGG | KEGG:05213 | Endometrial cancer | 37 | 54 | 2.68e-02 |
KEGG | KEGG:04666 | Fc gamma R-mediated phagocytosis | 49 | 75 | 3.31e-02 |
KEGG | KEGG:04659 | Th17 cell differentiation | 40 | 60 | 3.92e-02 |
KEGG | KEGG:05131 | Shigellosis | 121 | 204 | 3.93e-02 |
KEGG | KEGG:05207 | Chemical carcinogenesis - receptor activation | 81 | 132 | 3.98e-02 |
KEGG | KEGG:04625 | C-type lectin receptor signaling pathway | 48 | 74 | 4.08e-02 |
KEGG | KEGG:00514 | Other types of O-glycan biosynthesis | 25 | 35 | 4.08e-02 |
KEGG | KEGG:04912 | GnRH signaling pathway | 48 | 74 | 4.08e-02 |
KEGG | KEGG:04930 | Type II diabetes mellitus | 25 | 35 | 4.08e-02 |
KEGG | KEGG:04061 | Viral protein interaction with cytokine and cytokine receptor | 15 | 19 | 4.25e-02 |
KEGG | KEGG:04614 | Renin-angiotensin system | 9 | 10 | 4.35e-02 |
KEGG | KEGG:05033 | Nicotine addiction | 9 | 10 | 4.35e-02 |
KEGG | KEGG:00564 | Glycerophospholipid metabolism | 46 | 71 | 4.58e-02 |
KEGG | KEGG:05030 | Cocaine addiction | 23 | 32 | 4.59e-02 |
KEGG | KEGG:04080 | Neuroactive ligand-receptor interaction | 63 | 101 | 4.76e-02 |
KEGG | KEGG:05231 | Choline metabolism in cancer | 51 | 80 | 4.91e-02 |
# LR_resgenes <- gost(query = LR_NG_list$ENTREZID,
# organism = "hsapiens",
# significant = FALSE,
# ordered_query = FALSE,
# domain_scope = "custom",
# measure_underrepresentation = FALSE,
# evcodes = FALSE,
# user_threshold = 0.05,
# correction_method = c("fdr"),
# custom_bg = background_df$ENTREZID,
# sources=c("GO:BP","KEGG"))
# saveRDS(LR_resgenes,"data/GO_KEGG_analysis/LR_resgenes.RDS")
LRnom <- gostplot(LR_resgenes, capped = FALSE, interactive = TRUE)
# LRnom
LRnomtable <- LR_resgenes$result %>%
dplyr::select(c(source, term_id,
term_name,intersection_size,
term_size, p_value))# %>%
LRnomtable %>%
filter(source=="GO:BP", p_value < 0.05) %>%
mutate_at(.vars = 6, .funs = scientific_format()) %>%
kable(.,caption = "GO:BP terms found in LR neargenes" ) %>%
kable_paper("striped", full_width = FALSE) %>%
kable_styling(
full_width = FALSE,
position = "left",
bootstrap_options = c("striped", "hover")
) %>%
scroll_box(width = "100%", height = "400px")
source | term_id | term_name | intersection_size | term_size | p_value |
---|---|---|---|---|---|
GO:BP | GO:0032501 | multicellular organismal process | 3517 | 4504 | 2.85e-37 |
GO:BP | GO:0048731 | system development | 2194 | 2719 | 1.88e-35 |
GO:BP | GO:0007154 | cell communication | 3123 | 3983 | 2.81e-34 |
GO:BP | GO:0009653 | anatomical structure morphogenesis | 1527 | 1844 | 8.13e-34 |
GO:BP | GO:0048856 | anatomical structure development | 3035 | 3867 | 8.13e-34 |
GO:BP | GO:0023052 | signaling | 3073 | 3918 | 8.13e-34 |
GO:BP | GO:0007275 | multicellular organism development | 2520 | 3170 | 1.90e-33 |
GO:BP | GO:0032502 | developmental process | 3261 | 4179 | 1.90e-33 |
GO:BP | GO:0007165 | signal transduction | 2834 | 3611 | 9.26e-31 |
GO:BP | GO:0050896 | response to stimulus | 4108 | 5379 | 4.91e-29 |
GO:BP | GO:0051716 | cellular response to stimulus | 3575 | 4640 | 6.17e-29 |
GO:BP | GO:0007399 | nervous system development | 1449 | 1775 | 5.17e-26 |
GO:BP | GO:0022008 | neurogenesis | 1048 | 1251 | 8.68e-26 |
GO:BP | GO:0048869 | cellular developmental process | 2217 | 2804 | 1.25e-25 |
GO:BP | GO:0030154 | cell differentiation | 2216 | 2803 | 1.35e-25 |
GO:BP | GO:0048513 | animal organ development | 1616 | 2004 | 1.66e-24 |
GO:BP | GO:0050793 | regulation of developmental process | 1384 | 1697 | 2.10e-24 |
GO:BP | GO:0048699 | generation of neurons | 907 | 1076 | 7.45e-24 |
GO:BP | GO:0007166 | cell surface receptor signaling pathway | 1460 | 1801 | 1.06e-23 |
GO:BP | GO:0010646 | regulation of cell communication | 1940 | 2444 | 2.20e-23 |
GO:BP | GO:0030182 | neuron differentiation | 856 | 1014 | 7.74e-23 |
GO:BP | GO:0023051 | regulation of signaling | 1933 | 2438 | 8.19e-23 |
GO:BP | GO:0051239 | regulation of multicellular organismal process | 1547 | 1924 | 2.85e-22 |
GO:BP | GO:0016477 | cell migration | 848 | 1011 | 7.88e-21 |
GO:BP | GO:0007155 | cell adhesion | 791 | 941 | 7.79e-20 |
GO:BP | GO:0009887 | animal organ morphogenesis | 581 | 673 | 1.35e-19 |
GO:BP | GO:0048583 | regulation of response to stimulus | 2124 | 2717 | 1.94e-19 |
GO:BP | GO:0009966 | regulation of signal transduction | 1713 | 2166 | 9.59e-19 |
GO:BP | GO:0048468 | cell development | 1504 | 1886 | 1.08e-18 |
GO:BP | GO:0048870 | cell motility | 924 | 1120 | 2.51e-18 |
GO:BP | GO:0009888 | tissue development | 1096 | 1348 | 7.00e-18 |
GO:BP | GO:0000902 | cell morphogenesis | 607 | 713 | 1.85e-17 |
GO:BP | GO:0007267 | cell-cell signaling | 892 | 1082 | 1.86e-17 |
GO:BP | GO:0003008 | system process | 935 | 1139 | 2.58e-17 |
GO:BP | GO:0040012 | regulation of locomotion | 612 | 720 | 2.58e-17 |
GO:BP | GO:2000145 | regulation of cell motility | 596 | 700 | 3.50e-17 |
GO:BP | GO:0072359 | circulatory system development | 723 | 864 | 4.90e-17 |
GO:BP | GO:0035295 | tube development | 663 | 787 | 6.44e-17 |
GO:BP | GO:0030334 | regulation of cell migration | 570 | 668 | 7.71e-17 |
GO:BP | GO:0051094 | positive regulation of developmental process | 760 | 913 | 8.43e-17 |
GO:BP | GO:0031175 | neuron projection development | 628 | 743 | 1.18e-16 |
GO:BP | GO:0040011 | locomotion | 676 | 805 | 1.28e-16 |
GO:BP | GO:0048666 | neuron development | 701 | 838 | 1.92e-16 |
GO:BP | GO:0035239 | tube morphogenesis | 545 | 638 | 2.70e-16 |
GO:BP | GO:0032989 | cellular anatomical entity morphogenesis | 505 | 588 | 5.26e-16 |
GO:BP | GO:0048646 | anatomical structure formation involved in morphogenesis | 698 | 837 | 1.02e-15 |
GO:BP | GO:0048522 | positive regulation of cellular process | 3005 | 3954 | 1.16e-15 |
GO:BP | GO:0050789 | regulation of biological process | 5544 | 7516 | 1.29e-15 |
GO:BP | GO:0030030 | cell projection organization | 961 | 1182 | 1.55e-15 |
GO:BP | GO:0048518 | positive regulation of biological process | 3254 | 4301 | 2.05e-15 |
GO:BP | GO:2000026 | regulation of multicellular organismal development | 784 | 951 | 2.95e-15 |
GO:BP | GO:0048858 | cell projection morphogenesis | 432 | 498 | 3.12e-15 |
GO:BP | GO:0120036 | plasma membrane bounded cell projection organization | 935 | 1150 | 4.30e-15 |
GO:BP | GO:0007167 | enzyme-linked receptor protein signaling pathway | 603 | 717 | 4.94e-15 |
GO:BP | GO:0120039 | plasma membrane bounded cell projection morphogenesis | 428 | 494 | 6.88e-15 |
GO:BP | GO:0048812 | neuron projection morphogenesis | 416 | 479 | 7.60e-15 |
GO:BP | GO:0001568 | blood vessel development | 452 | 525 | 1.08e-14 |
GO:BP | GO:0051093 | negative regulation of developmental process | 528 | 622 | 1.14e-14 |
GO:BP | GO:0045595 | regulation of cell differentiation | 874 | 1073 | 1.96e-14 |
GO:BP | GO:0022603 | regulation of anatomical structure morphogenesis | 517 | 609 | 2.32e-14 |
GO:BP | GO:0050794 | regulation of cellular process | 5279 | 7153 | 2.55e-14 |
GO:BP | GO:0001944 | vasculature development | 472 | 552 | 3.18e-14 |
GO:BP | GO:0065007 | biological regulation | 5684 | 7734 | 8.19e-14 |
GO:BP | GO:0051240 | positive regulation of multicellular organismal process | 845 | 1040 | 2.20e-13 |
GO:BP | GO:0141124 | intracellular signaling cassette | 1051 | 1314 | 3.49e-13 |
GO:BP | GO:0048667 | cell morphogenesis involved in neuron differentiation | 377 | 435 | 4.36e-13 |
GO:BP | GO:0071495 | cellular response to endogenous stimulus | 840 | 1035 | 4.46e-13 |
GO:BP | GO:0065008 | regulation of biological quality | 1480 | 1893 | 1.18e-12 |
GO:BP | GO:0034330 | cell junction organization | 461 | 545 | 3.79e-12 |
GO:BP | GO:0051128 | regulation of cellular component organization | 1454 | 1862 | 4.53e-12 |
GO:BP | GO:0048514 | blood vessel morphogenesis | 386 | 450 | 6.46e-12 |
GO:BP | GO:0045597 | positive regulation of cell differentiation | 496 | 591 | 6.75e-12 |
GO:BP | GO:0098609 | cell-cell adhesion | 475 | 564 | 6.89e-12 |
GO:BP | GO:0001503 | ossification | 268 | 302 | 8.52e-12 |
GO:BP | GO:0009719 | response to endogenous stimulus | 957 | 1197 | 8.53e-12 |
GO:BP | GO:0048519 | negative regulation of biological process | 2841 | 3764 | 8.92e-12 |
GO:BP | GO:0048589 | developmental growth | 425 | 501 | 1.43e-11 |
GO:BP | GO:0048523 | negative regulation of cellular process | 2682 | 3550 | 3.51e-11 |
GO:BP | GO:0045596 | negative regulation of cell differentiation | 385 | 452 | 6.08e-11 |
GO:BP | GO:0072001 | renal system development | 219 | 244 | 1.04e-10 |
GO:BP | GO:0030155 | regulation of cell adhesion | 428 | 508 | 1.07e-10 |
GO:BP | GO:0035556 | intracellular signal transduction | 1511 | 1951 | 1.59e-10 |
GO:BP | GO:0007409 | axonogenesis | 293 | 337 | 2.10e-10 |
GO:BP | GO:0060429 | epithelium development | 645 | 792 | 2.40e-10 |
GO:BP | GO:0044057 | regulation of system process | 330 | 384 | 2.44e-10 |
GO:BP | GO:0007417 | central nervous system development | 570 | 694 | 2.75e-10 |
GO:BP | GO:0002062 | chondrocyte differentiation | 87 | 88 | 3.70e-10 |
GO:BP | GO:0001822 | kidney development | 212 | 237 | 5.13e-10 |
GO:BP | GO:0003013 | circulatory system process | 362 | 426 | 5.59e-10 |
GO:BP | GO:0010975 | regulation of neuron projection development | 306 | 355 | 6.78e-10 |
GO:BP | GO:0051960 | regulation of nervous system development | 293 | 339 | 9.50e-10 |
GO:BP | GO:0061564 | axon development | 319 | 372 | 9.59e-10 |
GO:BP | GO:0006810 | transport | 2261 | 2984 | 9.59e-10 |
GO:BP | GO:0051049 | regulation of transport | 873 | 1098 | 1.14e-09 |
GO:BP | GO:0042221 | response to chemical | 1764 | 2304 | 1.45e-09 |
GO:BP | GO:0051179 | localization | 2800 | 3731 | 1.60e-09 |
GO:BP | GO:0120035 | regulation of plasma membrane bounded cell projection organization | 422 | 505 | 1.66e-09 |
GO:BP | GO:0098657 | import into cell | 512 | 622 | 1.70e-09 |
GO:BP | GO:0030900 | forebrain development | 239 | 272 | 1.84e-09 |
GO:BP | GO:0060322 | head development | 448 | 539 | 1.95e-09 |
GO:BP | GO:0032879 | regulation of localization | 1126 | 1439 | 1.96e-09 |
GO:BP | GO:0070848 | response to growth factor | 454 | 547 | 2.15e-09 |
GO:BP | GO:0016055 | Wnt signaling pathway | 307 | 358 | 2.17e-09 |
GO:BP | GO:0031344 | regulation of cell projection organization | 430 | 516 | 2.26e-09 |
GO:BP | GO:0001525 | angiogenesis | 325 | 381 | 2.26e-09 |
GO:BP | GO:0010647 | positive regulation of cell communication | 961 | 1218 | 2.40e-09 |
GO:BP | GO:0048729 | tissue morphogenesis | 381 | 453 | 2.59e-09 |
GO:BP | GO:0023056 | positive regulation of signaling | 963 | 1221 | 2.63e-09 |
GO:BP | GO:0051241 | negative regulation of multicellular organismal process | 575 | 706 | 3.23e-09 |
GO:BP | GO:0051056 | regulation of small GTPase mediated signal transduction | 207 | 233 | 3.62e-09 |
GO:BP | GO:0007423 | sensory organ development | 329 | 387 | 3.96e-09 |
GO:BP | GO:0198738 | cell-cell signaling by wnt | 307 | 359 | 4.12e-09 |
GO:BP | GO:0001501 | skeletal system development | 297 | 347 | 6.89e-09 |
GO:BP | GO:0007169 | transmembrane receptor protein tyrosine kinase signaling pathway | 382 | 456 | 6.97e-09 |
GO:BP | GO:0007420 | brain development | 414 | 498 | 9.84e-09 |
GO:BP | GO:0071363 | cellular response to growth factor stimulus | 437 | 528 | 1.05e-08 |
GO:BP | GO:0051234 | establishment of localization | 2438 | 3240 | 1.13e-08 |
GO:BP | GO:0030111 | regulation of Wnt signaling pathway | 228 | 261 | 1.72e-08 |
GO:BP | GO:0050767 | regulation of neurogenesis | 251 | 290 | 1.77e-08 |
GO:BP | GO:0061448 | connective tissue development | 183 | 205 | 1.79e-08 |
GO:BP | GO:0034329 | cell junction assembly | 277 | 323 | 1.82e-08 |
GO:BP | GO:0070887 | cellular response to chemical stimulus | 1350 | 1751 | 2.34e-08 |
GO:BP | GO:0001667 | ameboidal-type cell migration | 293 | 344 | 2.79e-08 |
GO:BP | GO:0008015 | blood circulation | 303 | 357 | 3.22e-08 |
GO:BP | GO:0040013 | negative regulation of locomotion | 213 | 243 | 3.23e-08 |
GO:BP | GO:0061061 | muscle structure development | 441 | 536 | 4.28e-08 |
GO:BP | GO:0071310 | cellular response to organic substance | 1013 | 1297 | 4.30e-08 |
GO:BP | GO:0048584 | positive regulation of response to stimulus | 1166 | 1504 | 4.67e-08 |
GO:BP | GO:0016043 | cellular component organization | 3556 | 4802 | 4.67e-08 |
GO:BP | GO:0009967 | positive regulation of signal transduction | 861 | 1093 | 4.67e-08 |
GO:BP | GO:0048598 | embryonic morphogenesis | 353 | 422 | 4.79e-08 |
GO:BP | GO:0006897 | endocytosis | 407 | 492 | 4.79e-08 |
GO:BP | GO:0007507 | heart development | 412 | 499 | 6.15e-08 |
GO:BP | GO:0051216 | cartilage development | 133 | 145 | 6.15e-08 |
GO:BP | GO:0035265 | organ growth | 118 | 127 | 6.64e-08 |
GO:BP | GO:0030001 | metal ion transport | 431 | 524 | 6.85e-08 |
GO:BP | GO:0030029 | actin filament-based process | 519 | 640 | 9.17e-08 |
GO:BP | GO:0006468 | protein phosphorylation | 757 | 958 | 1.97e-07 |
GO:BP | GO:0030335 | positive regulation of cell migration | 330 | 395 | 2.27e-07 |
GO:BP | GO:2000147 | positive regulation of cell motility | 340 | 408 | 2.34e-07 |
GO:BP | GO:0048638 | regulation of developmental growth | 211 | 243 | 2.36e-07 |
GO:BP | GO:1901888 | regulation of cell junction assembly | 141 | 156 | 2.55e-07 |
GO:BP | GO:0060070 | canonical Wnt signaling pathway | 210 | 242 | 2.87e-07 |
GO:BP | GO:2000146 | negative regulation of cell motility | 190 | 217 | 3.19e-07 |
GO:BP | GO:0030336 | negative regulation of cell migration | 184 | 210 | 4.95e-07 |
GO:BP | GO:0099177 | regulation of trans-synaptic signaling | 273 | 323 | 5.14e-07 |
GO:BP | GO:0016310 | phosphorylation | 894 | 1145 | 5.17e-07 |
GO:BP | GO:0071417 | cellular response to organonitrogen compound | 365 | 442 | 5.21e-07 |
GO:BP | GO:0040017 | positive regulation of locomotion | 345 | 416 | 5.21e-07 |
GO:BP | GO:0043547 | positive regulation of GTPase activity | 105 | 113 | 5.34e-07 |
GO:BP | GO:0009790 | embryo development | 652 | 821 | 5.82e-07 |
GO:BP | GO:1903522 | regulation of blood circulation | 171 | 194 | 5.88e-07 |
GO:BP | GO:0050804 | modulation of chemical synaptic transmission | 272 | 322 | 5.89e-07 |
GO:BP | GO:0045664 | regulation of neuron differentiation | 119 | 130 | 6.08e-07 |
GO:BP | GO:0009987 | cellular process | 7680 | 10686 | 6.88e-07 |
GO:BP | GO:0042592 | homeostatic process | 887 | 1137 | 7.63e-07 |
GO:BP | GO:0016192 | vesicle-mediated transport | 898 | 1152 | 7.94e-07 |
GO:BP | GO:0060284 | regulation of cell development | 462 | 570 | 7.94e-07 |
GO:BP | GO:0002009 | morphogenesis of an epithelium | 308 | 369 | 8.32e-07 |
GO:BP | GO:0072073 | kidney epithelium development | 103 | 111 | 8.68e-07 |
GO:BP | GO:0044087 | regulation of cellular component biogenesis | 603 | 757 | 8.81e-07 |
GO:BP | GO:1902531 | regulation of intracellular signal transduction | 999 | 1289 | 9.23e-07 |
GO:BP | GO:0043087 | regulation of GTPase activity | 148 | 166 | 9.45e-07 |
GO:BP | GO:0007264 | small GTPase-mediated signal transduction | 324 | 390 | 9.49e-07 |
GO:BP | GO:0043010 | camera-type eye development | 199 | 230 | 1.11e-06 |
GO:BP | GO:0031589 | cell-substrate adhesion | 221 | 258 | 1.20e-06 |
GO:BP | GO:0051130 | positive regulation of cellular component organization | 672 | 850 | 1.22e-06 |
GO:BP | GO:0010243 | response to organonitrogen compound | 548 | 685 | 1.29e-06 |
GO:BP | GO:0048585 | negative regulation of response to stimulus | 927 | 1193 | 1.31e-06 |
GO:BP | GO:0090132 | epithelium migration | 209 | 243 | 1.39e-06 |
GO:BP | GO:0010631 | epithelial cell migration | 209 | 243 | 1.39e-06 |
GO:BP | GO:0048705 | skeletal system morphogenesis | 133 | 148 | 1.50e-06 |
GO:BP | GO:0001649 | osteoblast differentiation | 154 | 174 | 1.52e-06 |
GO:BP | GO:0090130 | tissue migration | 212 | 247 | 1.57e-06 |
GO:BP | GO:0014706 | striated muscle tissue development | 185 | 213 | 1.76e-06 |
GO:BP | GO:0060828 | regulation of canonical Wnt signaling pathway | 177 | 203 | 1.85e-06 |
GO:BP | GO:0099537 | trans-synaptic signaling | 382 | 467 | 1.85e-06 |
GO:BP | GO:0050808 | synapse organization | 282 | 337 | 1.90e-06 |
GO:BP | GO:0099536 | synaptic signaling | 394 | 483 | 2.08e-06 |
GO:BP | GO:0040007 | growth | 556 | 697 | 2.08e-06 |
GO:BP | GO:0023057 | negative regulation of signaling | 809 | 1036 | 2.33e-06 |
GO:BP | GO:0045165 | cell fate commitment | 135 | 151 | 2.47e-06 |
GO:BP | GO:0001654 | eye development | 224 | 263 | 2.50e-06 |
GO:BP | GO:0031214 | biomineral tissue development | 98 | 106 | 2.95e-06 |
GO:BP | GO:0065009 | regulation of molecular function | 1003 | 1299 | 2.95e-06 |
GO:BP | GO:0007268 | chemical synaptic transmission | 378 | 463 | 3.20e-06 |
GO:BP | GO:0098916 | anterograde trans-synaptic signaling | 378 | 463 | 3.20e-06 |
GO:BP | GO:0048880 | sensory system development | 226 | 266 | 3.30e-06 |
GO:BP | GO:0021537 | telencephalon development | 170 | 195 | 3.35e-06 |
GO:BP | GO:0008016 | regulation of heart contraction | 146 | 165 | 3.38e-06 |
GO:BP | GO:0060560 | developmental growth involved in morphogenesis | 166 | 190 | 3.38e-06 |
GO:BP | GO:0007178 | transmembrane receptor protein serine/threonine kinase signaling pathway | 240 | 284 | 3.39e-06 |
GO:BP | GO:1901652 | response to peptide | 305 | 368 | 3.54e-06 |
GO:BP | GO:0030036 | actin cytoskeleton organization | 456 | 566 | 3.61e-06 |
GO:BP | GO:0030855 | epithelial cell differentiation | 351 | 428 | 3.63e-06 |
GO:BP | GO:1901700 | response to oxygen-containing compound | 850 | 1093 | 3.66e-06 |
GO:BP | GO:0009893 | positive regulation of metabolic process | 1968 | 2622 | 3.98e-06 |
GO:BP | GO:0010648 | negative regulation of cell communication | 806 | 1034 | 4.01e-06 |
GO:BP | GO:0003007 | heart morphogenesis | 188 | 218 | 4.02e-06 |
GO:BP | GO:0048871 | multicellular organismal-level homeostasis | 433 | 536 | 4.09e-06 |
GO:BP | GO:0003206 | cardiac chamber morphogenesis | 101 | 110 | 4.40e-06 |
GO:BP | GO:0150063 | visual system development | 224 | 264 | 4.48e-06 |
GO:BP | GO:0010720 | positive regulation of cell development | 259 | 309 | 4.57e-06 |
GO:BP | GO:0030278 | regulation of ossification | 75 | 79 | 4.77e-06 |
GO:BP | GO:0141091 | transforming growth factor beta receptor superfamily signaling pathway | 220 | 259 | 4.77e-06 |
GO:BP | GO:0010632 | regulation of epithelial cell migration | 164 | 188 | 4.82e-06 |
GO:BP | GO:0090596 | sensory organ morphogenesis | 152 | 173 | 4.96e-06 |
GO:BP | GO:0010033 | response to organic substance | 1322 | 1736 | 5.17e-06 |
GO:BP | GO:1901698 | response to nitrogen compound | 583 | 736 | 5.60e-06 |
GO:BP | GO:0098660 | inorganic ion transmembrane transport | 421 | 521 | 5.60e-06 |
GO:BP | GO:0009968 | negative regulation of signal transduction | 759 | 972 | 5.63e-06 |
GO:BP | GO:0044093 | positive regulation of molecular function | 618 | 783 | 6.01e-06 |
GO:BP | GO:0006811 | monoatomic ion transport | 570 | 719 | 6.22e-06 |
GO:BP | GO:0050770 | regulation of axonogenesis | 113 | 125 | 6.45e-06 |
GO:BP | GO:0006812 | monoatomic cation transport | 491 | 614 | 6.45e-06 |
GO:BP | GO:0003205 | cardiac chamber development | 134 | 151 | 7.05e-06 |
GO:BP | GO:0048639 | positive regulation of developmental growth | 108 | 119 | 7.29e-06 |
GO:BP | GO:0071840 | cellular component organization or biogenesis | 3665 | 4988 | 7.88e-06 |
GO:BP | GO:0048771 | tissue remodeling | 103 | 113 | 8.09e-06 |
GO:BP | GO:0008150 | biological_process | 8053 | 11244 | 8.24e-06 |
GO:BP | GO:0098662 | inorganic cation transmembrane transport | 389 | 480 | 8.92e-06 |
GO:BP | GO:0031401 | positive regulation of protein modification process | 442 | 550 | 9.09e-06 |
GO:BP | GO:0045937 | positive regulation of phosphate metabolic process | 376 | 463 | 9.22e-06 |
GO:BP | GO:0010562 | positive regulation of phosphorus metabolic process | 376 | 463 | 9.22e-06 |
GO:BP | GO:0060047 | heart contraction | 168 | 194 | 9.64e-06 |
GO:BP | GO:1901699 | cellular response to nitrogen compound | 388 | 479 | 1.01e-05 |
GO:BP | GO:0007186 | G protein-coupled receptor signaling pathway | 317 | 386 | 1.06e-05 |
GO:BP | GO:0034220 | monoatomic ion transmembrane transport | 469 | 587 | 1.45e-05 |
GO:BP | GO:0007010 | cytoskeleton organization | 885 | 1146 | 1.58e-05 |
GO:BP | GO:0048738 | cardiac muscle tissue development | 173 | 201 | 1.58e-05 |
GO:BP | GO:0071560 | cellular response to transforming growth factor beta stimulus | 184 | 215 | 1.61e-05 |
GO:BP | GO:0097485 | neuron projection guidance | 150 | 172 | 1.61e-05 |
GO:BP | GO:0007411 | axon guidance | 150 | 172 | 1.61e-05 |
GO:BP | GO:0043434 | response to peptide hormone | 261 | 314 | 1.62e-05 |
GO:BP | GO:0035108 | limb morphogenesis | 100 | 110 | 1.62e-05 |
GO:BP | GO:0035107 | appendage morphogenesis | 100 | 110 | 1.62e-05 |
GO:BP | GO:0043062 | extracellular structure organization | 191 | 224 | 1.66e-05 |
GO:BP | GO:0045229 | external encapsulating structure organization | 191 | 224 | 1.66e-05 |
GO:BP | GO:0060627 | regulation of vesicle-mediated transport | 307 | 374 | 1.72e-05 |
GO:BP | GO:0071559 | response to transforming growth factor beta | 187 | 219 | 1.76e-05 |
GO:BP | GO:0003231 | cardiac ventricle development | 104 | 115 | 1.79e-05 |
GO:BP | GO:0050673 | epithelial cell proliferation | 250 | 300 | 1.81e-05 |
GO:BP | GO:0097435 | supramolecular fiber organization | 503 | 633 | 1.84e-05 |
GO:BP | GO:0060411 | cardiac septum morphogenesis | 64 | 67 | 1.93e-05 |
GO:BP | GO:0030198 | extracellular matrix organization | 190 | 223 | 1.95e-05 |
GO:BP | GO:0050877 | nervous system process | 478 | 600 | 2.01e-05 |
GO:BP | GO:0007389 | pattern specification process | 239 | 286 | 2.02e-05 |
GO:BP | GO:0003015 | heart process | 175 | 204 | 2.07e-05 |
GO:BP | GO:0048568 | embryonic organ development | 252 | 303 | 2.23e-05 |
GO:BP | GO:0030178 | negative regulation of Wnt signaling pathway | 120 | 135 | 2.28e-05 |
GO:BP | GO:0010604 | positive regulation of macromolecule metabolic process | 1810 | 2415 | 2.60e-05 |
GO:BP | GO:0030010 | establishment of cell polarity | 111 | 124 | 2.60e-05 |
GO:BP | GO:0048588 | developmental cell growth | 155 | 179 | 2.61e-05 |
GO:BP | GO:0007160 | cell-matrix adhesion | 147 | 169 | 2.79e-05 |
GO:BP | GO:0090287 | regulation of cellular response to growth factor stimulus | 209 | 248 | 2.92e-05 |
GO:BP | GO:0098655 | monoatomic cation transmembrane transport | 398 | 495 | 3.00e-05 |
GO:BP | GO:0060562 | epithelial tube morphogenesis | 219 | 261 | 3.14e-05 |
GO:BP | GO:0048592 | eye morphogenesis | 97 | 107 | 3.16e-05 |
GO:BP | GO:0035023 | regulation of Rho protein signal transduction | 62 | 65 | 3.31e-05 |
GO:BP | GO:0044089 | positive regulation of cellular component biogenesis | 318 | 390 | 3.48e-05 |
GO:BP | GO:0022407 | regulation of cell-cell adhesion | 232 | 278 | 3.53e-05 |
GO:BP | GO:0008283 | cell population proliferation | 1000 | 1306 | 3.75e-05 |
GO:BP | GO:0042391 | regulation of membrane potential | 235 | 282 | 3.76e-05 |
GO:BP | GO:0090257 | regulation of muscle system process | 153 | 177 | 3.77e-05 |
GO:BP | GO:0043408 | regulation of MAPK cascade | 346 | 427 | 3.77e-05 |
GO:BP | GO:1901701 | cellular response to oxygen-containing compound | 623 | 796 | 3.90e-05 |
GO:BP | GO:0006793 | phosphorus metabolic process | 1437 | 1904 | 3.96e-05 |
GO:BP | GO:0048762 | mesenchymal cell differentiation | 171 | 200 | 4.20e-05 |
GO:BP | GO:0002065 | columnar/cuboidal epithelial cell differentiation | 76 | 82 | 5.49e-05 |
GO:BP | GO:0042330 | taxis | 205 | 244 | 5.62e-05 |
GO:BP | GO:0006935 | chemotaxis | 205 | 244 | 5.62e-05 |
GO:BP | GO:0045785 | positive regulation of cell adhesion | 249 | 301 | 5.82e-05 |
GO:BP | GO:0072006 | nephron development | 103 | 115 | 5.86e-05 |
GO:BP | GO:0006796 | phosphate-containing compound metabolic process | 1420 | 1883 | 6.23e-05 |
GO:BP | GO:0060537 | muscle tissue development | 278 | 339 | 6.40e-05 |
GO:BP | GO:0051173 | positive regulation of nitrogen compound metabolic process | 1640 | 2186 | 6.55e-05 |
GO:BP | GO:0031399 | regulation of protein modification process | 707 | 911 | 6.56e-05 |
GO:BP | GO:0003281 | ventricular septum development | 65 | 69 | 6.56e-05 |
GO:BP | GO:0030326 | embryonic limb morphogenesis | 80 | 87 | 6.61e-05 |
GO:BP | GO:0035113 | embryonic appendage morphogenesis | 80 | 87 | 6.61e-05 |
GO:BP | GO:0045667 | regulation of osteoblast differentiation | 89 | 98 | 7.03e-05 |
GO:BP | GO:0070167 | regulation of biomineral tissue development | 59 | 62 | 7.48e-05 |
GO:BP | GO:0042127 | regulation of cell population proliferation | 829 | 1077 | 8.19e-05 |
GO:BP | GO:0034762 | regulation of transmembrane transport | 246 | 298 | 9.01e-05 |
GO:BP | GO:0001823 | mesonephros development | 69 | 74 | 9.01e-05 |
GO:BP | GO:0051247 | positive regulation of protein metabolic process | 706 | 911 | 9.37e-05 |
GO:BP | GO:0031325 | positive regulation of cellular metabolic process | 1745 | 2333 | 9.39e-05 |
GO:BP | GO:0046903 | secretion | 491 | 622 | 9.45e-05 |
GO:BP | GO:0060485 | mesenchyme development | 205 | 245 | 9.67e-05 |
GO:BP | GO:0003279 | cardiac septum development | 92 | 102 | 9.77e-05 |
GO:BP | GO:0007159 | leukocyte cell-cell adhesion | 184 | 218 | 9.81e-05 |
GO:BP | GO:0032835 | glomerulus development | 52 | 54 | 1.02e-04 |
GO:BP | GO:0042327 | positive regulation of phosphorylation | 335 | 415 | 1.03e-04 |
GO:BP | GO:0051174 | regulation of phosphorus metabolic process | 627 | 805 | 1.08e-04 |
GO:BP | GO:0055123 | digestive system development | 87 | 96 | 1.11e-04 |
GO:BP | GO:0072163 | mesonephric epithelium development | 68 | 73 | 1.14e-04 |
GO:BP | GO:0072164 | mesonephric tubule development | 68 | 73 | 1.14e-04 |
GO:BP | GO:0000165 | MAPK cascade | 402 | 504 | 1.14e-04 |
GO:BP | GO:0019220 | regulation of phosphate metabolic process | 626 | 804 | 1.18e-04 |
GO:BP | GO:0051962 | positive regulation of nervous system development | 179 | 212 | 1.25e-04 |
GO:BP | GO:0051129 | negative regulation of cellular component organization | 440 | 555 | 1.32e-04 |
GO:BP | GO:0003012 | muscle system process | 266 | 325 | 1.35e-04 |
GO:BP | GO:0150115 | cell-substrate junction organization | 86 | 95 | 1.39e-04 |
GO:BP | GO:0030282 | bone mineralization | 72 | 78 | 1.44e-04 |
GO:BP | GO:0140352 | export from cell | 469 | 594 | 1.45e-04 |
GO:BP | GO:0001657 | ureteric bud development | 67 | 72 | 1.46e-04 |
GO:BP | GO:0007610 | behavior | 338 | 420 | 1.53e-04 |
GO:BP | GO:0007163 | establishment or maintenance of cell polarity | 156 | 183 | 1.62e-04 |
GO:BP | GO:0014855 | striated muscle cell proliferation | 56 | 59 | 1.66e-04 |
GO:BP | GO:0001763 | morphogenesis of a branching structure | 126 | 145 | 1.68e-04 |
GO:BP | GO:0010463 | mesenchymal cell proliferation | 36 | 36 | 1.79e-04 |
GO:BP | GO:0051336 | regulation of hydrolase activity | 346 | 431 | 1.79e-04 |
GO:BP | GO:0050807 | regulation of synapse organization | 148 | 173 | 1.83e-04 |
GO:BP | GO:0030100 | regulation of endocytosis | 166 | 196 | 1.84e-04 |
GO:BP | GO:0007517 | muscle organ development | 221 | 267 | 1.84e-04 |
GO:BP | GO:0003002 | regionalization | 214 | 258 | 1.92e-04 |
GO:BP | GO:0048565 | digestive tract development | 80 | 88 | 1.94e-04 |
GO:BP | GO:0007259 | receptor signaling pathway via JAK-STAT | 80 | 88 | 1.94e-04 |
GO:BP | GO:0007044 | cell-substrate junction assembly | 80 | 88 | 1.94e-04 |
GO:BP | GO:0048167 | regulation of synaptic plasticity | 121 | 139 | 2.06e-04 |
GO:BP | GO:0051961 | negative regulation of nervous system development | 97 | 109 | 2.06e-04 |
GO:BP | GO:0090090 | negative regulation of canonical Wnt signaling pathway | 97 | 109 | 2.06e-04 |
GO:BP | GO:0009605 | response to external stimulus | 1179 | 1559 | 2.07e-04 |
GO:BP | GO:1990138 | neuron projection extension | 117 | 134 | 2.10e-04 |
GO:BP | GO:0001764 | neuron migration | 113 | 129 | 2.13e-04 |
GO:BP | GO:0043085 | positive regulation of catalytic activity | 432 | 546 | 2.23e-04 |
GO:BP | GO:0001934 | positive regulation of protein phosphorylation | 319 | 396 | 2.28e-04 |
GO:BP | GO:0055017 | cardiac muscle tissue growth | 60 | 64 | 2.33e-04 |
GO:BP | GO:0046622 | positive regulation of organ growth | 35 | 35 | 2.39e-04 |
GO:BP | GO:0050803 | regulation of synapse structure or activity | 150 | 176 | 2.39e-04 |
GO:BP | GO:0048593 | camera-type eye morphogenesis | 79 | 87 | 2.41e-04 |
GO:BP | GO:0050768 | negative regulation of neurogenesis | 92 | 103 | 2.42e-04 |
GO:BP | GO:0007162 | negative regulation of cell adhesion | 157 | 185 | 2.46e-04 |
GO:BP | GO:0051641 | cellular localization | 1950 | 2623 | 2.46e-04 |
GO:BP | GO:0043269 | regulation of monoatomic ion transport | 232 | 282 | 2.48e-04 |
GO:BP | GO:0050920 | regulation of chemotaxis | 116 | 133 | 2.51e-04 |
GO:BP | GO:0031346 | positive regulation of cell projection organization | 235 | 286 | 2.58e-04 |
GO:BP | GO:0033002 | muscle cell proliferation | 131 | 152 | 2.62e-04 |
GO:BP | GO:1901653 | cellular response to peptide | 225 | 273 | 2.62e-04 |
GO:BP | GO:0045666 | positive regulation of neuron differentiation | 54 | 57 | 2.73e-04 |
GO:BP | GO:0055085 | transmembrane transport | 710 | 921 | 2.77e-04 |
GO:BP | GO:0042063 | gliogenesis | 201 | 242 | 2.88e-04 |
GO:BP | GO:0050769 | positive regulation of neurogenesis | 156 | 184 | 2.88e-04 |
GO:BP | GO:0061035 | regulation of cartilage development | 48 | 50 | 2.96e-04 |
GO:BP | GO:0007229 | integrin-mediated signaling pathway | 78 | 86 | 2.97e-04 |
GO:BP | GO:0009725 | response to hormone | 479 | 610 | 3.10e-04 |
GO:BP | GO:0016331 | morphogenesis of embryonic epithelium | 107 | 122 | 3.12e-04 |
GO:BP | GO:0032330 | regulation of chondrocyte differentiation | 34 | 34 | 3.19e-04 |
GO:BP | GO:0097696 | receptor signaling pathway via STAT | 82 | 91 | 3.25e-04 |
GO:BP | GO:0016358 | dendrite development | 155 | 183 | 3.40e-04 |
GO:BP | GO:0090092 | regulation of transmembrane receptor protein serine/threonine kinase signaling pathway | 176 | 210 | 3.40e-04 |
GO:BP | GO:0050678 | regulation of epithelial cell proliferation | 206 | 249 | 3.70e-04 |
GO:BP | GO:0060993 | kidney morphogenesis | 63 | 68 | 3.81e-04 |
GO:BP | GO:0032970 | regulation of actin filament-based process | 245 | 300 | 3.88e-04 |
GO:BP | GO:0010721 | negative regulation of cell development | 154 | 182 | 4.03e-04 |
GO:BP | GO:0001952 | regulation of cell-matrix adhesion | 81 | 90 | 4.08e-04 |
GO:BP | GO:0061138 | morphogenesis of a branching epithelium | 117 | 135 | 4.31e-04 |
GO:BP | GO:0032940 | secretion by cell | 434 | 551 | 4.55e-04 |
GO:BP | GO:0051057 | positive regulation of small GTPase mediated signal transduction | 52 | 55 | 4.65e-04 |
GO:BP | GO:0007015 | actin filament organization | 288 | 357 | 4.70e-04 |
GO:BP | GO:0072009 | nephron epithelium development | 76 | 84 | 4.70e-04 |
GO:BP | GO:0001656 | metanephros development | 57 | 61 | 4.93e-04 |
GO:BP | GO:0042325 | regulation of phosphorylation | 532 | 683 | 5.17e-04 |
GO:BP | GO:0030500 | regulation of bone mineralization | 46 | 48 | 5.17e-04 |
GO:BP | GO:0003018 | vascular process in circulatory system | 163 | 194 | 5.18e-04 |
GO:BP | GO:0007179 | transforming growth factor beta receptor signaling pathway | 145 | 171 | 5.55e-04 |
GO:BP | GO:1901342 | regulation of vasculature development | 166 | 198 | 5.59e-04 |
GO:BP | GO:0021953 | central nervous system neuron differentiation | 88 | 99 | 5.59e-04 |
GO:BP | GO:0007266 | Rho protein signal transduction | 96 | 109 | 5.76e-04 |
GO:BP | GO:0001775 | cell activation | 490 | 627 | 5.92e-04 |
GO:BP | GO:0045216 | cell-cell junction organization | 130 | 152 | 6.10e-04 |
GO:BP | GO:0031032 | actomyosin structure organization | 155 | 184 | 6.10e-04 |
GO:BP | GO:1902893 | regulation of miRNA transcription | 56 | 60 | 6.33e-04 |
GO:BP | GO:0018105 | peptidyl-serine phosphorylation | 137 | 161 | 6.34e-04 |
GO:BP | GO:0002521 | leukocyte differentiation | 298 | 371 | 6.34e-04 |
GO:BP | GO:1903037 | regulation of leukocyte cell-cell adhesion | 165 | 197 | 6.49e-04 |
GO:BP | GO:0060412 | ventricular septum morphogenesis | 39 | 40 | 6.49e-04 |
GO:BP | GO:0051050 | positive regulation of transport | 448 | 571 | 6.53e-04 |
GO:BP | GO:0048041 | focal adhesion assembly | 70 | 77 | 6.59e-04 |
GO:BP | GO:0021987 | cerebral cortex development | 83 | 93 | 6.59e-04 |
GO:BP | GO:0006816 | calcium ion transport | 215 | 262 | 6.66e-04 |
GO:BP | GO:0051345 | positive regulation of hydrolase activity | 218 | 266 | 6.91e-04 |
GO:BP | GO:0043542 | endothelial cell migration | 147 | 174 | 7.07e-04 |
GO:BP | GO:0043583 | ear development | 129 | 151 | 7.16e-04 |
GO:BP | GO:1902533 | positive regulation of intracellular signal transduction | 554 | 714 | 7.24e-04 |
GO:BP | GO:0060419 | heart growth | 65 | 71 | 7.27e-04 |
GO:BP | GO:0018209 | peptidyl-serine modification | 143 | 169 | 7.61e-04 |
GO:BP | GO:0060043 | regulation of cardiac muscle cell proliferation | 31 | 31 | 8.05e-04 |
GO:BP | GO:0018212 | peptidyl-tyrosine modification | 139 | 164 | 8.23e-04 |
GO:BP | GO:0006898 | receptor-mediated endocytosis | 153 | 182 | 8.31e-04 |
GO:BP | GO:0010959 | regulation of metal ion transport | 197 | 239 | 8.31e-04 |
GO:BP | GO:0098771 | inorganic ion homeostasis | 280 | 348 | 8.43e-04 |
GO:BP | GO:0010594 | regulation of endothelial cell migration | 117 | 136 | 8.45e-04 |
GO:BP | GO:0032870 | cellular response to hormone stimulus | 344 | 433 | 8.75e-04 |
GO:BP | GO:0046620 | regulation of organ growth | 64 | 70 | 9.22e-04 |
GO:BP | GO:0043068 | positive regulation of programmed cell death | 310 | 388 | 9.34e-04 |
GO:BP | GO:0050772 | positive regulation of axonogenesis | 59 | 64 | 1.00e-03 |
GO:BP | GO:0048645 | animal organ formation | 49 | 52 | 1.00e-03 |
GO:BP | GO:0021543 | pallium development | 116 | 135 | 1.02e-03 |
GO:BP | GO:0045765 | regulation of angiogenesis | 162 | 194 | 1.03e-03 |
GO:BP | GO:0090066 | regulation of anatomical structure size | 303 | 379 | 1.03e-03 |
GO:BP | GO:0043410 | positive regulation of MAPK cascade | 234 | 288 | 1.08e-03 |
GO:BP | GO:0098900 | regulation of action potential | 37 | 38 | 1.15e-03 |
GO:BP | GO:0010810 | regulation of cell-substrate adhesion | 137 | 162 | 1.15e-03 |
GO:BP | GO:0018108 | peptidyl-tyrosine phosphorylation | 137 | 162 | 1.15e-03 |
GO:BP | GO:0061005 | cell differentiation involved in kidney development | 37 | 38 | 1.15e-03 |
GO:BP | GO:0010717 | regulation of epithelial to mesenchymal transition | 76 | 85 | 1.20e-03 |
GO:BP | GO:0022604 | regulation of cell morphogenesis | 161 | 193 | 1.20e-03 |
GO:BP | GO:0032409 | regulation of transporter activity | 126 | 148 | 1.20e-03 |
GO:BP | GO:0030177 | positive regulation of Wnt signaling pathway | 96 | 110 | 1.23e-03 |
GO:BP | GO:0043588 | skin development | 147 | 175 | 1.24e-03 |
GO:BP | GO:0001932 | regulation of protein phosphorylation | 499 | 642 | 1.27e-03 |
GO:BP | GO:0070588 | calcium ion transmembrane transport | 174 | 210 | 1.29e-03 |
GO:BP | GO:0010633 | negative regulation of epithelial cell migration | 48 | 51 | 1.29e-03 |
GO:BP | GO:0061326 | renal tubule development | 67 | 74 | 1.29e-03 |
GO:BP | GO:0021954 | central nervous system neuron development | 53 | 57 | 1.31e-03 |
GO:BP | GO:0035148 | tube formation | 107 | 124 | 1.33e-03 |
GO:BP | GO:0061351 | neural precursor cell proliferation | 103 | 119 | 1.39e-03 |
GO:BP | GO:0071375 | cellular response to peptide hormone stimulus | 190 | 231 | 1.39e-03 |
GO:BP | GO:0042692 | muscle cell differentiation | 260 | 323 | 1.43e-03 |
GO:BP | GO:0051246 | regulation of protein metabolic process | 1197 | 1595 | 1.44e-03 |
GO:BP | GO:0007157 | heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules | 29 | 29 | 1.47e-03 |
GO:BP | GO:0044409 | symbiont entry into host | 95 | 109 | 1.48e-03 |
GO:BP | GO:0055021 | regulation of cardiac muscle tissue growth | 42 | 44 | 1.49e-03 |
GO:BP | GO:0008284 | positive regulation of cell population proliferation | 471 | 605 | 1.52e-03 |
GO:BP | GO:0006814 | sodium ion transport | 117 | 137 | 1.61e-03 |
GO:BP | GO:0071772 | response to BMP | 102 | 118 | 1.67e-03 |
GO:BP | GO:0060348 | bone development | 124 | 146 | 1.67e-03 |
GO:BP | GO:0048008 | platelet-derived growth factor receptor signaling pathway | 47 | 50 | 1.67e-03 |
GO:BP | GO:0071773 | cellular response to BMP stimulus | 102 | 118 | 1.67e-03 |
GO:BP | GO:0050900 | leukocyte migration | 162 | 195 | 1.70e-03 |
GO:BP | GO:0007188 | adenylate cyclase-modulating G protein-coupled receptor signaling pathway | 98 | 113 | 1.73e-03 |
GO:BP | GO:1901343 | negative regulation of vasculature development | 61 | 67 | 1.82e-03 |
GO:BP | GO:2000181 | negative regulation of blood vessel morphogenesis | 61 | 67 | 1.82e-03 |
GO:BP | GO:0003151 | outflow tract morphogenesis | 61 | 67 | 1.82e-03 |
GO:BP | GO:0022612 | gland morphogenesis | 82 | 93 | 1.87e-03 |
GO:BP | GO:0007416 | synapse assembly | 116 | 136 | 1.91e-03 |
GO:BP | GO:0045665 | negative regulation of neuron differentiation | 41 | 43 | 1.95e-03 |
GO:BP | GO:0060038 | cardiac muscle cell proliferation | 41 | 43 | 1.95e-03 |
GO:BP | GO:0008285 | negative regulation of cell population proliferation | 369 | 469 | 1.98e-03 |
GO:BP | GO:0060421 | positive regulation of heart growth | 28 | 28 | 1.99e-03 |
GO:BP | GO:0072175 | epithelial tube formation | 101 | 117 | 1.99e-03 |
GO:BP | GO:2000628 | regulation of miRNA metabolic process | 65 | 72 | 1.99e-03 |
GO:BP | GO:0061614 | miRNA transcription | 56 | 61 | 1.99e-03 |
GO:BP | GO:0060420 | regulation of heart growth | 46 | 49 | 2.11e-03 |
GO:BP | GO:0090109 | regulation of cell-substrate junction assembly | 51 | 55 | 2.11e-03 |
GO:BP | GO:1903053 | regulation of extracellular matrix organization | 46 | 49 | 2.11e-03 |
GO:BP | GO:0051893 | regulation of focal adhesion assembly | 51 | 55 | 2.11e-03 |
GO:BP | GO:0030048 | actin filament-based movement | 93 | 107 | 2.14e-03 |
GO:BP | GO:0030097 | hemopoiesis | 484 | 624 | 2.20e-03 |
GO:BP | GO:1903131 | mononuclear cell differentiation | 225 | 278 | 2.21e-03 |
GO:BP | GO:0110020 | regulation of actomyosin structure organization | 77 | 87 | 2.24e-03 |
GO:BP | GO:0010586 | miRNA metabolic process | 77 | 87 | 2.24e-03 |
GO:BP | GO:0043065 | positive regulation of apoptotic process | 302 | 380 | 2.24e-03 |
GO:BP | GO:0016525 | negative regulation of angiogenesis | 60 | 66 | 2.25e-03 |
GO:BP | GO:0060541 | respiratory system development | 136 | 162 | 2.30e-03 |
GO:BP | GO:0034765 | regulation of monoatomic ion transmembrane transport | 173 | 210 | 2.34e-03 |
GO:BP | GO:1904062 | regulation of monoatomic cation transmembrane transport | 156 | 188 | 2.47e-03 |
GO:BP | GO:0022898 | regulation of transmembrane transporter activity | 118 | 139 | 2.47e-03 |
GO:BP | GO:0050790 | regulation of catalytic activity | 682 | 893 | 2.49e-03 |
GO:BP | GO:0150116 | regulation of cell-substrate junction organization | 55 | 60 | 2.49e-03 |
GO:BP | GO:0002064 | epithelial cell development | 125 | 148 | 2.49e-03 |
GO:BP | GO:0071407 | cellular response to organic cyclic compound | 301 | 379 | 2.49e-03 |
GO:BP | GO:0008360 | regulation of cell shape | 92 | 106 | 2.55e-03 |
GO:BP | GO:0051963 | regulation of synapse assembly | 68 | 76 | 2.59e-03 |
GO:BP | GO:1901890 | positive regulation of cell junction assembly | 68 | 76 | 2.59e-03 |
GO:BP | GO:0045663 | positive regulation of myoblast differentiation | 34 | 35 | 2.59e-03 |
GO:BP | GO:0032412 | regulation of monoatomic ion transmembrane transporter activity | 114 | 134 | 2.62e-03 |
GO:BP | GO:0098901 | regulation of cardiac muscle cell action potential | 27 | 27 | 2.64e-03 |
GO:BP | GO:0010464 | regulation of mesenchymal cell proliferation | 27 | 27 | 2.64e-03 |
GO:BP | GO:0006942 | regulation of striated muscle contraction | 72 | 81 | 2.66e-03 |
GO:BP | GO:0010976 | positive regulation of neuron projection development | 110 | 129 | 2.79e-03 |
GO:BP | GO:0055117 | regulation of cardiac muscle contraction | 59 | 65 | 2.79e-03 |
GO:BP | GO:0008361 | regulation of cell size | 124 | 147 | 2.92e-03 |
GO:BP | GO:0030509 | BMP signaling pathway | 95 | 110 | 2.94e-03 |
GO:BP | GO:0072080 | nephron tubule development | 63 | 70 | 3.04e-03 |
GO:BP | GO:0046849 | bone remodeling | 54 | 59 | 3.14e-03 |
GO:BP | GO:0071695 | anatomical structure maturation | 127 | 151 | 3.16e-03 |
GO:BP | GO:0032101 | regulation of response to external stimulus | 505 | 654 | 3.25e-03 |
GO:BP | GO:0060840 | artery development | 75 | 85 | 3.32e-03 |
GO:BP | GO:0061337 | cardiac conduction | 75 | 85 | 3.32e-03 |
GO:BP | GO:0033135 | regulation of peptidyl-serine phosphorylation | 75 | 85 | 3.32e-03 |
GO:BP | GO:1903039 | positive regulation of leukocyte cell-cell adhesion | 123 | 146 | 3.43e-03 |
GO:BP | GO:0061572 | actin filament bundle organization | 112 | 132 | 3.69e-03 |
GO:BP | GO:0036211 | protein modification process | 1696 | 2291 | 3.69e-03 |
GO:BP | GO:0014013 | regulation of gliogenesis | 62 | 69 | 3.80e-03 |
GO:BP | GO:0043270 | positive regulation of monoatomic ion transport | 108 | 127 | 3.95e-03 |
GO:BP | GO:0061333 | renal tubule morphogenesis | 53 | 58 | 3.95e-03 |
GO:BP | GO:0072028 | nephron morphogenesis | 53 | 58 | 3.95e-03 |
GO:BP | GO:0048864 | stem cell development | 66 | 74 | 3.95e-03 |
GO:BP | GO:0010634 | positive regulation of epithelial cell migration | 108 | 127 | 3.95e-03 |
GO:BP | GO:0014897 | striated muscle hypertrophy | 66 | 74 | 3.95e-03 |
GO:BP | GO:0098727 | maintenance of cell number | 122 | 145 | 4.00e-03 |
GO:BP | GO:0031345 | negative regulation of cell projection organization | 122 | 145 | 4.00e-03 |
GO:BP | GO:0031623 | receptor internalization | 78 | 89 | 4.00e-03 |
GO:BP | GO:0060173 | limb development | 115 | 136 | 4.00e-03 |
GO:BP | GO:0048736 | appendage development | 115 | 136 | 4.00e-03 |
GO:BP | GO:0042476 | odontogenesis | 70 | 79 | 4.00e-03 |
GO:BP | GO:0048878 | chemical homeostasis | 516 | 670 | 4.18e-03 |
GO:BP | GO:0000003 | reproduction | 672 | 882 | 4.19e-03 |
GO:BP | GO:0045669 | positive regulation of osteoblast differentiation | 48 | 52 | 4.27e-03 |
GO:BP | GO:0051017 | actin filament bundle assembly | 111 | 131 | 4.30e-03 |
GO:BP | GO:0046718 | symbiont entry into host cell | 89 | 103 | 4.40e-03 |
GO:BP | GO:0060350 | endochondral bone morphogenesis | 43 | 46 | 4.41e-03 |
GO:BP | GO:0006937 | regulation of muscle contraction | 107 | 126 | 4.64e-03 |
GO:BP | GO:0030324 | lung development | 121 | 144 | 4.68e-03 |
GO:BP | GO:0031099 | regeneration | 121 | 144 | 4.68e-03 |
GO:BP | GO:0003300 | cardiac muscle hypertrophy | 65 | 73 | 4.84e-03 |
GO:BP | GO:0060349 | bone morphogenesis | 65 | 73 | 4.84e-03 |
GO:BP | GO:0055023 | positive regulation of cardiac muscle tissue growth | 25 | 25 | 4.84e-03 |
GO:BP | GO:0055006 | cardiac cell development | 69 | 78 | 4.91e-03 |
GO:BP | GO:0050890 | cognition | 174 | 213 | 4.91e-03 |
GO:BP | GO:0030323 | respiratory tube development | 124 | 148 | 5.02e-03 |
GO:BP | GO:0098742 | cell-cell adhesion via plasma-membrane adhesion molecules | 127 | 152 | 5.40e-03 |
GO:BP | GO:0042733 | embryonic digit morphogenesis | 47 | 51 | 5.44e-03 |
GO:BP | GO:0003208 | cardiac ventricle morphogenesis | 56 | 62 | 5.44e-03 |
GO:BP | GO:0045778 | positive regulation of ossification | 37 | 39 | 5.46e-03 |
GO:BP | GO:0019827 | stem cell population maintenance | 120 | 143 | 5.48e-03 |
GO:BP | GO:0040008 | regulation of growth | 361 | 462 | 5.58e-03 |
GO:BP | GO:0042981 | regulation of apoptotic process | 780 | 1031 | 5.58e-03 |
GO:BP | GO:0023061 | signal release | 251 | 315 | 5.62e-03 |
GO:BP | GO:0010628 | positive regulation of gene expression | 571 | 746 | 5.64e-03 |
GO:BP | GO:0050731 | positive regulation of peptidyl-tyrosine phosphorylation | 80 | 92 | 5.70e-03 |
GO:BP | GO:0071805 | potassium ion transmembrane transport | 102 | 120 | 5.86e-03 |
GO:BP | GO:0086004 | regulation of cardiac muscle cell contraction | 31 | 32 | 5.94e-03 |
GO:BP | GO:0001838 | embryonic epithelial tube formation | 91 | 106 | 5.94e-03 |
GO:BP | GO:0035850 | epithelial cell differentiation involved in kidney development | 31 | 32 | 5.94e-03 |
GO:BP | GO:0007043 | cell-cell junction assembly | 91 | 106 | 5.94e-03 |
GO:BP | GO:0014033 | neural crest cell differentiation | 68 | 77 | 5.96e-03 |
GO:BP | GO:0072088 | nephron epithelium morphogenesis | 51 | 56 | 6.14e-03 |
GO:BP | GO:0048708 | astrocyte differentiation | 51 | 56 | 6.14e-03 |
GO:BP | GO:0010817 | regulation of hormone levels | 253 | 318 | 6.26e-03 |
GO:BP | GO:0003006 | developmental process involved in reproduction | 443 | 573 | 6.28e-03 |
GO:BP | GO:0001894 | tissue homeostasis | 136 | 164 | 6.30e-03 |
GO:BP | GO:0060249 | anatomical structure homeostasis | 136 | 164 | 6.30e-03 |
GO:BP | GO:0046777 | protein autophosphorylation | 119 | 142 | 6.32e-03 |
GO:BP | GO:0048839 | inner ear development | 112 | 133 | 6.38e-03 |
GO:BP | GO:0071875 | adrenergic receptor signaling pathway | 24 | 24 | 6.47e-03 |
GO:BP | GO:0098868 | bone growth | 24 | 24 | 6.47e-03 |
GO:BP | GO:0010001 | glial cell differentiation | 149 | 181 | 6.53e-03 |
GO:BP | GO:0048469 | cell maturation | 94 | 110 | 6.60e-03 |
GO:BP | GO:0031016 | pancreas development | 46 | 50 | 6.74e-03 |
GO:BP | GO:2000630 | positive regulation of miRNA metabolic process | 46 | 50 | 6.74e-03 |
GO:BP | GO:0030038 | contractile actin filament bundle assembly | 79 | 91 | 6.76e-03 |
GO:BP | GO:0043149 | stress fiber assembly | 79 | 91 | 6.76e-03 |
GO:BP | GO:0007272 | ensheathment of neurons | 101 | 119 | 6.78e-03 |
GO:BP | GO:0008366 | axon ensheathment | 101 | 119 | 6.78e-03 |
GO:BP | GO:0001837 | epithelial to mesenchymal transition | 115 | 137 | 6.81e-03 |
GO:BP | GO:0010596 | negative regulation of endothelial cell migration | 36 | 38 | 6.91e-03 |
GO:BP | GO:0090100 | positive regulation of transmembrane receptor protein serine/threonine kinase signaling pathway | 75 | 86 | 6.95e-03 |
GO:BP | GO:0060041 | retina development in camera-type eye | 90 | 105 | 6.95e-03 |
GO:BP | GO:1902895 | positive regulation of miRNA transcription | 41 | 44 | 7.04e-03 |
GO:BP | GO:0034103 | regulation of tissue remodeling | 41 | 44 | 7.04e-03 |
GO:BP | GO:0022414 | reproductive process | 664 | 874 | 7.20e-03 |
GO:BP | GO:0043067 | regulation of programmed cell death | 800 | 1060 | 7.23e-03 |
GO:BP | GO:0060341 | regulation of cellular localization | 592 | 776 | 7.41e-03 |
GO:BP | GO:0003179 | heart valve morphogenesis | 50 | 55 | 7.57e-03 |
GO:BP | GO:0048732 | gland development | 245 | 308 | 7.60e-03 |
GO:BP | GO:0021955 | central nervous system neuron axonogenesis | 30 | 31 | 7.69e-03 |
GO:BP | GO:0035725 | sodium ion transmembrane transport | 82 | 95 | 7.72e-03 |
GO:BP | GO:0010977 | negative regulation of neuron projection development | 93 | 109 | 7.74e-03 |
GO:BP | GO:0061458 | reproductive system development | 167 | 205 | 7.87e-03 |
GO:BP | GO:0008544 | epidermis development | 170 | 209 | 8.09e-03 |
GO:BP | GO:0021675 | nerve development | 54 | 60 | 8.17e-03 |
GO:BP | GO:1990778 | protein localization to cell periphery | 229 | 287 | 8.29e-03 |
GO:BP | GO:0032231 | regulation of actin filament bundle assembly | 74 | 85 | 8.37e-03 |
GO:BP | GO:0007369 | gastrulation | 117 | 140 | 8.48e-03 |
GO:BP | GO:0003170 | heart valve development | 58 | 65 | 8.52e-03 |
GO:BP | GO:0060291 | long-term synaptic potentiation | 58 | 65 | 8.52e-03 |
GO:BP | GO:0048754 | branching morphogenesis of an epithelial tube | 96 | 113 | 8.54e-03 |
GO:BP | GO:0051924 | regulation of calcium ion transport | 127 | 153 | 8.56e-03 |
GO:BP | GO:0061036 | positive regulation of cartilage development | 23 | 23 | 8.56e-03 |
GO:BP | GO:0003416 | endochondral bone growth | 23 | 23 | 8.56e-03 |
GO:BP | GO:0002685 | regulation of leukocyte migration | 103 | 122 | 8.56e-03 |
GO:BP | GO:0002063 | chondrocyte development | 23 | 23 | 8.56e-03 |
GO:BP | GO:0060037 | pharyngeal system development | 23 | 23 | 8.56e-03 |
GO:BP | GO:0097553 | calcium ion transmembrane import into cytosol | 103 | 122 | 8.56e-03 |
GO:BP | GO:0014896 | muscle hypertrophy | 66 | 75 | 8.57e-03 |
GO:BP | GO:0090288 | negative regulation of cellular response to growth factor stimulus | 66 | 75 | 8.57e-03 |
GO:BP | GO:0031328 | positive regulation of cellular biosynthetic process | 1366 | 1841 | 8.68e-03 |
GO:BP | GO:1903115 | regulation of actin filament-based movement | 35 | 37 | 8.77e-03 |
GO:BP | GO:0002090 | regulation of receptor internalization | 40 | 43 | 8.85e-03 |
GO:BP | GO:0045321 | leukocyte activation | 410 | 530 | 8.87e-03 |
GO:BP | GO:0006813 | potassium ion transport | 113 | 135 | 9.08e-03 |
GO:BP | GO:0050870 | positive regulation of T cell activation | 113 | 135 | 9.08e-03 |
GO:BP | GO:0051051 | negative regulation of transport | 228 | 286 | 9.08e-03 |
GO:BP | GO:0042552 | myelination | 99 | 117 | 9.19e-03 |
GO:BP | GO:0014910 | regulation of smooth muscle cell migration | 49 | 54 | 9.22e-03 |
GO:BP | GO:0072078 | nephron tubule morphogenesis | 49 | 54 | 9.22e-03 |
GO:BP | GO:0042475 | odontogenesis of dentin-containing tooth | 49 | 54 | 9.22e-03 |
GO:BP | GO:0055074 | calcium ion homeostasis | 175 | 216 | 9.37e-03 |
GO:BP | GO:0030098 | lymphocyte differentiation | 200 | 249 | 9.41e-03 |
GO:BP | GO:0001659 | temperature homeostasis | 109 | 130 | 9.82e-03 |
GO:BP | GO:0009612 | response to mechanical stimulus | 126 | 152 | 9.82e-03 |
GO:BP | GO:0035270 | endocrine system development | 73 | 84 | 9.82e-03 |
GO:BP | GO:0034764 | positive regulation of transmembrane transport | 109 | 130 | 9.82e-03 |
GO:BP | GO:0048562 | embryonic organ morphogenesis | 149 | 182 | 9.82e-03 |
GO:BP | GO:0048546 | digestive tract morphogenesis | 29 | 30 | 9.82e-03 |
GO:BP | GO:0046850 | regulation of bone remodeling | 29 | 30 | 9.82e-03 |
GO:BP | GO:0021700 | developmental maturation | 165 | 203 | 9.84e-03 |
GO:BP | GO:1990845 | adaptive thermogenesis | 102 | 121 | 9.84e-03 |
GO:BP | GO:0009952 | anterior/posterior pattern specification | 102 | 121 | 9.84e-03 |
GO:BP | GO:0050867 | positive regulation of cell activation | 165 | 203 | 9.84e-03 |
GO:BP | GO:0007346 | regulation of mitotic cell cycle | 328 | 420 | 9.87e-03 |
GO:BP | GO:0009891 | positive regulation of biosynthetic process | 1376 | 1856 | 9.87e-03 |
GO:BP | GO:0048259 | regulation of receptor-mediated endocytosis | 69 | 79 | 1.00e-02 |
GO:BP | GO:0050680 | negative regulation of epithelial cell proliferation | 84 | 98 | 1.00e-02 |
GO:BP | GO:0030031 | cell projection assembly | 348 | 447 | 1.01e-02 |
GO:BP | GO:0042110 | T cell activation | 242 | 305 | 1.01e-02 |
GO:BP | GO:0048644 | muscle organ morphogenesis | 57 | 64 | 1.01e-02 |
GO:BP | GO:0010718 | positive regulation of epithelial to mesenchymal transition | 44 | 48 | 1.02e-02 |
GO:BP | GO:0014032 | neural crest cell development | 61 | 69 | 1.02e-02 |
GO:BP | GO:0001755 | neural crest cell migration | 44 | 48 | 1.02e-02 |
GO:BP | GO:0071396 | cellular response to lipid | 304 | 388 | 1.04e-02 |
GO:BP | GO:0060048 | cardiac muscle contraction | 98 | 116 | 1.05e-02 |
GO:BP | GO:0099173 | postsynapse organization | 122 | 147 | 1.05e-02 |
GO:BP | GO:0045598 | regulation of fat cell differentiation | 80 | 93 | 1.05e-02 |
GO:BP | GO:0033043 | regulation of organelle organization | 720 | 953 | 1.07e-02 |
GO:BP | GO:0032880 | regulation of protein localization | 528 | 691 | 1.08e-02 |
GO:BP | GO:0050730 | regulation of peptidyl-tyrosine phosphorylation | 115 | 138 | 1.09e-02 |
GO:BP | GO:0031641 | regulation of myelination | 34 | 36 | 1.10e-02 |
GO:BP | GO:0003203 | endocardial cushion morphogenesis | 34 | 36 | 1.10e-02 |
GO:BP | GO:0048608 | reproductive structure development | 164 | 202 | 1.10e-02 |
GO:BP | GO:0033036 | macromolecule localization | 1702 | 2309 | 1.10e-02 |
GO:BP | GO:0006874 | intracellular calcium ion homeostasis | 164 | 202 | 1.10e-02 |
GO:BP | GO:0003177 | pulmonary valve development | 22 | 22 | 1.11e-02 |
GO:BP | GO:0060045 | positive regulation of cardiac muscle cell proliferation | 22 | 22 | 1.11e-02 |
GO:BP | GO:0050921 | positive regulation of chemotaxis | 72 | 83 | 1.15e-02 |
GO:BP | GO:0050679 | positive regulation of epithelial cell proliferation | 118 | 142 | 1.15e-02 |
GO:BP | GO:0007611 | learning or memory | 154 | 189 | 1.16e-02 |
GO:BP | GO:0051235 | maintenance of location | 201 | 251 | 1.16e-02 |
GO:BP | GO:0006936 | muscle contraction | 204 | 255 | 1.17e-02 |
GO:BP | GO:0002028 | regulation of sodium ion transport | 52 | 58 | 1.18e-02 |
GO:BP | GO:0033138 | positive regulation of peptidyl-serine phosphorylation | 52 | 58 | 1.18e-02 |
GO:BP | GO:0021915 | neural tube development | 111 | 133 | 1.18e-02 |
GO:BP | GO:0045661 | regulation of myoblast differentiation | 52 | 58 | 1.18e-02 |
GO:BP | GO:0050865 | regulation of cell activation | 273 | 347 | 1.19e-02 |
GO:BP | GO:0002696 | positive regulation of leukocyte activation | 160 | 197 | 1.21e-02 |
GO:BP | GO:0120031 | plasma membrane bounded cell projection assembly | 340 | 437 | 1.21e-02 |
GO:BP | GO:0007492 | endoderm development | 56 | 63 | 1.21e-02 |
GO:BP | GO:0086001 | cardiac muscle cell action potential | 56 | 63 | 1.21e-02 |
GO:BP | GO:0032535 | regulation of cellular component size | 228 | 287 | 1.21e-02 |
GO:BP | GO:0010232 | vascular transport | 60 | 68 | 1.21e-02 |
GO:BP | GO:0019915 | lipid storage | 60 | 68 | 1.21e-02 |
GO:BP | GO:0043502 | regulation of muscle adaptation | 60 | 68 | 1.21e-02 |
GO:BP | GO:0150104 | transport across blood-brain barrier | 60 | 68 | 1.21e-02 |
GO:BP | GO:0071675 | regulation of mononuclear cell migration | 60 | 68 | 1.21e-02 |
GO:BP | GO:0150117 | positive regulation of cell-substrate junction organization | 28 | 29 | 1.24e-02 |
GO:BP | GO:0060563 | neuroepithelial cell differentiation | 28 | 29 | 1.24e-02 |
GO:BP | GO:1990776 | response to angiotensin | 28 | 29 | 1.24e-02 |
GO:BP | GO:0002067 | glandular epithelial cell differentiation | 43 | 47 | 1.24e-02 |
GO:BP | GO:0014743 | regulation of muscle hypertrophy | 43 | 47 | 1.24e-02 |
GO:BP | GO:0014015 | positive regulation of gliogenesis | 43 | 47 | 1.24e-02 |
GO:BP | GO:0045860 | positive regulation of protein kinase activity | 150 | 184 | 1.26e-02 |
GO:BP | GO:0070252 | actin-mediated cell contraction | 75 | 87 | 1.29e-02 |
GO:BP | GO:0008104 | protein localization | 1478 | 2000 | 1.34e-02 |
GO:BP | GO:0018193 | peptidyl-amino acid modification | 427 | 555 | 1.34e-02 |
GO:BP | GO:1905314 | semi-lunar valve development | 38 | 41 | 1.35e-02 |
GO:BP | GO:0022409 | positive regulation of cell-cell adhesion | 143 | 175 | 1.35e-02 |
GO:BP | GO:1905330 | regulation of morphogenesis of an epithelium | 38 | 41 | 1.35e-02 |
GO:BP | GO:0010171 | body morphogenesis | 38 | 41 | 1.35e-02 |
GO:BP | GO:0001936 | regulation of endothelial cell proliferation | 82 | 96 | 1.37e-02 |
GO:BP | GO:0070727 | cellular macromolecule localization | 1485 | 2010 | 1.38e-02 |
GO:BP | GO:0045444 | fat cell differentiation | 146 | 179 | 1.39e-02 |
GO:BP | GO:0001935 | endothelial cell proliferation | 96 | 114 | 1.40e-02 |
GO:BP | GO:0051090 | regulation of DNA-binding transcription factor activity | 193 | 241 | 1.40e-02 |
GO:BP | GO:0051492 | regulation of stress fiber assembly | 67 | 77 | 1.40e-02 |
GO:BP | GO:0050863 | regulation of T cell activation | 165 | 204 | 1.40e-02 |
GO:BP | GO:0051046 | regulation of secretion | 309 | 396 | 1.43e-02 |
GO:BP | GO:1904892 | regulation of receptor signaling pathway via STAT | 51 | 57 | 1.43e-02 |
GO:BP | GO:0055013 | cardiac muscle cell development | 63 | 72 | 1.43e-02 |
GO:BP | GO:0014812 | muscle cell migration | 63 | 72 | 1.43e-02 |
GO:BP | GO:0008589 | regulation of smoothened signaling pathway | 63 | 72 | 1.43e-02 |
GO:BP | GO:0032956 | regulation of actin cytoskeleton organization | 208 | 261 | 1.44e-02 |
GO:BP | GO:0060384 | innervation | 21 | 21 | 1.45e-02 |
GO:BP | GO:0042634 | regulation of hair cycle | 21 | 21 | 1.45e-02 |
GO:BP | GO:0007224 | smoothened signaling pathway | 99 | 118 | 1.50e-02 |
GO:BP | GO:0035019 | somatic stem cell population maintenance | 42 | 46 | 1.55e-02 |
GO:BP | GO:0072171 | mesonephric tubule morphogenesis | 42 | 46 | 1.55e-02 |
GO:BP | GO:0003197 | endocardial cushion development | 42 | 46 | 1.55e-02 |
GO:BP | GO:0010611 | regulation of cardiac muscle hypertrophy | 42 | 46 | 1.55e-02 |
GO:BP | GO:0032868 | response to insulin | 164 | 203 | 1.58e-02 |
GO:BP | GO:0016266 | O-glycan processing | 27 | 28 | 1.60e-02 |
GO:BP | GO:0048675 | axon extension | 81 | 95 | 1.60e-02 |
GO:BP | GO:0098739 | import across plasma membrane | 102 | 122 | 1.60e-02 |
GO:BP | GO:0010557 | positive regulation of macromolecule biosynthetic process | 1326 | 1791 | 1.60e-02 |
GO:BP | GO:0038127 | ERBB signaling pathway | 88 | 104 | 1.64e-02 |
GO:BP | GO:0072132 | mesenchyme morphogenesis | 46 | 51 | 1.68e-02 |
GO:BP | GO:0099003 | vesicle-mediated transport in synapse | 138 | 169 | 1.70e-02 |
GO:BP | GO:0048286 | lung alveolus development | 37 | 40 | 1.71e-02 |
GO:BP | GO:0002376 | immune system process | 1050 | 1410 | 1.72e-02 |
GO:BP | GO:0006954 | inflammatory response | 330 | 425 | 1.72e-02 |
GO:BP | GO:0006915 | apoptotic process | 1026 | 1377 | 1.74e-02 |
GO:BP | GO:0003229 | ventricular cardiac muscle tissue development | 50 | 56 | 1.75e-02 |
GO:BP | GO:0062013 | positive regulation of small molecule metabolic process | 84 | 99 | 1.77e-02 |
GO:BP | GO:0071230 | cellular response to amino acid stimulus | 58 | 66 | 1.77e-02 |
GO:BP | GO:0060415 | muscle tissue morphogenesis | 54 | 61 | 1.78e-02 |
GO:BP | GO:1903530 | regulation of secretion by cell | 286 | 366 | 1.81e-02 |
GO:BP | GO:0048640 | negative regulation of developmental growth | 73 | 85 | 1.82e-02 |
GO:BP | GO:0031667 | response to nutrient levels | 277 | 354 | 1.85e-02 |
GO:BP | GO:0051251 | positive regulation of lymphocyte activation | 150 | 185 | 1.87e-02 |
GO:BP | GO:0001704 | formation of primary germ layer | 80 | 94 | 1.90e-02 |
GO:BP | GO:0140747 | regulation of ncRNA transcription | 69 | 80 | 1.93e-02 |
GO:BP | GO:0060675 | ureteric bud morphogenesis | 41 | 45 | 1.94e-02 |
GO:BP | GO:0090183 | regulation of kidney development | 20 | 20 | 1.96e-02 |
GO:BP | GO:0002053 | positive regulation of mesenchymal cell proliferation | 20 | 20 | 1.96e-02 |
GO:BP | GO:0014070 | response to organic cyclic compound | 463 | 606 | 2.10e-02 |
GO:BP | GO:0090497 | mesenchymal cell migration | 45 | 50 | 2.10e-02 |
GO:BP | GO:0072210 | metanephric nephron development | 26 | 27 | 2.11e-02 |
GO:BP | GO:1904385 | cellular response to angiotensin | 26 | 27 | 2.11e-02 |
GO:BP | GO:0060416 | response to growth hormone | 26 | 27 | 2.11e-02 |
GO:BP | GO:1904646 | cellular response to amyloid-beta | 26 | 27 | 2.11e-02 |
GO:BP | GO:0055008 | cardiac muscle tissue morphogenesis | 49 | 55 | 2.16e-02 |
GO:BP | GO:0046578 | regulation of Ras protein signal transduction | 36 | 39 | 2.16e-02 |
GO:BP | GO:0021536 | diencephalon development | 36 | 39 | 2.16e-02 |
GO:BP | GO:0046425 | regulation of receptor signaling pathway via JAK-STAT | 49 | 55 | 2.16e-02 |
GO:BP | GO:0051983 | regulation of chromosome segregation | 100 | 120 | 2.17e-02 |
GO:BP | GO:0014909 | smooth muscle cell migration | 53 | 60 | 2.17e-02 |
GO:BP | GO:0051301 | cell division | 415 | 541 | 2.17e-02 |
GO:BP | GO:0046683 | response to organophosphorus | 79 | 93 | 2.24e-02 |
GO:BP | GO:0001508 | action potential | 86 | 102 | 2.26e-02 |
GO:BP | GO:0050801 | monoatomic ion homeostasis | 315 | 406 | 2.34e-02 |
GO:BP | GO:0009792 | embryo development ending in birth or egg hatching | 400 | 521 | 2.36e-02 |
GO:BP | GO:0007548 | sex differentiation | 145 | 179 | 2.36e-02 |
GO:BP | GO:0030217 | T cell differentiation | 148 | 183 | 2.41e-02 |
GO:BP | GO:0006638 | neutral lipid metabolic process | 75 | 88 | 2.41e-02 |
GO:BP | GO:0061387 | regulation of extent of cell growth | 75 | 88 | 2.41e-02 |
GO:BP | GO:1902903 | regulation of supramolecular fiber organization | 239 | 304 | 2.42e-02 |
GO:BP | GO:0031644 | regulation of nervous system process | 64 | 74 | 2.42e-02 |
GO:BP | GO:0051649 | establishment of localization in cell | 1161 | 1566 | 2.42e-02 |
GO:BP | GO:0014074 | response to purine-containing compound | 89 | 106 | 2.43e-02 |
GO:BP | GO:0008277 | regulation of G protein-coupled receptor signaling pathway | 82 | 97 | 2.44e-02 |
GO:BP | GO:0044772 | mitotic cell cycle phase transition | 297 | 382 | 2.48e-02 |
GO:BP | GO:0035264 | multicellular organism growth | 99 | 119 | 2.51e-02 |
GO:BP | GO:0035051 | cardiocyte differentiation | 109 | 132 | 2.51e-02 |
GO:BP | GO:0045685 | regulation of glial cell differentiation | 44 | 49 | 2.57e-02 |
GO:BP | GO:0046942 | carboxylic acid transport | 163 | 203 | 2.57e-02 |
GO:BP | GO:0090263 | positive regulation of canonical Wnt signaling pathway | 71 | 83 | 2.57e-02 |
GO:BP | GO:0086003 | cardiac muscle cell contraction | 56 | 64 | 2.60e-02 |
GO:BP | GO:0060740 | prostate gland epithelium morphogenesis | 19 | 19 | 2.62e-02 |
GO:BP | GO:0010878 | cholesterol storage | 19 | 19 | 2.62e-02 |
GO:BP | GO:0060512 | prostate gland morphogenesis | 19 | 19 | 2.62e-02 |
GO:BP | GO:0048566 | embryonic digestive tract development | 19 | 19 | 2.62e-02 |
GO:BP | GO:0071378 | cellular response to growth hormone stimulus | 19 | 19 | 2.62e-02 |
GO:BP | GO:0003184 | pulmonary valve morphogenesis | 19 | 19 | 2.62e-02 |
GO:BP | GO:2000027 | regulation of animal organ morphogenesis | 52 | 59 | 2.63e-02 |
GO:BP | GO:0046503 | glycerolipid catabolic process | 35 | 38 | 2.70e-02 |
GO:BP | GO:0045668 | negative regulation of osteoblast differentiation | 35 | 38 | 2.70e-02 |
GO:BP | GO:0002066 | columnar/cuboidal epithelial cell development | 35 | 38 | 2.70e-02 |
GO:BP | GO:0007200 | phospholipase C-activating G protein-coupled receptor signaling pathway | 35 | 38 | 2.70e-02 |
GO:BP | GO:0050773 | regulation of dendrite development | 67 | 78 | 2.71e-02 |
GO:BP | GO:0030510 | regulation of BMP signaling pathway | 67 | 78 | 2.71e-02 |
GO:BP | GO:0009991 | response to extracellular stimulus | 293 | 377 | 2.71e-02 |
GO:BP | GO:0010092 | specification of animal organ identity | 25 | 26 | 2.72e-02 |
GO:BP | GO:0000278 | mitotic cell cycle | 577 | 763 | 2.73e-02 |
GO:BP | GO:0070371 | ERK1 and ERK2 cascade | 156 | 194 | 2.80e-02 |
GO:BP | GO:0006639 | acylglycerol metabolic process | 74 | 87 | 2.81e-02 |
GO:BP | GO:0007613 | memory | 74 | 87 | 2.81e-02 |
GO:BP | GO:0043009 | chordate embryonic development | 389 | 507 | 2.83e-02 |
GO:BP | GO:0030501 | positive regulation of bone mineralization | 30 | 32 | 2.85e-02 |
GO:BP | GO:0071604 | transforming growth factor beta production | 30 | 32 | 2.85e-02 |
GO:BP | GO:0072583 | clathrin-dependent endocytosis | 39 | 43 | 3.00e-02 |
GO:BP | GO:0072659 | protein localization to plasma membrane | 189 | 238 | 3.02e-02 |
GO:BP | GO:0044784 | metaphase/anaphase transition of cell cycle | 77 | 91 | 3.08e-02 |
GO:BP | GO:0034767 | positive regulation of monoatomic ion transmembrane transport | 77 | 91 | 3.08e-02 |
GO:BP | GO:0006637 | acyl-CoA metabolic process | 55 | 63 | 3.11e-02 |
GO:BP | GO:0002688 | regulation of leukocyte chemotaxis | 55 | 63 | 3.11e-02 |
GO:BP | GO:0035383 | thioester metabolic process | 55 | 63 | 3.11e-02 |
GO:BP | GO:0002694 | regulation of leukocyte activation | 245 | 313 | 3.13e-02 |
GO:BP | GO:0051058 | negative regulation of small GTPase mediated signal transduction | 43 | 48 | 3.15e-02 |
GO:BP | GO:0008219 | cell death | 1056 | 1423 | 3.15e-02 |
GO:BP | GO:0022408 | negative regulation of cell-cell adhesion | 94 | 113 | 3.16e-02 |
GO:BP | GO:0008543 | fibroblast growth factor receptor signaling pathway | 51 | 58 | 3.17e-02 |
GO:BP | GO:0033674 | positive regulation of kinase activity | 158 | 197 | 3.17e-02 |
GO:BP | GO:0048844 | artery morphogenesis | 51 | 58 | 3.17e-02 |
GO:BP | GO:0012501 | programmed cell death | 1053 | 1419 | 3.20e-02 |
GO:BP | GO:0032526 | response to retinoic acid | 66 | 77 | 3.20e-02 |
GO:BP | GO:0033993 | response to lipid | 437 | 573 | 3.31e-02 |
GO:BP | GO:0099504 | synaptic vesicle cycle | 123 | 151 | 3.37e-02 |
GO:BP | GO:0003176 | aortic valve development | 34 | 37 | 3.39e-02 |
GO:BP | GO:0070169 | positive regulation of biomineral tissue development | 34 | 37 | 3.39e-02 |
GO:BP | GO:1902305 | regulation of sodium ion transmembrane transport | 34 | 37 | 3.39e-02 |
GO:BP | GO:0009611 | response to wounding | 296 | 382 | 3.43e-02 |
GO:BP | GO:0016049 | cell growth | 296 | 382 | 3.43e-02 |
GO:BP | GO:0045926 | negative regulation of growth | 148 | 184 | 3.44e-02 |
GO:BP | GO:1903169 | regulation of calcium ion transmembrane transport | 90 | 108 | 3.45e-02 |
GO:BP | GO:0035336 | long-chain fatty-acyl-CoA metabolic process | 18 | 18 | 3.49e-02 |
GO:BP | GO:0010743 | regulation of macrophage derived foam cell differentiation | 18 | 18 | 3.49e-02 |
GO:BP | GO:0071880 | adenylate cyclase-activating adrenergic receptor signaling pathway | 18 | 18 | 3.49e-02 |
GO:BP | GO:0060396 | growth hormone receptor signaling pathway | 18 | 18 | 3.49e-02 |
GO:BP | GO:0055080 | monoatomic cation homeostasis | 310 | 401 | 3.49e-02 |
GO:BP | GO:0006909 | phagocytosis | 113 | 138 | 3.49e-02 |
GO:BP | GO:1902905 | positive regulation of supramolecular fiber organization | 113 | 138 | 3.49e-02 |
GO:BP | GO:0035025 | positive regulation of Rho protein signal transduction | 24 | 25 | 3.50e-02 |
GO:BP | GO:0099171 | presynaptic modulation of chemical synaptic transmission | 24 | 25 | 3.50e-02 |
GO:BP | GO:0060351 | cartilage development involved in endochondral bone morphogenesis | 24 | 25 | 3.50e-02 |
GO:BP | GO:0007091 | metaphase/anaphase transition of mitotic cell cycle | 76 | 90 | 3.57e-02 |
GO:BP | GO:0015849 | organic acid transport | 163 | 204 | 3.57e-02 |
GO:BP | GO:0007219 | Notch signaling pathway | 116 | 142 | 3.58e-02 |
GO:BP | GO:1902904 | negative regulation of supramolecular fiber organization | 103 | 125 | 3.58e-02 |
GO:BP | GO:0071634 | regulation of transforming growth factor beta production | 29 | 31 | 3.59e-02 |
GO:BP | GO:0045687 | positive regulation of glial cell differentiation | 29 | 31 | 3.59e-02 |
GO:BP | GO:0030857 | negative regulation of epithelial cell differentiation | 29 | 31 | 3.59e-02 |
GO:BP | GO:1904645 | response to amyloid-beta | 29 | 31 | 3.59e-02 |
GO:BP | GO:0060688 | regulation of morphogenesis of a branching structure | 29 | 31 | 3.59e-02 |
GO:BP | GO:0106106 | cold-induced thermogenesis | 93 | 112 | 3.59e-02 |
GO:BP | GO:0019058 | viral life cycle | 184 | 232 | 3.64e-02 |
GO:BP | GO:0051591 | response to cAMP | 54 | 62 | 3.68e-02 |
GO:BP | GO:0070372 | regulation of ERK1 and ERK2 cascade | 141 | 175 | 3.71e-02 |
GO:BP | GO:0030705 | cytoskeleton-dependent intracellular transport | 144 | 179 | 3.77e-02 |
GO:BP | GO:0051899 | membrane depolarization | 50 | 57 | 3.78e-02 |
GO:BP | GO:0097009 | energy homeostasis | 50 | 57 | 3.78e-02 |
GO:BP | GO:0032147 | activation of protein kinase activity | 50 | 57 | 3.78e-02 |
GO:BP | GO:0033555 | multicellular organismal response to stress | 50 | 57 | 3.78e-02 |
GO:BP | GO:0009953 | dorsal/ventral pattern formation | 42 | 47 | 3.79e-02 |
GO:BP | GO:0051653 | spindle localization | 46 | 52 | 3.82e-02 |
GO:BP | GO:0001708 | cell fate specification | 46 | 52 | 3.82e-02 |
GO:BP | GO:0048863 | stem cell differentiation | 153 | 191 | 3.87e-02 |
GO:BP | GO:0006629 | lipid metabolic process | 692 | 923 | 3.92e-02 |
GO:BP | GO:0033045 | regulation of sister chromatid segregation | 82 | 98 | 4.09e-02 |
GO:BP | GO:0120161 | regulation of cold-induced thermogenesis | 92 | 111 | 4.16e-02 |
GO:BP | GO:0048813 | dendrite morphogenesis | 92 | 111 | 4.16e-02 |
GO:BP | GO:0010876 | lipid localization | 233 | 298 | 4.16e-02 |
GO:BP | GO:0051495 | positive regulation of cytoskeleton organization | 118 | 145 | 4.17e-02 |
GO:BP | GO:0038179 | neurotrophin signaling pathway | 33 | 36 | 4.19e-02 |
GO:BP | GO:0044272 | sulfur compound biosynthetic process | 105 | 128 | 4.24e-02 |
GO:BP | GO:1903708 | positive regulation of hemopoiesis | 95 | 115 | 4.35e-02 |
GO:BP | GO:1902107 | positive regulation of leukocyte differentiation | 95 | 115 | 4.35e-02 |
GO:BP | GO:0046649 | lymphocyte activation | 341 | 444 | 4.38e-02 |
GO:BP | GO:0035567 | non-canonical Wnt signaling pathway | 53 | 61 | 4.43e-02 |
GO:BP | GO:0099072 | regulation of postsynaptic membrane neurotransmitter receptor levels | 53 | 61 | 4.43e-02 |
GO:BP | GO:0042303 | molting cycle | 64 | 75 | 4.44e-02 |
GO:BP | GO:0042633 | hair cycle | 64 | 75 | 4.44e-02 |
GO:BP | GO:0045453 | bone resorption | 37 | 41 | 4.48e-02 |
GO:BP | GO:0048872 | homeostasis of number of cells | 176 | 222 | 4.48e-02 |
GO:BP | GO:0021952 | central nervous system projection neuron axonogenesis | 23 | 24 | 4.48e-02 |
GO:BP | GO:0022029 | telencephalon cell migration | 37 | 41 | 4.48e-02 |
GO:BP | GO:0010812 | negative regulation of cell-substrate adhesion | 37 | 41 | 4.48e-02 |
GO:BP | GO:0003272 | endocardial cushion formation | 23 | 24 | 4.48e-02 |
GO:BP | GO:0051894 | positive regulation of focal adhesion assembly | 23 | 24 | 4.48e-02 |
GO:BP | GO:0061383 | trabecula morphogenesis | 37 | 41 | 4.48e-02 |
GO:BP | GO:0043491 | phosphatidylinositol 3-kinase/protein kinase B signal transduction | 170 | 214 | 4.48e-02 |
GO:BP | GO:0045124 | regulation of bone resorption | 23 | 24 | 4.48e-02 |
GO:BP | GO:0051146 | striated muscle cell differentiation | 185 | 234 | 4.48e-02 |
GO:BP | GO:2000737 | negative regulation of stem cell differentiation | 23 | 24 | 4.48e-02 |
GO:BP | GO:0050919 | negative chemotaxis | 37 | 41 | 4.48e-02 |
GO:BP | GO:0002431 | Fc receptor mediated stimulatory signaling pathway | 23 | 24 | 4.48e-02 |
GO:BP | GO:0046661 | male sex differentiation | 88 | 106 | 4.50e-02 |
GO:BP | GO:0001937 | negative regulation of endothelial cell proliferation | 28 | 30 | 4.50e-02 |
GO:BP | GO:0060914 | heart formation | 28 | 30 | 4.50e-02 |
GO:BP | GO:0001974 | blood vessel remodeling | 28 | 30 | 4.50e-02 |
GO:BP | GO:0060323 | head morphogenesis | 28 | 30 | 4.50e-02 |
GO:BP | GO:1901990 | regulation of mitotic cell cycle phase transition | 229 | 293 | 4.51e-02 |
GO:BP | GO:0016032 | viral process | 255 | 328 | 4.53e-02 |
GO:BP | GO:0034505 | tooth mineralization | 17 | 17 | 4.53e-02 |
GO:BP | GO:0009065 | glutamine family amino acid catabolic process | 17 | 17 | 4.53e-02 |
GO:BP | GO:0003215 | cardiac right ventricle morphogenesis | 17 | 17 | 4.53e-02 |
GO:BP | GO:0032528 | microvillus organization | 17 | 17 | 4.53e-02 |
GO:BP | GO:0060977 | coronary vasculature morphogenesis | 17 | 17 | 4.53e-02 |
GO:BP | GO:0050771 | negative regulation of axonogenesis | 45 | 51 | 4.57e-02 |
GO:BP | GO:0006865 | amino acid transport | 81 | 97 | 4.64e-02 |
GO:BP | GO:0006470 | protein dephosphorylation | 142 | 177 | 4.64e-02 |
GO:BP | GO:0070482 | response to oxygen levels | 208 | 265 | 4.71e-02 |
GO:BP | GO:0006869 | lipid transport | 205 | 261 | 4.73e-02 |
GO:BP | GO:0051494 | negative regulation of cytoskeleton organization | 104 | 127 | 4.74e-02 |
GO:BP | GO:0008593 | regulation of Notch signaling pathway | 67 | 79 | 4.76e-02 |
GO:BP | GO:0035303 | regulation of dephosphorylation | 67 | 79 | 4.76e-02 |
GO:BP | GO:0002573 | myeloid leukocyte differentiation | 123 | 152 | 4.81e-02 |
GO:BP | GO:0006887 | exocytosis | 187 | 237 | 4.84e-02 |
GO:BP | GO:0001942 | hair follicle development | 56 | 65 | 4.93e-02 |
LRnomtable %>%
filter(source=="KEGG", p_value < 0.05) %>%
mutate_at(.vars = 6, .funs = scientific_format()) %>%
kable(., caption = "KEGG terms found in LR neargenes") %>%
kable_paper("striped", full_width = FALSE) %>%
kable_styling(
full_width = FALSE,
position = "left",
bootstrap_options = c("striped", "hover")
) %>%
scroll_box(width = "100%", height = "400px")
source | term_id | term_name | intersection_size | term_size | p_value |
---|---|---|---|---|---|
KEGG | KEGG:05200 | Pathways in cancer | 328 | 391 | 3.55e-07 |
KEGG | KEGG:04360 | Axon guidance | 137 | 155 | 2.59e-05 |
KEGG | KEGG:05205 | Proteoglycans in cancer | 142 | 162 | 3.40e-05 |
KEGG | KEGG:04971 | Gastric acid secretion | 50 | 51 | 4.56e-05 |
KEGG | KEGG:04310 | Wnt signaling pathway | 118 | 133 | 4.79e-05 |
KEGG | KEGG:04024 | cAMP signaling pathway | 129 | 147 | 5.16e-05 |
KEGG | KEGG:04510 | Focal adhesion | 146 | 169 | 7.29e-05 |
KEGG | KEGG:04015 | Rap1 signaling pathway | 140 | 162 | 8.94e-05 |
KEGG | KEGG:04970 | Salivary secretion | 52 | 54 | 8.94e-05 |
KEGG | KEGG:04014 | Ras signaling pathway | 141 | 164 | 1.28e-04 |
KEGG | KEGG:04520 | Adherens junction | 76 | 83 | 1.28e-04 |
KEGG | KEGG:04022 | cGMP-PKG signaling pathway | 113 | 129 | 1.52e-04 |
KEGG | KEGG:04550 | Signaling pathways regulating pluripotency of stem cells | 90 | 101 | 2.61e-04 |
KEGG | KEGG:04611 | Platelet activation | 79 | 88 | 4.18e-04 |
KEGG | KEGG:04020 | Calcium signaling pathway | 137 | 161 | 4.18e-04 |
KEGG | KEGG:04810 | Regulation of actin cytoskeleton | 143 | 169 | 4.86e-04 |
KEGG | KEGG:05163 | Human cytomegalovirus infection | 135 | 160 | 9.35e-04 |
KEGG | KEGG:04928 | Parathyroid hormone synthesis, secretion and action | 70 | 78 | 9.35e-04 |
KEGG | KEGG:04924 | Renin secretion | 47 | 50 | 9.35e-04 |
KEGG | KEGG:04911 | Insulin secretion | 57 | 62 | 9.35e-04 |
KEGG | KEGG:05146 | Amoebiasis | 57 | 62 | 9.35e-04 |
KEGG | KEGG:04512 | ECM-receptor interaction | 60 | 66 | 1.17e-03 |
KEGG | KEGG:04270 | Vascular smooth muscle contraction | 81 | 92 | 1.17e-03 |
KEGG | KEGG:04010 | MAPK signaling pathway | 189 | 231 | 1.24e-03 |
KEGG | KEGG:04925 | Aldosterone synthesis and secretion | 67 | 75 | 1.55e-03 |
KEGG | KEGG:04916 | Melanogenesis | 67 | 75 | 1.55e-03 |
KEGG | KEGG:04918 | Thyroid hormone synthesis | 49 | 53 | 1.59e-03 |
KEGG | KEGG:04927 | Cortisol synthesis and secretion | 43 | 46 | 2.09e-03 |
KEGG | KEGG:04972 | Pancreatic secretion | 52 | 57 | 2.29e-03 |
KEGG | KEGG:04151 | PI3K-Akt signaling pathway | 202 | 250 | 2.43e-03 |
KEGG | KEGG:04148 | Efferocytosis | 102 | 120 | 2.50e-03 |
KEGG | KEGG:04933 | AGE-RAGE signaling pathway in diabetic complications | 76 | 87 | 2.50e-03 |
KEGG | KEGG:04390 | Hippo signaling pathway | 109 | 129 | 2.50e-03 |
KEGG | KEGG:04974 | Protein digestion and absorption | 51 | 56 | 2.53e-03 |
KEGG | KEGG:04261 | Adrenergic signaling in cardiomyocytes | 105 | 124 | 2.57e-03 |
KEGG | KEGG:05165 | Human papillomavirus infection | 202 | 252 | 4.72e-03 |
KEGG | KEGG:04728 | Dopaminergic synapse | 83 | 97 | 5.30e-03 |
KEGG | KEGG:04713 | Circadian entrainment | 60 | 68 | 5.44e-03 |
KEGG | KEGG:04976 | Bile secretion | 38 | 41 | 6.05e-03 |
KEGG | KEGG:04750 | Inflammatory mediator regulation of TRP channels | 63 | 72 | 6.33e-03 |
KEGG | KEGG:05412 | Arrhythmogenic right ventricular cardiomyopathy | 59 | 67 | 6.33e-03 |
KEGG | KEGG:04926 | Relaxin signaling pathway | 85 | 100 | 6.37e-03 |
KEGG | KEGG:04961 | Endocrine and other factor-regulated calcium reabsorption | 37 | 40 | 7.11e-03 |
KEGG | KEGG:04350 | TGF-beta signaling pathway | 77 | 90 | 7.11e-03 |
KEGG | KEGG:05417 | Lipid and atherosclerosis | 118 | 143 | 7.35e-03 |
KEGG | KEGG:04658 | Th1 and Th2 cell differentiation | 45 | 50 | 8.33e-03 |
KEGG | KEGG:04072 | Phospholipase D signaling pathway | 90 | 107 | 8.33e-03 |
KEGG | KEGG:04730 | Long-term depression | 36 | 39 | 8.49e-03 |
KEGG | KEGG:04630 | JAK-STAT signaling pathway | 71 | 83 | 1.00e-02 |
KEGG | KEGG:04340 | Hedgehog signaling pathway | 44 | 49 | 1.00e-02 |
KEGG | KEGG:04935 | Growth hormone synthesis, secretion and action | 81 | 96 | 1.09e-02 |
KEGG | KEGG:04919 | Thyroid hormone signaling pathway | 88 | 105 | 1.09e-02 |
KEGG | KEGG:05418 | Fluid shear stress and atherosclerosis | 91 | 109 | 1.13e-02 |
KEGG | KEGG:05414 | Dilated cardiomyopathy | 70 | 82 | 1.13e-02 |
KEGG | KEGG:05167 | Kaposi sarcoma-associated herpesvirus infection | 110 | 134 | 1.28e-02 |
KEGG | KEGG:04915 | Estrogen signaling pathway | 76 | 90 | 1.34e-02 |
KEGG | KEGG:04670 | Leukocyte transendothelial migration | 65 | 76 | 1.41e-02 |
KEGG | KEGG:05135 | Yersinia infection | 89 | 107 | 1.46e-02 |
KEGG | KEGG:05207 | Chemical carcinogenesis - receptor activation | 108 | 132 | 1.63e-02 |
KEGG | KEGG:04659 | Th17 cell differentiation | 52 | 60 | 2.00e-02 |
KEGG | KEGG:04514 | Cell adhesion molecules | 59 | 69 | 2.11e-02 |
KEGG | KEGG:04921 | Oxytocin signaling pathway | 93 | 113 | 2.12e-02 |
KEGG | KEGG:04371 | Apelin signaling pathway | 86 | 104 | 2.23e-02 |
KEGG | KEGG:04725 | Cholinergic synapse | 69 | 82 | 2.25e-02 |
KEGG | KEGG:04071 | Sphingolipid signaling pathway | 85 | 103 | 2.51e-02 |
KEGG | KEGG:00000 | KEGG root term | 3931 | 5451 | 2.51e-02 |
KEGG | KEGG:05210 | Colorectal cancer | 68 | 81 | 2.57e-02 |
KEGG | KEGG:04726 | Serotonergic synapse | 50 | 58 | 2.69e-02 |
KEGG | KEGG:04660 | T cell receptor signaling pathway | 70 | 84 | 3.20e-02 |
KEGG | KEGG:00512 | Mucin type O-glycan biosynthesis | 20 | 21 | 3.56e-02 |
KEGG | KEGG:03320 | PPAR signaling pathway | 41 | 47 | 3.59e-02 |
KEGG | KEGG:04625 | C-type lectin receptor signaling pathway | 62 | 74 | 3.77e-02 |
KEGG | KEGG:04724 | Glutamatergic synapse | 62 | 74 | 3.77e-02 |
KEGG | KEGG:05170 | Human immunodeficiency virus 1 infection | 119 | 149 | 3.95e-02 |
KEGG | KEGG:04720 | Long-term potentiation | 44 | 51 | 3.96e-02 |
KEGG | KEGG:05206 | MicroRNAs in cancer | 115 | 144 | 4.31e-02 |
KEGG | KEGG:04923 | Regulation of lipolysis in adipocytes | 36 | 41 | 4.31e-02 |
KEGG | KEGG:04742 | Taste transduction | 19 | 20 | 4.32e-02 |
KEGG | KEGG:05410 | Hypertrophic cardiomyopathy | 64 | 77 | 4.43e-02 |
KEGG | KEGG:04934 | Cushing syndrome | 96 | 119 | 4.45e-02 |
KEGG | KEGG:05130 | Pathogenic Escherichia coli infection | 114 | 143 | 4.67e-02 |
KEGG | KEGG:01521 | EGFR tyrosine kinase inhibitor resistance | 60 | 72 | 4.78e-02 |
KEGG | KEGG:05032 | Morphine addiction | 46 | 54 | 4.96e-02 |
# NR_resgenes <- gost(query = NR_NG_list$ENTREZID,
# organism = "hsapiens",
# significant = FALSE,
# ordered_query = FALSE,
# domain_scope = "custom",
# measure_underrepresentation = FALSE,
# evcodes = FALSE,
# user_threshold = 0.05,
# correction_method = c("fdr"),
# custom_bg = background_df$ENTREZID,
# sources=c("GO:BP","KEGG"))
# saveRDS(NR_resgenes,"data/GO_KEGG_analysis/NR_resgenes.RDS")
NRnom <- gostplot(NR_resgenes, capped = FALSE, interactive = TRUE)
# NRnom
NRnomtable <- NR_resgenes$result %>%
dplyr::select(c(source, term_id,
term_name,intersection_size,
term_size, p_value))# %>%
NRnomtable %>%
filter(source=="GO:BP", p_value < 0.05) %>%
mutate_at(.vars = 6, .funs = scientific_format()) %>%
kable(.,caption = "GO:BP terms found in NR neargenes" ) %>%
kable_paper("striped", full_width = FALSE) %>%
kable_styling(
full_width = FALSE,
position = "left",
bootstrap_options = c("striped", "hover")
) %>%
scroll_box(width = "100%", height = "400px")
source | term_id | term_name | intersection_size | term_size | p_value |
---|---|---|---|---|---|
GO:BP | GO:0007275 | multicellular organism development | 3082 | 3170 | 4.30e-05 |
GO:BP | GO:0032501 | multicellular organismal process | 4362 | 4504 | 4.30e-05 |
GO:BP | GO:0048523 | negative regulation of cellular process | 3446 | 3550 | 4.40e-05 |
GO:BP | GO:0051716 | cellular response to stimulus | 4491 | 4640 | 4.44e-05 |
GO:BP | GO:0007010 | cytoskeleton organization | 1127 | 1146 | 7.38e-05 |
GO:BP | GO:0048731 | system development | 2645 | 2719 | 7.49e-05 |
GO:BP | GO:0048856 | anatomical structure development | 3748 | 3867 | 7.49e-05 |
GO:BP | GO:0050896 | response to stimulus | 5196 | 5379 | 8.02e-05 |
GO:BP | GO:0050794 | regulation of cellular process | 6888 | 7153 | 2.38e-04 |
GO:BP | GO:0065007 | biological regulation | 7441 | 7734 | 3.22e-04 |
GO:BP | GO:0007154 | cell communication | 3855 | 3983 | 3.67e-04 |
GO:BP | GO:0048519 | negative regulation of biological process | 3645 | 3764 | 3.67e-04 |
GO:BP | GO:0009653 | anatomical structure morphogenesis | 1799 | 1844 | 3.67e-04 |
GO:BP | GO:0050789 | regulation of biological process | 7232 | 7516 | 3.99e-04 |
GO:BP | GO:0023052 | signaling | 3792 | 3918 | 4.48e-04 |
GO:BP | GO:0032502 | developmental process | 4042 | 4179 | 4.62e-04 |
GO:BP | GO:0008150 | biological_process | 10770 | 11244 | 6.46e-04 |
GO:BP | GO:0051128 | regulation of cellular component organization | 1815 | 1862 | 6.81e-04 |
GO:BP | GO:0071495 | cellular response to endogenous stimulus | 1016 | 1035 | 6.93e-04 |
GO:BP | GO:0050793 | regulation of developmental process | 1655 | 1697 | 1.16e-03 |
GO:BP | GO:0007165 | signal transduction | 3495 | 3611 | 1.16e-03 |
GO:BP | GO:0023051 | regulation of signaling | 2368 | 2438 | 1.48e-03 |
GO:BP | GO:0048583 | regulation of response to stimulus | 2636 | 2717 | 1.58e-03 |
GO:BP | GO:0009966 | regulation of signal transduction | 2106 | 2166 | 1.65e-03 |
GO:BP | GO:0007399 | nervous system development | 1729 | 1775 | 2.13e-03 |
GO:BP | GO:0016477 | cell migration | 991 | 1011 | 2.73e-03 |
GO:BP | GO:0022008 | neurogenesis | 1223 | 1251 | 2.76e-03 |
GO:BP | GO:0022603 | regulation of anatomical structure morphogenesis | 601 | 609 | 2.83e-03 |
GO:BP | GO:0000902 | cell morphogenesis | 702 | 713 | 2.92e-03 |
GO:BP | GO:0010646 | regulation of cell communication | 2372 | 2444 | 2.95e-03 |
GO:BP | GO:0030029 | actin filament-based process | 631 | 640 | 3.04e-03 |
GO:BP | GO:0048518 | positive regulation of biological process | 4153 | 4301 | 3.42e-03 |
GO:BP | GO:0009888 | tissue development | 1316 | 1348 | 3.77e-03 |
GO:BP | GO:0048522 | positive regulation of cellular process | 3820 | 3954 | 4.19e-03 |
GO:BP | GO:0048699 | generation of neurons | 1053 | 1076 | 4.37e-03 |
GO:BP | GO:0007155 | cell adhesion | 922 | 941 | 6.18e-03 |
GO:BP | GO:0048646 | anatomical structure formation involved in morphogenesis | 821 | 837 | 8.05e-03 |
GO:BP | GO:0009719 | response to endogenous stimulus | 1169 | 1197 | 8.05e-03 |
GO:BP | GO:0016043 | cellular component organization | 4630 | 4802 | 8.05e-03 |
GO:BP | GO:0009987 | cellular process | 10236 | 10686 | 8.78e-03 |
GO:BP | GO:0030036 | actin cytoskeleton organization | 558 | 566 | 8.78e-03 |
GO:BP | GO:0030182 | neuron differentiation | 992 | 1014 | 8.85e-03 |
GO:BP | GO:0048513 | animal organ development | 1946 | 2004 | 1.02e-02 |
GO:BP | GO:0065008 | regulation of biological quality | 1839 | 1893 | 1.13e-02 |
GO:BP | GO:0035295 | tube development | 772 | 787 | 1.14e-02 |
GO:BP | GO:0048870 | cell motility | 1094 | 1120 | 1.14e-02 |
GO:BP | GO:0048869 | cellular developmental process | 2714 | 2804 | 1.27e-02 |
GO:BP | GO:0030154 | cell differentiation | 2713 | 2803 | 1.27e-02 |
GO:BP | GO:0007267 | cell-cell signaling | 1057 | 1082 | 1.32e-02 |
GO:BP | GO:0007015 | actin filament organization | 354 | 357 | 1.44e-02 |
GO:BP | GO:0051239 | regulation of multicellular organismal process | 1868 | 1924 | 1.54e-02 |
GO:BP | GO:0032956 | regulation of actin cytoskeleton organization | 260 | 261 | 1.76e-02 |
GO:BP | GO:0048468 | cell development | 1831 | 1886 | 1.89e-02 |
GO:BP | GO:0031589 | cell-substrate adhesion | 257 | 258 | 1.90e-02 |
GO:BP | GO:1901700 | response to oxygen-containing compound | 1067 | 1093 | 1.90e-02 |
GO:BP | GO:0097435 | supramolecular fiber organization | 622 | 633 | 2.02e-02 |
GO:BP | GO:0032970 | regulation of actin filament-based process | 298 | 300 | 2.24e-02 |
GO:BP | GO:0035556 | intracellular signal transduction | 1893 | 1951 | 2.27e-02 |
GO:BP | GO:0032989 | cellular anatomical entity morphogenesis | 578 | 588 | 2.81e-02 |
GO:BP | GO:0071840 | cellular component organization or biogenesis | 4802 | 4988 | 4.57e-02 |
GO:BP | GO:0023056 | positive regulation of signaling | 1189 | 1221 | 4.59e-02 |
GO:BP | GO:0006996 | organelle organization | 2721 | 2815 | 4.63e-02 |
GO:BP | GO:0010647 | positive regulation of cell communication | 1186 | 1218 | 4.77e-02 |
NRnomtable %>%
filter(source=="KEGG", p_value < 0.05) %>%
mutate_at(.vars = 6, .funs = scientific_format()) %>%
kable(., caption = "KEGG terms found in NR neargenes") %>%
kable_paper("striped", full_width = FALSE) %>%
kable_styling(
full_width = FALSE,
position = "left",
bootstrap_options = c("striped", "hover")
) %>%
scroll_box(width = "100%", height = "400px")
source | term_id | term_name | intersection_size | term_size | p_value |
---|---|---|---|---|---|
NA | NA | NA | NA | NA | NA |
:—— | :——- | :——— | —————–: | ———: | :——- |
sessionInfo()
R version 4.3.1 (2023-06-16 ucrt)
Platform: x86_64-w64-mingw32/x64 (64-bit)
Running under: Windows 10 x64 (build 19045)
Matrix products: default
locale:
[1] LC_COLLATE=English_United States.utf8
[2] LC_CTYPE=English_United States.utf8
[3] LC_MONETARY=English_United States.utf8
[4] LC_NUMERIC=C
[5] LC_TIME=English_United States.utf8
time zone: America/Chicago
tzcode source: internal
attached base packages:
[1] grid stats4 stats graphics grDevices utils datasets
[8] methods base
other attached packages:
[1] biomaRt_2.58.2
[2] ggpubr_0.6.0
[3] BiocParallel_1.36.0
[4] scales_1.3.0
[5] VennDiagram_1.7.3
[6] futile.logger_1.4.3
[7] gridExtra_2.3
[8] ggfortify_0.4.17
[9] edgeR_4.0.16
[10] limma_3.58.1
[11] rtracklayer_1.62.0
[12] org.Hs.eg.db_3.18.0
[13] TxDb.Hsapiens.UCSC.hg38.knownGene_3.18.0
[14] GenomicFeatures_1.54.4
[15] AnnotationDbi_1.64.1
[16] Biobase_2.62.0
[17] GenomicRanges_1.54.1
[18] GenomeInfoDb_1.38.8
[19] IRanges_2.36.0
[20] S4Vectors_0.40.2
[21] BiocGenerics_0.48.1
[22] ChIPseeker_1.38.0
[23] gprofiler2_0.2.3
[24] RColorBrewer_1.1-3
[25] broom_1.0.5
[26] kableExtra_1.4.0
[27] lubridate_1.9.3
[28] forcats_1.0.0
[29] stringr_1.5.1
[30] dplyr_1.1.4
[31] purrr_1.0.2
[32] readr_2.1.5
[33] tidyr_1.3.1
[34] tibble_3.2.1
[35] ggplot2_3.5.1
[36] tidyverse_2.0.0
[37] workflowr_1.7.1
loaded via a namespace (and not attached):
[1] fs_1.6.4
[2] matrixStats_1.3.0
[3] bitops_1.0-7
[4] enrichplot_1.22.0
[5] HDO.db_0.99.1
[6] httr_1.4.7
[7] tools_4.3.1
[8] backports_1.4.1
[9] utf8_1.2.4
[10] R6_2.5.1
[11] lazyeval_0.2.2
[12] withr_3.0.0
[13] prettyunits_1.2.0
[14] cli_3.6.2
[15] formatR_1.14
[16] scatterpie_0.2.2
[17] labeling_0.4.3
[18] sass_0.4.9
[19] Rsamtools_2.18.0
[20] systemfonts_1.0.6
[21] yulab.utils_0.1.4
[22] DOSE_3.28.2
[23] svglite_2.1.3
[24] plotrix_3.8-4
[25] rstudioapi_0.16.0
[26] RSQLite_2.3.6
[27] generics_0.1.3
[28] gridGraphics_0.5-1
[29] TxDb.Hsapiens.UCSC.hg19.knownGene_3.2.2
[30] BiocIO_1.12.0
[31] crosstalk_1.2.1
[32] vroom_1.6.5
[33] gtools_3.9.5
[34] car_3.1-2
[35] GO.db_3.18.0
[36] Matrix_1.6-5
[37] fansi_1.0.6
[38] abind_1.4-5
[39] lifecycle_1.0.4
[40] whisker_0.4.1
[41] yaml_2.3.8
[42] carData_3.0-5
[43] SummarizedExperiment_1.32.0
[44] gplots_3.1.3.1
[45] qvalue_2.34.0
[46] SparseArray_1.2.4
[47] BiocFileCache_2.10.2
[48] blob_1.2.4
[49] promises_1.3.0
[50] crayon_1.5.2
[51] lattice_0.22-6
[52] cowplot_1.1.3
[53] KEGGREST_1.42.0
[54] pillar_1.9.0
[55] knitr_1.46
[56] fgsea_1.28.0
[57] rjson_0.2.21
[58] boot_1.3-30
[59] codetools_0.2-20
[60] fastmatch_1.1-4
[61] glue_1.7.0
[62] getPass_0.2-4
[63] ggfun_0.1.4
[64] data.table_1.15.4
[65] vctrs_0.6.5
[66] png_0.1-8
[67] treeio_1.26.0
[68] gtable_0.3.5
[69] cachem_1.0.8
[70] xfun_0.43
[71] S4Arrays_1.2.1
[72] mime_0.12
[73] tidygraph_1.3.1
[74] statmod_1.5.0
[75] interactiveDisplayBase_1.40.0
[76] nlme_3.1-164
[77] ggtree_3.10.1
[78] bit64_4.0.5
[79] progress_1.2.3
[80] filelock_1.0.3
[81] rprojroot_2.0.4
[82] bslib_0.7.0
[83] KernSmooth_2.23-22
[84] colorspace_2.1-0
[85] DBI_1.2.2
[86] tidyselect_1.2.1
[87] processx_3.8.4
[88] bit_4.0.5
[89] compiler_4.3.1
[90] curl_5.2.1
[91] git2r_0.33.0
[92] xml2_1.3.6
[93] DelayedArray_0.28.0
[94] plotly_4.10.4
[95] shadowtext_0.1.3
[96] caTools_1.18.2
[97] callr_3.7.6
[98] rappdirs_0.3.3
[99] digest_0.6.35
[100] rmarkdown_2.26
[101] XVector_0.42.0
[102] htmltools_0.5.8.1
[103] pkgconfig_2.0.3
[104] MatrixGenerics_1.14.0
[105] highr_0.10
[106] dbplyr_2.5.0
[107] fastmap_1.1.1
[108] rlang_1.1.3
[109] htmlwidgets_1.6.4
[110] shiny_1.8.1.1
[111] farver_2.1.1
[112] jquerylib_0.1.4
[113] jsonlite_1.8.8
[114] GOSemSim_2.28.1
[115] RCurl_1.98-1.14
[116] magrittr_2.0.3
[117] GenomeInfoDbData_1.2.11
[118] ggplotify_0.1.2
[119] patchwork_1.2.0
[120] munsell_0.5.1
[121] Rcpp_1.0.12
[122] ape_5.8
[123] viridis_0.6.5
[124] stringi_1.8.3
[125] ggraph_2.2.1
[126] zlibbioc_1.48.2
[127] MASS_7.3-60.0.1
[128] AnnotationHub_3.10.1
[129] plyr_1.8.9
[130] parallel_4.3.1
[131] ggrepel_0.9.5
[132] Biostrings_2.70.3
[133] graphlayouts_1.1.1
[134] splines_4.3.1
[135] hms_1.1.3
[136] locfit_1.5-9.9
[137] ps_1.7.6
[138] igraph_2.0.3
[139] ggsignif_0.6.4
[140] reshape2_1.4.4
[141] futile.options_1.0.1
[142] BiocVersion_3.18.1
[143] XML_3.99-0.16.1
[144] evaluate_0.23
[145] lambda.r_1.2.4
[146] BiocManager_1.30.22
[147] tzdb_0.4.0
[148] tweenr_2.0.3
[149] httpuv_1.6.15
[150] polyclip_1.10-6
[151] ggforce_0.4.2
[152] xtable_1.8-4
[153] restfulr_0.0.15
[154] tidytree_0.4.6
[155] rstatix_0.7.2
[156] later_1.3.2
[157] viridisLite_0.4.2
[158] aplot_0.2.2
[159] memoise_2.0.1
[160] GenomicAlignments_1.38.2
[161] timechange_0.3.0